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Abstract 
 
Epithelial tissues coat our body surfaces and act as a strong mechanical barrier against external 
stresses like pathogens and chemicals. They are robust tissues made up of polarised epithelial cells 
that are strongly adhered to one another. However, during development, these tissues behave like a 
‘fluid’ and undergo extensive rearrangement. This mechanical robustness and fluidity is conferred 
to them by the specialized adhesive structures called zonula adherens (ZA). It is an E-cadherin 
based adhesion-complex, which acts like a Velcro, thus stitching epithelial cells together. 
Remarkably, ZA also regulates proper co-ordination of adhesion, cytoskeleton and mechanical 
tension in response to the developmental cues, thus ensuring the cohesive behaviour of epithelial 
tissues during morphogenetic events. To achieve this multi-step process of epithelial homeostasis, 
ZA acts as an anchorage site for the convergence of many signalling pathways; most important of 
them are being modulated by Rho GTPases. Rho GTPases are powerful molecular switches, whose 
spatio-temporal activity needs to be finely balanced by GEFs, GAPs and GDIs. Various studies 
have established an undisputed contribution of Rho GTPases in ZA biogenesis and functions, but 
the mechanistic details have been missing. Also, a great deal of knowledge is lacking about the 
upstream elements, which are required to produce an active Rho at the ZA. This study aims to 
identify the molecules and mechanisms underlying the regulation and functions of junctional Rho 
signalling. 
 
I initiated the study by aiming for a deeper understanding of how Rho GTPase produces a 
functional ZA. I have proposed that ECT2, earlier believed to be cytokinetic Rho-GEF, mediates 
Rho functions at the ZA. ECT2 depletion led to gross disruption of ZA architecture, with significant 
loss of E-cadherin from junctions. Further, ECT2 KD did not affect steady-state junctional actin 
content but perturbed the junctional localization of myosin IIA, thus establishing myosin IIA as a 
downstream effector of Rho-ECT2 pathway. Indeed, the disrupted cadherin phenotype was restored 
in ECT2 KD cells by driving the expression of Myosin IIA. Also, using laser nanoscissors, I found 
that ECT2-Rho-Myosin II signalling pathway regulates junctional tension. Depletion of ECT2, 
Myosin IIA or pharmacological inhibition of Rho led to reduction in the cortical tension, thus 
suggesting that these molecules act in concert to maintain this functional property of the ZA. Next, 
to understand the impact of ECT2-Rho pathway on the dynamic properties of E-Cadherin, I 
performed FRAP on GFP-E-cadherin. Using this tool, I have demonstrated that ZA is composed of 
two dynamically distinct pools of E-cadherin. The apical pool posses a lesser mobile fraction and 
thus is more stabilized and restricted, while the sub-apical pool has a larger mobile fraction. This 
differential stabilization of the pools was abolished when the ECT2-Rho pathway was perturbed, 
 III 
thus establishing an important role of ECT2-Rho signalling in stabilizing cadherin at the apical zone 
of the cells. Taken together, these findings identify ECT2 as a major upstream regulator of 
junctional Rho signalling, which is vital for ZA organization and functions. Also, using genetic 
ablation and reconstitution approaches, I have demonstrated that the interaction between cadherin 
and Rho GTPase is reciprocal and indeed E-cadherin is required for junctional Rho localization and 
activity by anchoring the upstream Rho activators; ECT2 and centralspindlin complex.  
 
The other aspect of this study involved the unravelling of a novel signalling network that ensures to 
produce a robust and spatially restricted GTP-Rho zone at the ZA.  Using a combination of 
pharmacological and genetic manipulations along with activity/location based Rho biosensors; I 
have uncovered that this signalling cascade involves an unexpected feedback loop from myosin 
IIA-ROCK to Rho. Myosin IIA is essential for Rho signalling at the ZA by specifically blocking the 
action of the GAP; p190B. Depletion or inhibition of myosin II led to the increased cortical 
localization of the p190B and decreased Rho activity accompanied by the broadening of the ZA 
Rho zone. Interestingly, this cross-talk between myosin IIA and p190B GAP is mediated by another 
small GTPase Rnd3, as depletion of Rnd3 compromised the junctional enrichment of p190B GAP. 
Further, I have illustrated a role for ROCK-1 in this pathway, as inhibiting ROCK-1 mediated 
phosphorylation of Rnd3 promotes its junctional association and a concomitant increase in p190B 
GAP localization, thus depleting junctional Rho. Also, I discovered that myosin IIA directly 
influences this whole cascade by acting as a scaffold for ROCK-1 via its rod-domain. Myosin IIA 
could support junctional ROCK-1 localization, independent of its actin-binding capacity and motor 
functions. Finally, using numerical simulations, we modeled this signaling architecture and 
observed that the junctional Rho signaling exhibits ‘bistability’ and toggles between Rho-ON to 
Rho-OFF states. Strikingly, addition of the myosin to ROCK loop turns the switch to ON, thus 
further corroborating with our experimental findings. In summary, our results identify a novel 
regulatory pathway, orchestrated by myosin IIA, which is essential for the sustenance of the 
spatially restricted GTP-Rho zone at the ZA.  
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Chapter 1: General Introduction and Literature Review 
 
 
1.1 Cell-cell adhesion 
 
Epithelial tissues line our body surfaces and protect the exteriors and interiors of our body 
(Fristrom, 1988; Schock and Perrimon, 2002). Epithelial cohesion requires them to be connected to 
each other via various macromolecular complexes, defined as intercellular junctions. There are 
mainly three kinds of intercellular junctions in vertebrates: tight junctions, adherens junctions and 
desmosomes. These intercellular adhesion complexes are crucial for the biogenesis, maintenance 
and function of epithelia (Schock and Perrimon, 2002). 
 
Tight junctions are located in the most apical region and serve to prevent the diffusion of small 
molecules and ions through the space between cells (Matter and Balda, 2007). They also maintain 
cell polarity by acting as a fence, which bars the mixing of apical and baso-lateral membrane 
components (Hartsock and Nelson, 2008). Desmosomes are spot-like adhesions arranged on the 
lateral surface of cells. They tether intermediate filaments at membrane-associated plaques, thus 
forming a three-dimensional scaffold, which provides the tissue with mechanical rigidity and 
resistance (Delva et al., 2009). 
 
Adherens junctions are cadherin-based adhesive structures, which perform an array of functions, 
including the initiation and stabilization of cell-cell adhesion, regulating actin cytoskeleton and 
intracellular signaling, to name a few (Niessen et al., 2011). Ultrastructurally, adherens junction can 
be identified as a plasma membrane structure composed of dense plaque on opposing membranes, 
which holds two membranes together (Meng and Takeichi, 2009). They are the first to get 
assembled at the initial sites of cell-cell contact and precede the formation of other junctional 
complexes (desmosomes and tight junctions). Stable adhesion mediated by adherens junctions 
brings the membranes of adjacent cells in close proximity, thus allowing the formation of other 
junctions. Also, it ensures proper targeting of junctional constituents on the membrane by providing 
spatial cues and triggers signaling events that are required for the assembly of desmosomes and 
tight junctions (Benjamin and Nelson, 2008; Braga, 2002). 
 
The Zonula Adherens (ZA) is an important feature of epithelial morphology (Braga, 2000). It is the 
apical-most part of these cadherin-based adherens junctions characterized by the presence of a 
circumferential actomyosin belt and a ring of E-cadherin.  It provides strong adhesive strength that 
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prevents tissues from dissociating into individual cells. However, it is also a dynamic entity that 
facilitates the organizational changes that take place during the various stages of morphogenesis, 
which give rise to the various shapes and appearances of different organs of the body (Gumbiner, 
2005). It is therefore important to understand the underlying mechanisms behind regulation of this 
adhesive structure. Over the years, various studies have been done to address the issue of how the 
ZA modulates, and is modulated by, various signaling pathways. Although this question is not fully 
unravelled yet, it has built up a complex yet intriguing picture of signaling molecules that are active 
at the ZA; Rho GTPase is one of them. In this study, I aim to expand our basic understanding of the 
interplay between E-cadherin adhesion, the actomyosin apparatus and RhoA signaling. 
 
1.2 Molecular architecture of Zonula Adherens 
 
Cadherins and catenins constitute the major components of the Zonula Adherens (Fig 1.1) (Harris 
and Tepass, 2010). The classical cadherins belong to a 
large superfamily of cell-cell adhesion molecules, which 
show various expression patterns and support calcium-
dependent adhesion (Niessen et al., 2011). They are 
transmembrane glycoproteins, classified based on the 
tissues in which they are expressed. For example, E-
cadherin is expressed in epithelia and N-cadherin is 
widely expressed in the nervous system. E-cadherin is one 
of most studied of the classical cadherins (Overduin et al., 
1995).  
 
Figure 1.1 Schematic representing molecular architecture of the 
Zonula Adherens. Lateral dimer of E-cadherin traverses the 
membrane and engages in homophilic ligation with the opposing 
dimer. The cytoplasmic tail binds to α, β and p120-catenin and 
also associates with the actomyosin cytoskeleton. 
 
Along the intercellular interface within epithelia, E-
cadherin organizes itself into two distinct pools: apical; 
which is the concentrated zone of E-cadherin at the ZA and lateral; which consists of small clusters 
and puncta of E-cadherin throughout lateral axis of the cell-cell contact (Fig 1.2) (Kametani and 
Takeichi, 2007; Wu et al., 2014). These two pools of cadherin differ in terms of morphology, 
stability and also generate different levels of contractile tension (Priya et al., 2013; Wu et al., 2014). 
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Figure 1.2 E-cadherin organization in MCF-7 epithelial cells.  At the apical zone of the cell, E-cadherin forms a 
tight belt like structure, referred to as ZA. This appears like a linear peri-junctional staining in the fixed MCF-7 
epithelial cells (a). The lateral surface of the cell is decorated by small clusters of E-cadherin, as evident in the en 
face contacts (b) 
 
The extracellular domain of E-cadherin engages in homophilic binding with the extracellular 
domain of E-cadherin present on the opposing cell (Fig 1.1). It is a ‘rod’ like structure consisting of 
five cadherin repeats and calcium binding sites. The cytoplasmic domains are highly conserved 
among classical cadherins as they mediate binding with cytoplasmic molecules called catenins. 
Catenins are often considered as molecular sensors that integrate cell-cell junctions and 
cytoskeleton dynamics with various signaling pathways. The catenin family comprises p120-
catenin, β-catenin and α-catenin (Fig 1.1). Some of the important functions mediated by these 
catenins include regulation of Rho GTPases by p120-catenin (Perez-Moreno and Fuchs, 2006), 
modulating actin dynamics by α-catenin (Drees et al., 2005), and stabilization of the unstructured 
cytoplasmic domain of E-cadherin by β-catenin (Huber et al., 2001; Benjamin and Nelson, 2008). 
1.3 Zonula Adherens is an active site of Rho GTPase signaling 
 
Cadherin-based junctions have significant impacts on various cellular processes like embryogenesis 
and tissue homeostasis. They are not merely passive adhesion molecules; instead they actively 
participate in dynamic morphogenetic events like tissue segregation, gastrulation and 
synaptogenesis (Halbleib and Nelson, 2006; Harris and Tepass, 2010; Schock and Perrimon, 2002).  
The fact that the ZA contributes to all these multi-faceted processes suggests that it can contribute 
beyond its canonical adhesive function. Indeed, it is increasingly becoming apparent that cadherins 
can initiate a number of cellular and molecular events by the productive ligation of two cadherin 
receptors on opposing cells and thus act as signaling receptors (McCormack et al., 2013; Niessen et 
al., 2011; Ratheesh et al., 2013; Wheelock and Johnson, 2003; Yap and Kovacs, 2003) 
 
The field of cadherin-signaling biology has been dominated by the three best-characterized 
members of the Rho GTPase family: RhoA, Rac1 and Cdc42 (Braga and Yap, 2005; Fukata and 
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Kaibuchi, 2001; Ratheesh et al., 2013). The first insight into the functional relationship between 
cadherins and small GTPases came with the observation that small GTPases (mainly Rho and Rac) 
localize to cadherin-based junctions (Braga et al., 1997; Braga et al., 2000). These small GTPases 
are important for junctional integrity and support junctional biogenesis by regulating the assembly 
and dynamics of the cellular cytoskeleton and/or by initiating certain signaling events required to 
maintain the epithelial phenotype (Braga, 2002; Fukata and Kaibuchi, 2001; Kovacs et al., 2002a; 
Niessen et al., 2011; Ratheesh et al., 2012; Ratheesh et al., 2013; Terry et al., 2011). In turn, 
cadherins can modulate the activity and localization of these small GTPases at junctions 
(McCormack et al., 2013; Priya et al., 2013), thereby suggesting that functional co-operation 
between them is reciprocal. 
 
Using a recombinant functional E-cadherin ligand consisting of the full ectodomain of E-cadherin 
fused to the Fc region of IgG, Kovacs et al reported that Rac gets recruited and activated at newly 
formed cadherin-adhesive sites (Kovacs et al., 2002a). This early activation of Rac was important 
for contact maturation via the actin cytoskeleton, because when Rac was inhibited this process was 
compromised (Kovacs et al., 2002a). E-cadherin facilitates contact formation by recruiting the Arp 
2/3 complex (an actin nucleator which relies on Rac for its activation) to nascent adhesive sites 
during initiation of junction formation. So cadherin-mediated homophilic adhesion leads to 
recruitment of Rac and Arp 2/3 complex at nascent adhesive sites, which leads to actin assembly 
and contact-zone extension (Kovacs et al., 2002b). Further, binding to p120 catenin was essential 
for E-cadherin to activate Rac1 (Goodwin et al., 2003). Also, by manipulating extracellular calcium 
levels to initiate the formation of cell-cell contacts (often referred as “calcium-switch assay”), Braga 
and colleagues have reported that E-cadherin clustering activates Rac1 in keratinocytes (Betson et 
al., 2002).  
 
Another small GTPase required for cadherin homeostasis is Rho; however the impact of cadherin 
signaling on Rho activity is still not very conclusive. Using the calcium switch assay, Noren et al 
showed that upon E-cadherin ligation Rac1 gets activated, but the activity of Rho is diminished 
(Noren et al., 2001). Further they demonstrated that this cadherin-mediated inhibition of Rho occurs 
by activation of a GAP called p190RhoGAP (Noren et al., 2003). It is also believed that Rac and 
Rho occupy different contact zones during junction formation (Yamada and Nelson, 2007). As cells 
first make contact, Rac takes the center stage along with Arp2/3 and is later replaced by Rho 
(Yamada and Nelson, 2007) The other interesting candidate thought to regulate Rho at junctions is 
p120-catenin. Overexpression studies in fibroblasts showed that p120-catenin could mimic the 
phenotype induced by Rho inhibition. It sequesters Rho in the cytoplasm in a GDP-bound state, 
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thus further inhibiting it (Anastasiadis et al., 2000). Interestingly, Rac can also induce translocation 
of p190 Rho GAP to adherens junction, where it gets coupled with p120 (Wildenberg et al., 2006). 
Here, p120 acts as a platform to bring the GAP and its substrate Rho together and thus inhibit Rho 
(Wildenberg et al., 2006).  
 
In the light of the above observations, one can appreciate that cadherin based junctions act as an 
active site for Rho GTPase signaling. These small GTPases have far-ranging impacts on cellular 
morphogenetic processes like wound healing, epithelial-mesenchymal transition and maintaining 
epithelial polarity (Van Aelst and Symons, 2002). So, the understanding of their precise regulation 
and effects is important not only for the basic biology but also for the better understanding of 
diseases. 
 
1.4 Rho GTPases 
 
Rho GTPases belong to the Ras superfamily and are 
molecular switches that cycle between two 
conformational states: a GTP-bound state which is 
'active' and a GDP-bound state which is 'inactive' 
(Etienne-Manneville and Hall, 2002). Regulation of 
Rho GTPase occurs through a GDP–GTP cycle that is 
controlled by the opposing activities of guanine 
nucleotide-exchange factors (GEFs), which catalyze 
the exchange of GDP for GTP, and GTPase-
activating proteins (GAPs), which increase the rate of GTP hydrolysis to GDP.  
 
Fig 1.3 Regulation of the Rho GTPase cycle. The cycling between the ON and OFF state is facilitated by GEFs 
(promote the exchange of GDP to GTP), GAPs (catalyse GTP hydrolysis to GDP) and GDIs (sequester the GDP-
bound Rho in cytoplasm). 
 
Another layer of regulation is provided by Rho–GDP-dissociation inhibitors (RHOGDIs), which 
sequester Rho away from the GDP–GTP cycle (Fig 1.3). 
 
Rho, Rac and Cdc42 are the prominent members of this family and are believed to be the crucial 
regulators behind many cellular processes like polarity, cell migration, microtubule dynamics and 
transcription (Etienne-Manneville and Hall, 2002).  
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The Rho sub-family of small GTPases includes three proteins: RhoA, RhoB and RhoC. They are 
very similar in sequence and when overexpressed lead to the formation of stress fibers and 
contribute to contractility (Wheeler and Ridley, 2004). All these three isoforms share a sequence 
homology of around 85%. The c-terminus is the most divergent domain and determines their 
intracellular localization (Wheeler and Ridley, 2004). All the three isoforms get post-translationally 
modified at their c-terminus with the addition of a prenyl group at a conserved cysteine residue. 
This prenyl group anchors Rho GTPase to the membrane and is important for its stabilization 
(Wheeler and Ridley, 2004). The length of the prenyl group differs in the three isoforms, which 
leads to their differential localization, with RhoB localizing mainly to endosomes and lysosomes 
while RhoA and RhoC localize to the plasma membrane and cytosol (Wheeler and Ridley, 2004). 
These three isoforms also show differences in their function. For example, RhoB mainly inhibits 
growth, as opposed to RhoA and RhoC, and they can also bind to different effectors and regulators 
(Burridge and Wennerberg, 2004). 
 
Recently, there is a growing interest in the atypical members of the Rho family: Rnd1, Rnd2 and 
Rnd3 (Nobes et al., 1998; Riento et al., 2005b; Riou et al., 2013; Wennerberg et al., 2003). These 
are atypical in the sense that they don’t undergo the canonical GTP-GDP cycle, being deficient in 
the amino-acid residues required for GTPase activity. Thus they are always GTP-loaded and 
potentially constitutively active (Chardin, 2006). Their regulatory mechanisms involve gene-
expression, protein degradation, post-translation modification (e.g. phosphorylation) and sub-
cellular localization (Chardin, 2006; Riento et al., 2005b). Like other members of Rho family, they 
are also post-translationally modified at their c-terminus by farnesylation, thus enabling their 
membrane association (Chardin, 2006). Rnd1 and Rnd3 show prominent plasma membrane 
localization while Rnd2 is usually found in early endosomes (Chardin, 2006). Also, Rnd1 and Rnd3 
(but not Rnd2) can antagonize Rho activity primarily by promoting the GAP activity of p190-B 
RhoGAP (Oinuma et al., 2012; Riou et al., 2013; Wennerberg et al., 2003). Overexpression of these 
proteins leads to loss of focal adhesions, disrupts stress fibers and causes rounding of cells 
(Chardin, 2006) 
1.5 Rho GTPase effectors at the ZA (ROCK and Myosin II) 
 
The Rho GTPases regulate a variety of basic cellular processes like organization of acto-myosin 
cytoskeleton, gene transcription, trafficking and polarity. The ability of Rho to carry out these 
functions depends on its effectors (Bishop and Hall, 2000). A large number of Rho effectors have 
been identified to-date, including various kinases, phosphatases, scaffolding proteins and lipases. 
These effectors prefer GTP-bound Rho and show high specificity and selectivity for Rho family 
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members; i.e. a particular effector will only bind to a particular GTPase (Bustelo et al., 2007). 
Mutational analysis has revealed the presence of highly conserved GTPase binding domains (GBD) 
in these effectors, which provide the specificity (Bishop and Hall, 2000). Although these Rho-
effectors are highly diverse structurally, their activation by the GTPase involves certain similar 
mechanisms. So, upon binding, a GTPase can translocate the effector to the signaling-zone, anchors 
it to the membrane and/or induces a conformational change that activates the effector (Bustelo et 
al., 2007). Interestingly, once activated, these effectors can also modulate Rho GTPase signaling by 
regulating GEFs, GAPs or GDIs, thus implying the presence of extensive feed-back loops in 
GTPase signaling pathways (Ivetic and Ridley, 2004; Kitzing et al., 2007).  
1.5.1 ROCK 
 
One of the earliest identified Rho effectors were the ROCKs (Rho-dependent kinases).  They 
belong to the family of Ser/Thr protein kinases and two isoforms have been identified in 
mammalian cells: ROCK-1 and ROCK-2 (Amano et al., 2010; Julian and Olson, 2014; Riento and 
Ridley, 2003). Broadly, these kinases have an N-terminal kinase domain, followed by a coiled-coil 
domain and the c-terminus region. The kinase domain of both isoforms is highly conserved at the 
amino-acid level (92% identity), while overall they share 62% identity. The c-terminus comprises 
both a Rho-binding domain (RBD) and a PH domain. In the absence of GTP-Rho, ROCK exists in 
an autoinhibited conformation: binding between the C-terminal region and the N-terminal kinase 
domain inhibits ROCK activity. Binding of GTP-Rho to the RBD then releases this auto-inhibitory 
conformation to activate the kinase (Amano et al., 2010; Riento and Ridley, 2003; Schofield and 
Bernard, 2013) (Fig1.4).  
 
Since the kinase domain is highly conserved between these two isoforms, it has often been thought 
that these isoforms phosphorylate common substrates. Nonetheless, they differ in their expression, 
subcellular localization, functions and interactions (Amano et al., 2010; Schofield and Bernard, 
2013). 
ROCK-1 is highly transcribed in kidney, liver, spleen and lung, while ROCK-2 shows higher 
expression in brain and heart (Schofield and Bernard, 2013). The C-terminal PH domain mediates 
the subcellular localization of these kinases. ROCK-2 has been shown to localize in cytoplasm, at 
the plasma membrane and at cleavage furrow during cytokinesis (Schofield and Bernard, 2013). 
ROCK-1 localization is not well studied, however recent studies have shown that ROCK-1 can 
specifically concentrate at the apical junctions of the cells by associating with junctional protein 
shroom-3 (Nishimura and Takeichi, 2008) or p120-catenin (Smith et al., 2012). 
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Fig 1.4 Activation of ROCK via GTP-Rho. The pleckstrin homology (PH) domain and the Rho-binding domain 
(RBD) associate with the amino-terminal region of the protein and form an auto inhibitory loop. Binding of 
GTP-Rho to the RBD domain opens up the conformation, leading to activation of ROCK. 
 
ROCK-1, but not ROCK-2, has been proven to bind RhoE/Rnd3 (Riento et al., 2005a) and p120-
catenin (Smith et al., 2012), while MYPT1 (myosin phosphatase target subunit 1) interacts with 
ROCK-2 only (Wang et al., 2009). Further, genetic ablation studies have revealed that these two 
kinases have different functions, with ROCK-2 regulating cell-contraction and phagocytosis while 
ROCK-1 is essential for stress-fiber formation (Schofield and Bernard, 2013).   
 
ROCK proteins can phosphorylate a number of substrates, which are capable of 
modifying/organizing the actomyosin cytoskeleton inside the cells. Both of these isoforms modulate 
a plethora of signaling events by phosphorylating substrates such as RLC (regulatory light chain of 
myosin), MLCP (myosin light-chain phosphatase), LIM kinase 1 and 2 and profilin, to name but a 
few (Riento and Ridley, 2003). 
 
Non-muscle myosin (NMII) is one of the principal substrates of ROCK at the ZA (Shewan et al., 
2005) (discussed in detail further). Downstream of Rho, ROCK promotes the activation of NMII, 
which further supports cadherin clustering and stabilization, thus acting as a principal effector of the 
Rho-ROCK pathway at cadherin junctions (Fig 1.5) (Shewan et al., 2005). Phosphorylation of the 
regulatory light chain (RLC) of myosin stimulates its ATPase activity and this relies on the subtle 
balance between kinases (ROCK, MLCK) and phosphatases (MLCP; myosin light chain 
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phosphatase) (Julian and Olson, 2014; Schofield and Bernard, 2013). MLCK is a calcium dependent 
enzyme, known to phosphorylate Ser 19 of RLC; however in vitro studies have reported that ROCK 
can also phosphorylate the same site independent of calcium (Amano et al., 1996; Totsukawa et al., 
2000). In contrast to MLKC, ROCK can also phosphorylate the Myosin binding subunit (MBS) of 
MLCP at various Ser/Thr sites, which limits its activity and thus keeps NMII activated by 
increasing net RLC phosphorylation (Kawano et al., 1999; Kimura et al., 1996). Indeed MLCP 
inhibition may the dominant pathway via which ROCK can activate Myosin.  
 
Fig 1.5 Rho effectors at the ZA: Myosin II 
and ROCK. Upon activation by Rho, 
ROCK activates Myosin by two means: 
phosphorylation of the regulatory myosin 
light chain (MLC) and MLC phosphatases 
(MLCP). The active myosin then further 
mediates cadherin clustering and 
stabilization. 
 
1.5.2 Non-muscle Myosin II 
Non-muscle Myosin II (NMII) 
belongs to a superfamily of motor 
proteins and is responsible for 
generation of contractile forces and 
tension by catalysing ATP hydrolysis 
and translocation of actin filaments 
(Conti and Adelstein, 2008; Heissler 
and Manstein, 2013). There are three 
mammalian paralogs of Myosin II, which are encoded by separate genes: these are Myosin IIA, 
Myosin IIB and Myosin IIC. These paralogs are 64-78% identical at the amino-acid level. NMII is a 
large hexamer, consisting of a homodimer of heavy chains, which non-covalently associates with 
two pairs of light chains (Fig 1.6). The first ~ 800 amino acids of the heavy chain forms the 
catalytic head or motor domain. This domain harbors the actin-binding ATPase site and is the most 
conserved domain of heavy chain between different myosins. The next ~60 amino acids constitute 
the neck region, which contains binding sites for the ELC (Essential light chain) and the RLC 
(Regulatory light chain). This is followed by a ~1100 amino-acid rod domain, which is much-less 
well conserved between different isoforms (Conti and Adelstein, 2008; Heissler and Manstein, 
2013; Vicente-Manzanares et al., 2009) (Fig 1.6). 
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Although all the three NMII paralogs are known to perform mainly two similar functions that is 
ATP-dependent contraction of actin filaments and filament assembly; there is enough evidence 
suggesting these isoforms are not simply redundant. Indeed they exhibit distinct motor activity, 
cellular and tissue distribution, molecular interactions, upstream signaling regulators and functions 
(Betapudi, 2010; Sandquist and Means, 2008; Smutny et al., 2010; Wang et al., 2009). Using gene-
knockout technology in mice, it has been shown that NMIIA and NMIIB null mice have strikingly 
different developmental defects. While NMIA null mice embryos die early in development because 
 
 
 
 
 
 
 
Fig 1.6 Myosin IIA domain structure and functions: The head domain binds to actin and is responsible for its 
motor activity and contractile functions. The Rod domain mediates filament-assembly and is speculated to have 
regulatory roles by acting as a scaffold (Reproduced and Modified from Kopp et al, Kidney International, 2010) 
 of gross perturbation of cadherin-dependent junctions and tissue organization (Conti et al., 2004), 
the NMIIB null mice die just after the birth due to major developmental defects in heart and 
neurons (Conti and Adelstein, 2008). In cell-biological studies, these two isoforms have been 
shown to perform unique functions in cell motility, adhesion and wound healing (Betapudi, 2010; 
Sandquist and Means, 2008; Smutny et al., 2010). Interestingly, the C-terminal rod domain of NMII 
has been speculated to contribute towards these differences, which is not surprising considering that 
the rod domains of these isoforms are highly divergent (Sandquist and Means, 2008). Using 
chimeric NMII constructs, Sandquist et al have shown that the rod domain of NMII overcomes its 
motor functions and is the prime determinant of its subcellular distribution (Sandquist and Means, 
2008). The C-terminal rod fragment of NMII has been established to harbor isoform-specific 
regulatory elements; for example both isoforms are known to get phosphorylated within the rod 
domain via different kinases at distinct sites (Dulyaninova et al., 2007; Rosenberg and Ravid, 
2006). Also, the coiled-coil region in the rod domain of NMIIA shows a specific interaction with 
S100A4, which is a small calcium-binding protein known to influence filament assembly and cell 
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motility (Li and Bresnick, 2006). Strikingly, during cell division, it has been shown that the rod 
domain of NMIIA alone is sufficient to localize to the furrow, thus raising the possibility that 
myosin can participate in cellular functions by mechanisms that are independent of its motor-
activity or actin binding (Beach and Egelhoff, 2009). Indeed, the fact that the rod domain can 
localize to the cortex suggest that the NMII has yet to be identified binding partners and functions. 
Although myosins are best known for their capacity to generate contractile force, recent studies 
have indicated that Myosin can also act as a scaffolding protein for various signaling elements like 
kinases, GEFs or GAPs (Conti and Adelstein, 2008). Lee et al established that Dbl family of GEFs 
can bind to NMII via their highly conserved PH domain. This interaction was found to depend on 
NMII activity and is required to suppress the activity of these GEFs (Lee et al., 2010). Similarly, 
another GEF; MyoGEF has been proven to regulate cytokinesis by directly binding Myosin II and 
co-localizing with it during cleavage furrow (Wu et al., 2006). These observations hint towards a 
relatively unexplored signaling function of NMII, which is an exciting question for future studies. 
1.6 Rho GTPases supports cadherin mediated adhesion 
 
Cell-cell adhesions undergo constant rearrangement during a diverse range of physiological 
processes such as cell scattering, wound healing and also tumour metastasis (Fukata and Kaibuchi, 
2001). Rho GTPases are important for this process as they regulate both junctional biogenesis (from 
nascent contact formation to maturation) and junctional dynamics (Braga et al., 2000). 
 
Braga and colleagues first reported that treating cells with a Rho inhibitor or injecting them with a 
dominant negative Rac inhibited the accumulation of cadherin at sites of cell-cell contact (Braga et 
al., 1997). The importance of Rac in maintaining cadherin-dependent adhesion was further 
supported by Takaishi and colleagues, showing that overexpression of constitutive active Rac 
mutants led to accumulation of E-cadherin and actin filaments at sites of cell-cell contact (Takaishi 
et al., 1997). Rac GTPases can support adhesion by modulating the actin cytoskeleton through 
activation of various actin nucleators like Arp2/3 and WAVE (Niessen et al., 2011).The other RAC 
effector that has been reported at the ZA is IQGAP1 (Fukata and Kaibuchi, 2001). IQGAP1 
localized to the ZA and negatively regulated adhesion by interacting with β-catenin, which caused 
α-catenin to dissociate from the cadherin-catenin complex. Rac inhibits the interaction between 
IQGAP1 and β-catenin, and thus positively regulates cadherin-based adhesion (Fukata and 
Kaibuchi, 2001). 
Cdc42 has been shown to positively regulate cadherin based junctions (Fukata and Kaibuchi, 2001) 
but compared to Rho and Rac, its contribution is less well studied (Braga et al., 2000). 
 18 
 
Rho GTPases (mostly RhoA) are essential for maintaining the stability of cadherin-based junctions. 
It has been established that when Rho signaling is compromised via various means, it leads to the 
perturbation of cadherin-based junctions (Braga, 2000; Braga et al., 1997; Priya et al., 2013; 
Ratheesh et al., 2012; Ratheesh and Yap, 2012; Shewan et al., 2005; Smith et al., 2012; Takaishi et 
al., 1997). Rho signaling can contribute to adherens junction integrity by stabilizing cadherin 
receptors, cytoskeleton organization, generation of tension and possibly by facilitating E-cadherin 
clustering (Braga et al., 2000; Priya et al., 2013; Ratheesh et al., 2012; Ratheesh et al., 2013; 
Shewan et al., 2005; Smutny et al., 2010; Smutny et al., 2011) . 
 
Myosin II acts downstream of Rho to positively promote cadherin function. When treated with 
drugs (ML-7 and blebbistatin) that can inhibit Myosin II activity, cells could not concentrate E-
cadherin at apical junctions (Shewan et al., 2005). The recruitment and activity of Myosin II at 
junctions responded to the Rho pathway as inhibition of Rho kinase signaling not only led to the 
loss of Myosin II from junctions but also abolished its activity as suggested by the loss of MLC 
phosphorylation and decreased junctional staining of ppMLC (Shewan et al., 2005). Moreover, the 
phenotype observed after Rho kinase inhibition was very similar to that of Myosin inhibition, 
namely, inability to concentrate E-cadherin in junctions and reduced adhesion to cadherin-coated 
substrata. These observations placed Myosin II as a potent downstream effector that allows Rho to 
modulate the ZA (Shewan et al., 2005). 
 
Further, Smutny et al proposed that the two isoforms of Myosin II, IIA and IIB make distinct 
contributions to adherens junction function and assembly (Smutny et al., 2010). Both isoforms 
localized to junctions, but they responded to different upstream regulators. While junctional 
localization of Myosin IIA was dependent on the Rho/ROCK pathway, Myosin IIB was recruited to 
junctions in response to Rap1 (Smutny et al., 2010). Using a knockdown approach they showed that 
Myosin IIA supports cadherin clustering, cadherin concentration and proper adhesion at junctions, 
while Myosin IIB is responsible for maintaining a continuous distribution of E-cadherin along the 
junctions and also regulates normal levels of ZA-associated F-actin (Smutny et al., 2010). 
 
The above observations support a Rho-Myosin IIA-E-cadherin pathway required for the integrity of 
the ZA. However, to perform its biological functions, Rho must undergo a regulated 
activation/inactivation cycle facilitated by GEFs and GAPs. The spatio-temporal activity of these 
regulatory molecules decides the site and timing of Rho signaling.  
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1.7 Regulators of Rho GTPases; GEFs, GAPs and GDIs 
 
The nucleotide status of Rho is controlled by three sets of regulatory proteins: GEFs (guanine 
nucleotide exchange factors), which promote the exchange of GDP to GTP; GDIs (guanine 
nucleotide dissociation inhibitors), which sequester Rho in its GDP-bound state and GAPs (GTPase 
activating proteins), which accelerate the process of GTP hydrolysis. The activity and localization 
of these proteins ensure specificity of Rho signaling inside a cell (Etienne-Manneville and Hall, 
2002). 
 
GEFs are multidomain proteins that facilitate the release of GDP from Rho and promote the binding 
of GTP, thus activating Rho. In biological processes, activation of the small GTPases occurs within 
minutes or even less than that. GEFs can accelerate this process of nucleotide exchange activity by 
several folds (Bos et al., 2007). Inside cells, the concentration of GTP is usually ten times higher 
then GDP.  GEF favors the binding of GTP to GTPase by modifying the nucleotide-binding site of 
GTPase, such that GDP is released and replaced by GTP (Bos et al., 2007). 
 
Rho GDIs belong to a group of regulatory proteins that are capable of binding GDP bound inactive 
Rho and blocking nucleotide dissociation. In this capacity, they act as negative regulators of Rho by 
blocking GEF mediated exchange activity and maintaining it in a GDP-bound inactive form. They 
also act to extract inactive Rho from the membrane and sequester it in the cytoplasm (Kaibuchi et 
al., 1999) 
 
GAPs, like GEFs, are multidomain proteins, and many of these domains are lipid or protein 
interaction domains, suggesting their role as localization signals or scaffolding complexes (Bos et 
al., 2007) Although the GTPases have their own intrinsic GTP hydrolysis activity, this is usually 
very slow and requires an interaction with GAPs. These GAPs accelerate the hydrolysis step by 
several orders of magnitude and thus inactivate GTPases precisely and rapidly (Bos et al., 2007). 
GAPs are regulated by protein-protein interactions or post-translational modifications. These 
modifications induce a change in localization to a compartment where the GTPase is located, 
release from autoinhibition, or change in catalytic activity (Bos et al., 2007). 
 
These three sets of regulatory molecules orchestrate Rho signaling in a restricted manner, which is 
essential for junctional dynamics and integrity.  
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1.8 The Rho GEF: ECT2 
 
ECT2 belongs to Dbl family of GEFs for Rho GTPases and was first identified as a proto-oncogene 
(Miki et al., 1993). ECT2 is highly conserved across evolution, as human ECT2 shares a significant 
degree of similarity in its coding region with murine ECT2, Let-21 (ECT2 ortholog in 
Caenorhabditis elegans) and XECT2 (Xenopus ECT2) (Fields and Justilien, 2010). ECT2 is 
composed of various structural domains, each with a distinct role (Fig 1.7). The N-terminal half 
contains many domains which are common to cell-cycle regulators, while the C-terminal half is  
Fig 1.7 Schematic diagram of the domain structure of the ECT2 protein. N, Amino-terminal region; XRCC1, X-
ray repair complementing defective repair in Chinese hamster cells 1 domain; Cyclin B6, cyclin B6-like domain; 
BRCT, BRAC1 C-terminal domain;S, small central region; NLS, nuclear localization sequence; DH, Dbl-
homology domain; PH, pleckstrin-homology domain; C, Carboxyl-terminal region. 
 
 
mainly responsible for the Rho GEF catalytic activity (Tatsumoto et al., 1999). At the extreme N-
terminus lies a XRCC1 domain, which shows sequence homology to human XRCC1, a protein 
involved in DNA repair. The major structural motif in the N-terminal half is a tandem array of 
BRCT repeats, which are highly conserved in proteins involved in DNA repair and cell cycle 
checkpoint responses (Fields and Justilien, 2010). This BRCT motif can bind phosphorylated 
peptides (Manke et al., 2003) and it is suggested that it can also bind to the C-terminal half of 
ECT2, leading to autoinhibition (discussed in detail later). The C-terminal half is the catalytic core 
of the protein and contains a tandem array of Dbl-homology (DH) and pleckstrin-homology (PH) 
domains (Tatsumoto et al., 1999). The extreme c-terminus region of ECT2 does not exhibit 
significant homology to any known protein domains or motifs (Fields and Justilien, 2010). The N- 
and C- terminal domains of ECT2 are separated by a small central S domain, which harbors two 
nuclear localization sequences that regulate the intra-cellular localization of ECT2 (Fields and 
Justilien, 2010). 
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1.8.1 Biological functions of ECT2 
In Cytokinesis 
The best-characterized function of ECT2 is its contribution in cytokinesis (Glotzer, 2005; Piekny et 
al., 2005; Wolfe and Glotzer, 2009; Wolfe et al., 2009; Yuce et al., 2005). RhoA plays the role of 
chief modulator in cytokinesis by initiating the formation of the contractile ring (Werner and 
Glotzer, 2008). This involves the Rho-mediated activation of the actin assembly factor, formin, and 
phosphorylation of the regulatory light chain of myosin II. ECT2 acts as a primary GEF for Rho 
during cytokinesis. It ensures the correct localization and activation of Rho during cell division and 
is a crucial regulator for cytokinesis in all the eukaryotes analyzed to date (Werner and Glotzer, 
2008; Yuce et al., 2005).   
 
Fig 1.8 Action of ECT2 at the cytokinetic 
furrow: During anaphase, centralspindlin 
(MgcRacGAP and MKLP1) recruits ECT2 at 
the central spindle and activates it. ECT2 
further activates Rho, which leads to the 
assembly and constriction of contractile ring 
via Myosin II (adapted from Kamijo et al, 
2006) 
 
 
To facilitate Rho activity during 
cytokinesis, ECT2 collaborates with a 
protein complex called centralspindlin 
(Fig 1.8). Centralspindlin is an 
evolutionarily conserved protein 
complex, which is necessary for 
assembly of the central spindle: a 
microtubule-based structure formed 
during cytokinesis (Mishima et al., 
2002). It is a tetrameric complex that consists of a dimer of a kinesin protein called MKLP-1/ZEN-4 
which is attached to a dimer of the Rho family GTPase activating protein (GAP) called CYK-
4/MgcRacGAP (Glotzer, 2009). This complex stays at the centre of the central spindle during 
cytokinesis where it bundles microtubules, regulates RhoA and also recruits regulators of abscission 
(Glotzer, 2009) (Fig 1.8). 
 
ECT2 recruitment to the central spindle is regulated in a cell-cycle dependent manner through its 
association with MgcRacGAP (Wolfe and Glotzer, 2009). ECT2 interaction with MgcRacGAP is 
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dependent on phosphorylation. The tandem BRCT repeats at the N-terminus of ECT2 mediate its 
interaction with MgcRacGAP (Yuce et al., 2005). Polo-like kinase 1 (Plk1) phosphorylates 
MgcRacGAP, thus creating a phosphoepitope recognized by the BRCT domain of ECT2 (Wolfe et 
al., 2009). This direct interaction of ECT2 with MgcRacGAP activates ECT2 by relieving its 
autoinhibition. Thus the GEF domain becomes free to catalyze its enzymatic reaction (Yuce et al., 
2005). Recently, it has been reported that the extreme c-terminus of ECT2 directs it to the cortex 
during cell-division and ECT2 is actually present at the plasma membrane during anaphase to 
locally activate Rho. This targeting of ECT2 to the plasma membrane is controlled strictly in a 
spatio-temporal manner by centralspindlin and CDK1 (Su et al., 2011).  
 
Since ECT2 is essential for successful cell-division, it is required at a very early stage during 
development in mice (Cook et al., 2013). Genetic ablation of ECT2 results in embryonic lethality  
and there were gross defects in the pre-implantation stage (Cook et al., 2013). Interestingly, 
MgcRacGAP, which acts to activate ECT2 during cytokinesis, also shows a similar embryonic 
lethality (Cook et al., 2013). 
Regulation of the cell cycle 
Using the Xenopus egg cell-free system it has been demonstrated that ECT2 acts as a potential 
regulator of spindle assembly (Tatsumoto et al., 2003). ECT2 depletion leads to disruption in 
attachment of microtubules to kinetochores and also causes prometaphase delay and abnormal 
chromosome segregation (Oceguera-Yanez et al., 2005). Although most of the studies to date have 
related to the M phase, increasing evidence suggest that it does play role in G1-S progression. Using 
inducible knockdown cell-lines, it has been shown that depletion of ECT2 can trigger cell-cycle 
arrest in G1 phase (Scoumanne and Chen, 2006). 
As a polarity determinant 
Cell polarization is very important for various biological processes like cell division, cell migration 
and establishment of apico-basal polarity. An evolutionarily conserved multi protein complex called 
Par3/Par6/aPKC functions to establish polarity in various organisms such as C.elegans, Drosophila 
and also in mammalian epithelial cell lines (Liu et al., 2004). The Rho family of proteins also plays 
a key role in the regulation of cell polarity. Recently, two research articles from Toru Miki's group 
have suggested that ECT2 is important for polarity. Using highly polarized MDCK cell lines and 
the yeast two-hybrid system, they have shown that ECT2 interacts with the polarity component Par6 
and also associates with Par3 and PKCzeta (Liu et al., 2004). One of the mechanisms by which 
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ECT2 is thought to affect epithelial cell polarity is by recruiting Par3/Par6/aPKC polarity complex 
to the tight junctions (Liu et al., 2006) 
1.8.2 Regulation of ECT2 function 
 
ECT2 is subjected to several layers of regulation by intra-cellular localization, phosphorylation and 
inter- and intra-molecular interactions. 
Phosphorylation of ECT2 
Phosphorylation of ECT2 is a very dynamic and cell-cycle dependent process. The first studies on 
ECT2 phosphorylation were done by Toru Miki's group. They found that at G2/M phase, there is a 
mobility shift in the ECT2 band, and, when treated with phosphatase, this band reverts to normal 
size (Tatsumoto et al., 1999), thus suggesting that ECT2 gets phosphorylated at G2/M phase. The 
same group has suggested that the kinases, CDK1 and Plk1, phosphorylate ECT2 in vitro (Niiya et 
al., 2006). At G2/M phase, CDK1 phosphorylates ECT2 at Thr 412; which serves as a priming 
event to create a phosphospecific-binding site for Plk1 PBD and thus these two kinases act in 
concert to activate ECT2. Another report suggests that ECT2 gets phosphorylated at Thr 341 during 
G2/M phase by CDK1 (Hara et al., 2006). This mutation leads to a conformational change in ECT2, 
possibly leading to the open conformation, thus making it more accessible to other signaling 
molecules and further activating it (Hara et al., 2006). 
 
The other phosphorylation site on ECT2 that regulate its spatio-temporal localization is Thr 815. 
CDK1 is believed to phosphorylate ECT2 at Thr 815 at G2/M phase (Hara et al., 2006; Niiya et al., 
2006) and it has been shown recently that this modification prevents ECT2 from associating with 
the membrane before anaphase (Su et al., 2011). At the onset of anaphase CDK1 gets degraded and 
the subsequent dephosphorylation of this site leads to the translocation of ECT2 to the cortex 
thereby allowing it to activate Rho locally. 
 
Intracellular localization 
Tatsumoto et al studied localization of ECT2 in Hela cells. They reported that in interphase cells, 
ECT2 is predominantly nuclear, however as mitosis progresses and the nuclear envelope breaks 
down, ECT2 gets localized to the cytoplasm. This leads to its phosphorylation and activation 
(Tatsumoto et al., 1999). In metaphase, ECT2 accumulates in the region of the mitotic spindle.  In 
late anaphase and telophase, ECT2 is at the midzone, the origin of the cleavage furrow. During 
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cytokinesis, ECT2 accumulates at the midbody, which joins the two daughter cells (Tatsumoto et 
al., 1999). Recently Su et al demonstrated that during cytokinesis both the PH domain and the PBC 
domain target ECT2 to the plasma membrane to perform its cortical activity (Su et al., 2011). 
 
Localization of ECT2 affects its function. As opposed to nuclear ECT2, cytoplasmic ECT2 is 
believed to be a potent transforming factor, being capable of activating RhoA. Mutants of ECT2 in 
which the nuclear localization sequence (NLS) is truncated or disrupted get localized to cytoplasm 
throughout the cell cycle and show a transformed phenotype (Saito et al., 2004). 
 
Interestingly, recent studies have established that ECT2 shows junctional localization. In MDCK 
cells, Liu et al observed that ECT2 is junctional and interacts with junctional proteins like Par3 (Liu 
et al., 2006). 
Inter- and intra-molecular interactions 
ECT2 remains in an inactive or partially active state through inter- or intra- molecular interactions. 
The tandem BRCT domains of ECT2 play an important role in regulating the biochemical and 
biological functions of ECT2 (Kim et al., 2005). The N-terminus of ECT2 associates very strongly 
with the catalytic c-terminus thus regulating its activity by autoinhibition. When this interaction is 
lost, the ECT2 structure opens up, the autoinhibition is released and this leads to activation of 
RhoA. Consistent with this model, deletion of the BRCT domain generates a mutant that is 
constitutively capable of binding to RhoA and has greater basal GEF activity than the full length 
form. However, this BRCT domain is also required for ECT2 function in cytokinesis, as absence of 
functional BRCT domain leads to a multinucleated phenotype, indicating a failure of cytokinesis 
(Kim et al., 2005). 
 
ECT2 also interacts with other proteins to perform an array of diverse functions. One of the most 
intensively studied is its interaction with the centralspindlin complex in cytokinesis. The N-
terminus of ECT2 also associates with MgcRacGAP and this interaction is important for its activity 
and also for its recruitment to the cortex (Yuce et al., 2005).  
 
Another newly found interacting partner for ECT2 is KLEIP, which stands for Kelch-like ECT2 
interacting protein (Hara et al., 2004). Identified by the yeast two-hybrid system with ECT2 as a 
bait, KLEIP showed significant interaction with F-actin in vitro and is localized to cell-cell 
junctions (Hara et al., 2004). The impact of ECT2 on the junctional function of KLEIP was not 
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analyzed, but the interaction with KELIP hints at a role for ECT2 in junctional/cytoskeleton 
regulation.  
1.9 The Rho GAP: p190B Rho GAP 
 
The p190RhoGAP family comprises two members: p190-A and p190-B, which are widely, 
expressed in human, rat, fly and mouse (Chakravarty et al., 2000; Settleman et al., 1992). Both of 
these members are encoded by separate genes and share 50% sequence homology (Ponik et al., 
2013). Both are composed of three major motifs: a N-terminal GTP binding domain (GBD), a large 
middle domain responsible for various protein-protein interactions, and a C-terminal GAP domain 
(Tcherkezian and Lamarche-Vane, 2007). They show GAP activity towards RhoA, Rac 1 and 
Cdc42, with highest specificity for RhoA (Settleman et al., 1992).  For the sake of this study, we 
will focus on p190-B Rho GAP. 
1.9.1 Regulation of p190-B function 
 
p190-B has been shown to mediate the cross talk between Rac and Rho GTPase (Bustos et al., 
2008). Rac1 showed direct binding to p190-B but not to p190-A in a GTP-dependent manner 
(Bustos et al., 2008). This binding targets p190-B to the plasma membrane where it leads to loss of 
GTP-Rho from membranes (Bustos et al., 2008). Rac has also been shown to localize p190-B to 
junctions when MT dynamics were perturbed in MCF-7 epithelial cells (Ratheesh et al., 2012). 
Dominant-negative Rac or the Rac inhibitor NSC 23766 abolished junctional localization of p190-B 
induced by nocodazole. Also, a p190-B mutant that could not bind Rac was unable to localize at 
junctions, thus suggesting that p190-B recruitment to junctions responds to Rac signaling (Ratheesh 
et al., 2012). 
 
Also, IGF-1 can phosphorylate p190-B at tyrosine-306; this does not alter its GAP activity but 
translocates it to plasma membrane domains enriched in lipid-rafts. These domains are known to 
concentrate GTP-Rho and thus redistribution of p190-B to the same subcellular compartment 
promotes its ability to inactivate Rho (Sordella et al., 2003). It is possible that other phosphorylation 
events take place on p190-B, but it has not been explored yet. 
 
The Rnd GTPase protein (primarily Rnd3) has also been established to regulate p190-B localization 
and activity (Oinuma et al., 2012; Riou et al., 2013; Wennerberg et al., 2003). Using yeast two-
hybrid assay and immunoprecipitation experiments, it has been shown that the middle domain of 
p190-B binds to Rnd proteins (Wennerberg et al., 2003). Further, the ‘rounding’ phenotype elicited 
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by Rnd1/Rnd3 overexpression in cells was not observed in the background of p190-B depletion, 
suggesting that this function is mediated by p190-B. Rnd1/3 were shown to increase the GAP 
activity of p190-B towards RhoA by two-fold (Wennerberg et al., 2003). Apart from influencing its 
activity, Rnd1 and Rnd3 also control p190-B localization by targeting it to lipid rafts of plasma 
membrane via their N-terminus KERRA sequence. This targeting enhances their interaction with 
p190-B and also promotes its GAP activity (Oinuma et al., 2012). 
 
Rho-kinase or ROCK can also modulate the activity of p190-B. ROCK can phosphorylate both 
p190-A and p190-B. This phosphorylation inhibits the binding of p190-A to Rnd1, another Rnd 
family protein which can stimulate the GAP activity of p190-A. Thus, ROCK-mediated 
phosphorylation inhibits p190-A GAP activity and leads to ‘sustained’ Rho-signaling (Mori et al., 
2009). Also, ROCK-mediated phosphorylation can critically inhibit the association of Rnd3 with 
p190-B (Riento et al., 2005b; Riou et al., 2013). Phosphorylation of Rnd3 at its c-terminus by 
ROCK1 leads to its translocation from the plasma membrane to the cytoplasm. In the cytoplasm, 
14-3-3 binds to phosphorylated Rnd3 and sequesters it. This prevents Rnd3 from localizing to the 
membrane and activating p190-B and thus leads to active Rho signaling (Riou et al., 2013).  
1.9.2 p190-B Rho GAP in cell-adhesion and morphogenesis 
In morphogenesis 
p190-B is ubiquitously expressed in various human tissues like brain, heart, kidney, liver and 
mammary glands (Burbelo et al., 1998; Chakravarty et al., 2003; Chakravarty et al., 2000). 
Independent reports suggest that p190-B is essential for ductal morphogenesis in mice (Chakravarty 
et al., 2000; Ponik et al., 2013). In breast epithelial cells, p190B is required to spatially modulate 
RhoA activity at cell-cell contacts in response to tensional homeostasis (Ponik et al., 2013). p190-B 
showed high expression in terminal end buds and its deficiency in mice led to abnormal ductal 
morphogenesis, and aberrant insulin signaling (Chakravarty et al., 2003). Conversely, 
overexpression of p190B in mice under the control of a tetracycline-inducible promoter caused 
complete disruption of mammary gland architecture (Vargo-Gogola et al., 2006). Further, p190-B is 
essential for normal size development in mice via modulation of CREB activity as mice lacking 
p190-B were 30% smaller in size than their normal counterparts (Sordella et al., 2002). In mouse 
brain, p190-B exhibits abundant expression and is required for its proper development (Matheson et 
al., 2006). Specifically, proper axonal tract development and neuronal differentiation requires p190-
B function and thus its depletion leads to gross neurodevelopmental defects (Matheson et al., 2006). 
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In cell adhesion 
Members of p190RhoGAP family have been shown to modulate cadherin-based junctions (Noren et 
al., 2003; Wildenberg et al., 2006). Earlier studies showed that cadherin engagement facilitates 
phosphorylation of p190RhoGAP by Src kinase (though these studies did not assess which p190 
Rho GAP isoform was involved). This phosphorylation activates and targets p190 to adherens 
junctions and thus leads to GTP hydrolysis of Rho (Noren et al., 2003). According to a different 
study, Rac signaling can induce tyrosine phosphorylation and translocation of p190-A to 
membranes. Here p190-A interacts with p120 catenin, which directs its activity to adherens 
junctions and leads to local inactivation of the Rho-ROCK pathway. This transient reduction in 
contractility is required for the formation of nascent adherens junction formation and is initiated by 
Rac activation (Wildenberg et al., 2006). 
 
At mature epithelial junctions, p190B GAP localization is inhibited by centralspindlin complex to 
ensure active Rho-signaling, which is crucial for cadherin stability and junctional tension (Ratheesh 
et al., 2012). Microtubules support the recruitment of centralspindlin complex at junctions and 
hence treating cells with nocodazole, or depleting centralspindlin by RNAi led to the enrichment of 
p190-B at junctions. Also, p190-B was responsible for reducing junctional Rho signaling upon 
nocodazole treatment: depleting p190-B restored junctional Rho-GTP levels in nocodazole treated 
cells to the levels similar to control cells (Ratheesh et al., 2012). Interestingly, p190-B localization 
responded to Rac signaling as treatment with a Rac inhibitor or expressing dominant-negative Rac 
abolished junctional p190-B, even when treated with nocodazole (Ratheesh et al., 2012). The model 
implies that at steady state, the centralspindlin component MgcRacGAP, being a GAP for Rac, 
inhibits its activity at junctions and thus disables Rac-mediated localization of p190-B. When 
MgcRacGAP is depleted or its transport to junctions is compromised by blocking microtubules, Rac 
gets activated, and thus recruits p190-B, which further inactivates Rho (Ratheesh et al., 2012). 
 
1.10 RhoA during morphogenesis 
 
Morphogenesis involves coordinated self-assembly of cells into multi-layer tissues that undergo 
deformations like bending, folding, tube formation and pitting to generate specialized 3-D structures 
(Guillot and Lecuit, 2013; Mammoto et al., 2013). To achieve this plasticity, the contractile 
cytoskeleton of the cell (composed of F-actin and myosin II filaments) generates mechanical forces, 
which are transmitted across ECM and cell-junctions. In epithelial cells, cadherin-based junctions 
sense these forces and this leads to an active multicellular process called junctional remodeling 
(Gomez et al., 2011; Halbleib and Nelson, 2006; Niessen et al., 2011). Since Rho sits at the 
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interface of adherens junction and cytoskeleton, it plays a significant role in this co-ordination 
between cytoskeleton and adhesion and thus is essential in all the aspects of tissue morphogenesis 
in mammals. 
 
Rho acts as the prime regulator of actomyosin dependent changes in epithelial cells like neural-tube 
closure, gastrulation and tissue invagination (Mammoto et al., 2013). DRhoGEF2 (a Rho GEF) has 
been shown to be important for cell-shape changes required for gastrulation during early stages of 
Drosophila embryogenesis. Deletion of DRhoGEF2 or expression of dominant-negative Rho led to 
failure of gastrulation in Drosophila embryos (Barrett et al., 1997). Also, the transcription factor 
Twist induces the expression of T48 in Drosophila; this facilitates the concentration of RhoGEF2 at 
cell-junctions, thereby initiating mesoderm invagination by promoting Rho signaling (Kolsch et al., 
2007). Rho-ROCK activity is crucial for apical constriction during fly gastrulation and is facilitated 
by the transcription factor Snail, along with Fog (Mammoto et al., 2013). The process of Drosophila 
germ-band extension involves epithelial remodelling by cell intercalation, which is regulated by 
Rho-signaling (Guillot and Lecuit, 2013; Mammoto et al., 2013). Here Rho-mediated activation of 
ROCK leads to polarized localization of Myosin filaments at the junctional interface undergoing 
shrinkage and at the same time regulates the preferential localization and stability of adherens 
junction components at the growing interface (Bertet et al., 2004). The Rho effector Drok in 
Drosophila acts downstream of Frizzled (Fz) and Dishevelled (Dsh) to modulate epithelial 
polarization events like orientation of wing hairs (Winter et al., 2001). In chick embryos, 
spatiotemporal co-ordination between Rho localization, Myosin activation and neural plate 
formation has been observed. Rho, along with its downstream effector Myosin, gets concentrated at 
the apical surface of neural plate cells, and inactivating this cascade by pharmacological inhibitors 
led to gross disruptions in neural plate morphogenesis (Kinoshita et al., 2008). ROCK has been 
shown to regulate neural tube closure in chick embryos (Nishimura and Takeichi, 2008; Wei et al., 
2001). In the conditions when ROCK1 signal was diminished at the apical surface of neural plates, 
neural plates did not bend normally and did not close (Nishimura and Takeichi, 2008).  
 
RhoA null knockout mice are embryonic lethal (Thumkeo et al., 2013), but using strategies like 
conditional knockouts and gene-targeting, it has been established that Rho activity is necessary for 
cell-cell adhesion and contractility in epithelial tissues during development in mice (Thumkeo et al., 
2013).The Rho effector ROCK is necessary for eye-lid formation. ROCK mediated phosphorylation 
of MLC is required for eye-lid closure as gross defects in actin-filament organization and loss of 
pMLC were observed in the eyelid epithelia of ROCK-1 knockout mice (Shimizu et al., 2005). 
Similarly, using conditional knockout in lens epithelium, Chauhan et al reported that mutual 
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antagonism of Rho and Rac modulates apical constriction and the changes in cell-width required for 
epithelial invagination. RhoA, via ROCK, generates active Myosin and contractile actin, which is 
needed for apical constriction. Thus, when RhoA was deleted, lens pits were open in shape 
(Chauhan et al., 2011). In the central nervous system of mice, ablation of RhoA leads to disruption 
of adherens junctions, apical-basal cell polarity, aberrant proliferation of neuronal progenitors and 
defects in organization of ventricular region (Herzog et al., 2011; Katayama et al., 2011); thus 
RhoA is crucial for the integrity of neuroepithelium. In the lymphoid system, inhibition of RhoA 
activity by expressing C3-transferase leads to developmental block of T-cells because of defects in 
integrin dependent cell-matrix adhesion (Thumkeo et al., 2013). Another Rho effector, mDia is 
critical for the maintenance of adherens junctions and the apical actin belt in the neuroepithelium 
cells of mice. Loss of mDia led to disruption of adherens junction, the associated actin-belt and the 
apical-basal polarity in neuroepithelium cells during embryonic brain development in mice 
(Thumkeo et al., 2011). Modulation of cytoskeleton tension by Rho-ROCK signaling is essential for 
branching morphogenesis in embryonic mouse-lung (Moore et al., 2005). Also, depletion of RhoA 
in mice leads to abnormal platelet formation and blood coagulation (Pedersen and Brakebusch, 
2012). 
1.11 Perspective 
 
Epithelial morphogenesis is a multistep process, which requires precise co-ordination between cell-
cell adhesion and cytoskeleton (Mammoto et al., 2013). Adherens junctions constitute one of the 
major adhesion complexes in epithelia and give epithelia their characteristic cohesiveness. Despite 
acting as a static anchor for cells, adherens junctions undergo extensive reorganization to facilitate 
diverse morphogenetic processes like cell-shape change, intercalation, elongation or migration 
(Nishimura and Takeichi, 2009; Schock and Perrimon, 2002). Cadherin, one of the major 
component of adherens junctions, dictates the basic principles of morphogenesis right from 
embryonic development to adult tissue formation (Gumbiner, 2005). Cadherins, in association with 
catenins, respond to various developmental cues and enforce physiological changes like assembly 
and disassembly of junctions, cytoskeletal remodelling and cell sorting to name a few (Niessen et 
al., 2011). Given the variety of cellular processes that they are involved in, it is not surprising that 
these cadherin-based junctions collaborate with multiple signaling pathways, the best understood of 
them are Rho GTPases. 
 
Rho GTPases are master regulators of various cellular processes, ranging from cell division to 
epithelial-mesenchymal transition (Etienne-Manneville and Hall, 2002). There is ample evidence 
from cell-based experiments suggesting that cadherins regulate the activity and localization of these 
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GTPases, and, in turn, these GTPases are required for the maintenance of these adhesive structures 
(McCormack et al., 2013). Once activated, these GTPases initiate a signaling cascade via their 
effectors (like ROCK), which ultimately translates into junctional remodelling. This enables 
epithelia to adopt various shapes and forms with ‘ease’ during development (Mammoto et al., 
2013). However, its is important to emphasize here that most of the cellular and biochemical studies 
of Rho GTPases relied on cells in culture and one has to be cautious while discussing the relevance 
of these results in various developmental and physiological regulation occurring inside a organism. 
Nevertheless, the use of conditional knockouts and gene-targeting in mice have revealed that apart 
from few exception, most of the in vivo physiological roles of Rho align with its previously reported 
in vitro functions (Thumkeo et al., 2013). 
 
Rho GTPases are molecular switches, with their spatio-temporal activity tightly controlled by 
GEFs, GAPs and GDIs (Etienne-Manneville and Hall, 2002). Various morphogenetic processes 
require these Rho GTPases to undergo rapid activations and inactivation cycle. This is facilitated by 
these regulatory molecules as they can specifically increase the levels of active GTPase at a distinct 
sub-cellular site during junctional remodelling (Guillot and Lecuit, 2013). Since most of these GEFs 
and GAPs harbor additional domains (kinase domain, protein-protein interactions domain), this 
further enables them to control their localization and activity in a very precise manner (Bos et al., 
2007; Rossman et al., 2005); thus ensuring a strict regulation of Rho signaling. These GEFs and 
GAPs (Rho GDIs are not well-understood) act as the key mediators of Rho signaling and thus it is 
not surprising that the aberrant expression/activity/localization of these molecules lead to various 
physiological defects (Cook et al., 2013). Increasing evidence suggest that these GEFs and GAPs 
contribute to almost all the aspects of junctional biogenesis (McCormack et al., 2013) and are 
essential for the maintenance of junctional properties like tension and adhesiveness  (Ratheesh et 
al., 2012; Terry et al., 2011). Conversely, in many cases the localization and activity of these 
molecules are itself modulated by these junctional components (Ratheesh et al., 2012; Terry et al., 
2011). However, there are a number of outstanding questions like how these GEFs and GAPs 
specifically signal to Rho at a particular site, what are the molecular mechanisms controlling their 
localization, how do they achieve substrate-specificity in vivo and how do they mediate the cross-
talk between various small GTPases. 
 
Remodelling of adherens junction by Rho GTPases is a key feature of tissue morphogenesis and its 
dysregulation leads to various pathological conditions including cancer, neurodegenrative diseases 
and inflammatory diseases to name a few. So, to better understand the cross-talk between cadherins 
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and Rho GTPases and how this is linked to regulate cell-adhesion in development and disease, it is 
inevitable to study the molecules and mechanisms involved in Rho GTPase regulation. 
 
1.12 Research Aims 
 
Cadherins; one of the core constituents of zonula adherens mediates several aspects of 
morphogenesis and are being dynamically regulated in response to developmental or physiological 
signaling cues (Gumbiner, 2005). Cadherin act in concert with Rho GTPase signaling to acquire this 
plasticity during morphogenesis while holding the two cells together (Guillot and Lecuit, 2013; 
McCormack et al., 2013; Niessen et al., 2011). The contribution of Rho towards maintaining a 
functional zonula adherens in steady state and its dynamic reorganization during tissue-formation is 
undisputed but a great deal of knowledge is lacking about how Rho acts at junctions and what are 
the molecules that orchestrate this multi-faceted signalling event to generate a relevant biological 
response. 
 
In my PHD, I have tried to address the above questions by dissecting the mechanistic and functional 
details of junctional Rho signalling. Following are the broad aims that will form the basis of each 
research chapter: 
 
1. Understanding the significance of Rho-GEF ECT2 and Rho signaling for a functional 
zonula adherens. 
2. Addressing the interplay between E-cadherin and Rho-GTPase signalling 
3. Dissection of a novel feedback-loop co-ordinated by Myosin IIA, which sustains ZA Rho 
zone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: This chapter has been extended in the form a of review article, which has been accepted for publication in 
“Current Topics in Developmental Biology”. The accepted manuscript is attached in the Appendix 2. 
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Chapter 2: An ECT2-Rho pathway supports the zonula adherens 
 
2.1 Introduction 
 
The Zonula adherens (ZA) mediates cell-cell interaction between epithelial cells and a functional 
ZA is indispensible for the maintenance and morphology of the epithelial sheets that line our body 
(Niessen et al., 2011; Guillot and Lecuit, 2013; Gumbiner, 2005; Harris and Tepass, 2010; Munjal 
and Lecuit, 2014). Recent studies reveal that the ZA is not a static site of adhesion but modulates 
and, in turn, is modulated by a host of signaling molecules; Rho GTPases are among one of them 
(Braga, 2000; Braga, 2002; Braga and Yap, 2005; McCormack et al., 2013). Rho acts as the 
principal regulator in variety of cellular processes like epithelial remodelling, polarity, migration 
and trafficking (Jaffe and Hall, 2005; Ratheesh et al., 2013; Thumkeo et al., 2013). To understand 
the cell biology of Rho, it is essential to identify the molecular mechanisms that control its activity 
and localization. Being a potent molecular switch, Rho is subjected to a very tight spatio-temporal 
regulation by GEFs and GAPs (Cherfils and Zeghouf, 2013). These regulatory molecules have 
profound implications for many cellular events and their deviation from the normal functioning can 
have deleterious effects like cancer (Bos et al., 2007; Etienne-Manneville and Hall, 2002).  
 
ECT2 is a well-established Rho GEF, and is central to the process of cytokinesis (Yuce et al., 
2005). It was initially identified as an oncogene, important for cell cycle and the transformed 
phenotype (Fields and Justilien, 2010; Yuce et al., 2005). However there is emerging evidence 
indicating that it performs extra-cytokinetic functions such as regulation of polarity via conserved 
Par proteins (Liu et al., 2004) or modulation of the actin cytoskeleton by interacting with the 
junctional protein KLEIP (Hara et al., 2004). 
 
The zonula adherens is the major site for Rho signalling where Rho functions to confer junctional 
integrity and stability. But the precise mechanistic details of the Rho functions at ZA remain a 
largely unexplored area. In this research chapter, I will give an overview of how Rho modulates 
various core components of the ZA to maintain its organization via its GEF ECT2. 
 
The major part of the results presented in this chapter has been published in Nature Cell Biology, 2012 
Aug; 14(8): 818-28 of which I am second author. The paper is attached in Appendix 1. 
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2.2 Material and Methods 
 
Cell culture, transfection and Plasmids 
MCF-7 and Caco-2 cells were cultured in DMEM and RPMI complete growth medium respectively 
and grown at 37ºC in 5% CO2 atmosphere. Cells were transfected using Lipofectamine 2000 
(Invitrogen) for expression constructs according to manufacturer’s instructions and analysed 24-48 
hours after transfection. 
EGFP Myosin IIA (GFP-Myo IIA) and E-cadherin GFP constructs have been described previously 
(Smutny et al., 2010; Smutny et al., 2011). EGFP-ECT2 was a kind gift from Robert Saint 
(Australian National University).  
A lentivirus-based shRNA system was used to deplete ECT2 in MCF-7 cells. The lentivirus 
expression vector pLL5.0 (backbone pLL3.7) and the third-generation packaging constructs 
pMDLg/pRRE, RSV-Rev and pMD.G were gifts from Jim Bear (UNC Chapel Hill, North Carolina, 
USA). Algorithms from Dharmacon were used to predict sequences that would lead to silencing of 
human ECT2 (NM_018098). Predicted sequences were used to design shRNAs containing a stem 
loop sequence based on previous studies, and these were cloned into the lentivirus expression vector 
LentiLox pLL5.0 yielding pLL5.0 Cherry-sh-ECT2. In brief, shRNA was cloned downstream of the 
U6 promoter (HpaI and XhoI) into a modified version of lentivirus expression vector pLL5.0 
carrying a soluble cherry as reporter gene (pLL5.0 Cherry-shECT2). 
The generation and titer of lentivirus stocks has been described previously (Smutny et al., 2011). 
MCF-7 cells were infected with lentiviral particles at a multiplicity of infection of 10 per cell as 
described previously (Smutny et al., 2011) and used within the first week after infection. 
 
Antibodies and Inhibitors 
Primary antibodies used in this study were: (1) mouse monoclonal antibody (mAb) against the 
cytoplasmic domain of E-cadherin (transduction labs, cat #610182) 1:2500; (2) mouse mAb HECD-
1 against the ectodomain of E-cadherin 1:50 (a gift from Peggy Wheelock, University of Nebraska, 
Omaha, NE; with the permission of M. Takeichi); (3) rabbit polyclonal antibody (pAb) for non-
muscle myosin IIA heavy chain (Covance, cat #PRB-440P),1:1000); (4) rabbit pAb for non-muscle 
myosin IIB heavy chain (Covance, cat #PRB-445P),1:1000); (5) rabbit pAb (cat #A-6455)(1:2000) 
or mouse mAb (cat #A-1120)(1:200) against GFP (Molecular Probes/Invitrogen); (6) rabbit pAb 
(Invitrogen, cat #61-7300)(1:300) and (7) mouse mAb (Invitrogen cat #33-9100) against human 
ZO-1(1:300); (8) mouse monoclonal antibody against α catenin (Transduction Laboratories cat 
#610194),1:500); (9) rabbit polyclonal antibody against α-catenin (Zymed Laboratories cat 
#711200),1:500); (10) rabbit polyclonal antibody against α-catenin (a gift from Dr. Barry 
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Gumbiner, University of Virginia School of Medicine, USA; 1:100);  mouse mAbs against (11) 
RhoA (SantaCruz Biotechnology Inc,, cat #sc418, 1:100), (12) MKLP1(SantaCruz Biotechnology 
Inc, cat #sc-136473,1:300), (13) RacGAP1(SantaCruz Biotechnology Inc, cat #sc-166477, 1:300); 
and rabbit polyclonal antibodies against (14) ECT2 (SantaCruz Biotechnology Inc, cat #sc:1005, 
1:100) and Millipore (cat #07-1364), 1:50), (15) MKLP1(cat #sc: 22793, 1:50) and (16) 
RacGAP1(cat #sc:98617, 1:50) (SantaCruz Biotechnology Inc); mouse mABs against (17) p190 
(cat #610150, 1:50) and (18) p190B (cat #611612, 1:50) (BD Biosciences); (19) mouse mAB 
against β tubulin (cat #T4026) and (20) FLAG (cat #F4042) (Sigma, 1:500) ; (21) rat monoclonal 
anti-EB1/EB3 and (23) rat-anti-EB1 and rat anti-EB3 , 1:50, (cat # 010815H11, Absea, China). 
 F-actin was stained with AlexaFluor 488-phalloidin or 594-phalloidin (1:1,000 dilution; 
Invitrogen). Secondary antibodies were species-specific antibodies conjugated with AlexaFluor 
488, 594 or 647 (Invitrogen) (1:500) for immunofluorescence, or with horseradish peroxidase (Bio-
Rad Laboratories) (1:5000) for immunoblotting.  
 
Immunofluorescence microscopy 
Cells were fixed with 10% TCA on ice for 15 minutes for RhoA staining. For visualizing F-actin, 
cells were fixed with 4% paraformaldehyde in PBS at 22°C for 20 min. For both of the above, cells 
were subsequently permeabilized with 0.25% Triton-X-100 in PBS for 5 min at room temperature. 
Otherwise, cells were fixed with ice-cold methanol for 5 minutes on ice.   
Wide-field images were acquired with either an IX81 Olympus epi-illumination microscope (60X 
and 100X, 1.4 numerical aperture objectives) and a Hamamatsu Orca-1 ER camera driven by 
Metamorph imaging software (version 7; Universal Imaging) or a Personal Deltavision 
deconvolution microscope  (Applied Precision, 60 X, 1.4  numerical aperture objectives) and a 
Roper Coolsnap HQ2 monochrome camera. Confocal images were captured with a Zeiss 510 or a 
Zeiss 710 Meta laser-scanning confocal microscope, and z-stacks were processed with ImageJ 
(National Institutes of Health) software. Background correction, contrast adjustment and Z-
projections of raw data images were performed with ImageJ, Imaris (Bitplane) or Photoshop 
(Adobe).  
Fluorescence intensity at contacts was quantitated using the line scan function in ImageJ as 
described earlier (Smutny et al., 2011). 
 
FRAP Analysis 
Cells  
To address the issue of E-cadherin turnover, E-cadherin GFP was expressed in an endogenous E-
cadherin knockdown background by infecting MCF-7 cells with GFP tagged E-cadherin, which 
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simultaneously expresses a shRNA against E-cadherin. ECT2 and myosin IIA KD was performed 
by coinfecting the above cells with either lentivirus encoding shRNA designed against the 3'UTR 
region of ECT2 or lentivirus encoding shRNA against Myosin IIA (MYH9, (Smutny et al., 2010). 
48 hs after infection cells were split into glass bottom dishes (N 1.5, MatTek corporation, MA) and 
grown to full confluency. For image acquisition, cell were washed and incubated in the presence of 
imaging media (Hank’s balanced salt solution supplemented with 10 mM HEPES pH 7.4 and 5 mM 
CaCl2).  For these experiments, only cells co-expressing E-cadherin GFP and cherry were chosen to 
ensure the presence of knockdown phenotype. For inhibition of Rho signaling, cells were treated 
with 500 ng/µl of cell permeable C3 Transferase  (Rho inhibitor I, Cytoskeleton) in imaging media 
for 1 hour, washed off and incubated in the same. Cells with en face contacts were chosen which 
allowed us to precisely identify and photobleach the zonula adherens. 
Image acquisition and analysis  
FRAP experiments were performed on a LSM 510 Meta Zeiss confocal microscope with a heated 
stage maintained at 37°C. Images (416x416 pixels, 0.086 um/pixel) were acquired using 60x 
objective, 1.4 NA oil Plan Apochromat immersion lens at 4X digital magnification with 0.7 um 
optical section. Time-lapse images were acquired before and after photo bleaching with an interval 
of approx. 5 seconds per frame for the total time of 280 seconds. A constant ROI, 2.8 x 1.7 um with 
the longer axis parallel to the cell-cell contact, was marked for each experiment and the E-cadherin- 
GFP was bleached with 50 iterations of 488 nm laser with 100% transmission resulting in 
maximum bleach of approx. 70%. 
Image analysis was performed using Image J. Noise on images was reduced by applying a median 
filter of 2 pixels radii. Focal drifts were eliminated using Turbo-reg plug-in of Image J. To calculate 
FRAP profiles, a ROI at the bleached GFP-E-cadherin area was marked and the plug-in FRAP 
profiler (McMaster University, Canada) was applied to obtain fluorescence intensity profiles. 
Fluorescence intensities were normalized to pre-bleach values and imported into Prism software for 
statistics. Data from 11 replicates (3 independent experiments) were pooled and fitted to the 
equation: 
 
where F is the average fluorescence of the ROI, Mf is the mobile fraction, t ½ is the half time of 
recovery and t is time in seconds. Data shown is the average ± SEM and statistical significance 
assessed by t-test. 
 
 
 
€ 
F(t)
F(0) = Mf ⋅ (1− e
−
ln 2⋅t
t1/2 )
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Trypsin protection Assay 
The surface expression of E-cadherin was measured by sensitivity to surface trypsinization (as 
described previously (Verma et al., 2004). In brief, cells were incubated with crystalline trypsin 
(0.05% wt/vol) in HBSS in the presence of either 2 mM CaCl2 or 5 mM EDTA for 20 min at 37°C. 
Cells were collected and lysed directly into Laemmli sample buffer. Equal volumes of the cellular 
extracts were separated by SDS-PAGE followed by Western analysis with antibodies specific for 
the ectodomain of E-cadherin (HECD-1) and β-tubulin (as a loading control). 
 
Laser Ablation 
The cells and culture conditions used in ablation experiments were similar to those used for the 
FRAP experiments. 
Ablation experiments were performed on a LSM 510 Meta Zeiss confocal microscope equipped 
with a heating stage set to 37 oC for the duration of the experiment. Images (300x300 pixels, 0.19 
um/pixel) were acquired using 63x objective, 1.4 NA oil Plan Apochromat immersion lens at 1.5X 
digital magnification and pinhole adjusted to 3 Airy units to obtain optical sections 2 um thick. 
Time-lapse images were acquired before (3 frames) and after (4 frames) ablation with an interval of 
15 seconds per frame. For ablation, a tuneable Ti:Sapphire laser (Chameleon Ultra, Coherent 
Scientific, US) tuned to 790 nm was used to ablate cell contacts labeled with E-cadherin-GFP. A 
constant ROI, 3.8 x 0.6 um with the longer axis orthogonal to the cell-cell contact, was marked for 
each experiment and ablated with 30 iterations of 790 nm laser with 50 % transmission. GFP 
fluorescence was determined before and after the induced ablation using a 488 nm laser for 
excitation and 500-550 nm emission filter. 
Image analysis was performed using Image J. The distance (d) between vertices that define the 
ablated contact was measured as a function of time (t). Then obtained values d(t) were subtracted 
from the average distance before the ablation step d(0). After plotting the resulting values were 
fitted to the following equation: 
 
Then the instantaneous recoil (rate of recoil at t=0 s) was determined as: 
 Instantaneous recoil   
Average instantaneous recoil was determined for 10 to 15 contacts in three independent 
experiments and then normalized to the value observed in control conditions. 
 
3-D Cyst culture 
Caco-2 cells were transduced with lentivirus encoding ECT2 shRNA. Two days after infection cells 
were trypsinized, counted and diluted to 1.5 X 104 cells/ml in RPMI medium. This cell suspenion 
€ 
d(t) − d(0) = plateau⋅ (1− e−ktt)
€ 
= plateau⋅ k
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was mixed with matrigel (BD cat# 356230) at a final concentration of 2%. Eight well chamber-
slides (#Nun155411) were coated thinly with 100% matrigel and let to settle at 37 ° for 15 minutes. 
The cell suspenion was plated in these wells and placed in the 37 ° degree incubator with media 
changes (RPMI with 2% matrigel) every fourth day. Cysts were ready in 10-12 days. 
For immunofluorescence, cysts were removed from the incubator, washed twice with ice-cold PBS 
and fixed with 4% PFA in PBS for 30 minutes at room temperature. This was followed by two 
washes with ice-cold PBS, permeabilization with 0.5% Triton-X-100 in PBS for 15 minutes and 
blocking with 3% BSA (1 hour) at room temperature. Cysts were incubated with primary antibody 
over night at 4° and with secondary antibody for 1-2 hour at room temperature. After two PBS 
washes, cysts were incubated with the nuclear dye DAPI (1:500 in PBS) for 30 minutes which was 
again followed by two quick PBS washes. The cysts were stored in PBS and imaged within 24-36 
hours. 
2.3 Results and Discussion 
2.3.1: ECT2 localizes to zonula adherens and regulates its integrity 
 
I started with an aim to understand the molecular and mechanistic detail of Rho functions at ZA in a 
detailed fashion. Since Rho is activated by the enzymatic action of GEFs, a pilot experiment was 
done in the Yap laboratory where many Rho GEFs were screened for their junctional localization. 
Among them Rho GEF ECT2 was found to be present prominently at junctions (Ratheesh et al., 
2012). When the cells were depleted of ECT2, there was significant loss of junctional Rho staining 
and Rho activity as measured by activity-based Rho FRET biosensor, thus identifying ECT2 as a 
Rho regulator at junctions (Ratheesh et al., 2012). 
 
 
I began by characterizing the cellular localization of ECT2 in MCF-7 monolayers by 
immunofluorescence. ECT2 was found to be concentrated at the ZA along with E-cadherin (Fig 
2.1a) To further confirm the junctional localization of ECT2, a GFP-tagged transgene was 
expressed in MCF-7 cells and junctional ECT2 was observed in live cells along with a prominent 
nuclear fraction (Fig 2.1b). 
 
 
ECT2 is a well-established Rho GEF, known for its role in cytokinesis during cleavage furrow 
formation (Piekny et al., 2005). The prevalent notion in existing literature is that ECT2 displays 
exclusive nuclear localization in interphase cells (Fields and Justilien, 2010). However, the majority 
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of those experiments were performed on isolated cells (Mikawa et al., 2008; Su et al., 2011; Yuce et 
al., 2005), which do not make contact with each other, and thus this might have limited the 
junctional visualization of ECT2 in their system. Indeed a strong accumulation of ECT2 was 
visualized in our cells, thus enforcing that ECT2 is relevant for cell-cell junctions. 
 
 
  
Fig 2.1 Ect2 localization in MCF-7 monolayers. 
 
(a) MCF-7 cells monolayers were fixed in ice-cold methanol and stained for indicated proteins. Representative 
confocal images acquired at the apical junctions are shown. (b) GFP-Ect2 was transfected in MCF-7 cells and 
live cells were imaged 48 hours post-transfection. Represented is a still (sum of all the z-sections) from the movie. 
(scale bars=10 µm) 
 
 
 
To address the functional significance of junctional ECT2, shRNA-mediated knockdown of ECT2 
was performed. Lentivirus encoding shRNA directed against ECT2 was prepared and MCF-7 cells 
were infected. The cells were harvested 48-hours post-infection and ECT2 knockdown was 
confirmed with western blotting (Fig 2.2c). Also, a loss of junctional ECT2 by ~70% was observed 
in the MCF-7 cells infected with lentiviral shRNA, further confirming the specificity of ECT2 
immunostaining at junctions (Fig 2.2 a,b).  
Ect2 E-cadherin Merged
GFP-Ect2 in live cells
a
b
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Fig 2.2 Lentivirus mediated knockdown of ECT2. 
 
(a) Ect2 immunostaining in Control and Ect2 knockdown (Ect2 Kd) cells imaged by confocal microscopy (b) 
Represented are Gaussian fit curves of contact profiles in control (black) and Ect2 Kd cells (red) and peak 
fluorescence intensity at cell-cell contacts. Data represents mean ± S.E.M of data pooled from three independent 
experiments (n=30; ***P<0.0001,Student’s t-test) (c) Lysates from MCF-7 cells infected with lentivirus bearing 
an empty vector control (Ctrl) or an shRNA-directed against Ect2 (Ect2 kd) were immunoblotted for Ect2 and 
GAPDH (loading control) scale bars=10 µm 
 
 
To understand the impact of ECT2 depletion on the ZA, ECT2 knockdown cells were stained for 
junctional proteins. MCF-7 cells infected with lentivirus encoding ECT2 shRNA were grown to 
confluence till they formed a monolayer and E-cadherin immunostaining was performed in these 
cells. In control cells, a well-defined apical ring of E-cadherin, representing the ZA was observed 
along with punctate staining of E-cadherin at lateral clusters. In contrast, in ECT2 knockdown 
(ECT2 KD) cells, the apical ring pattern of the ZA was lost and E-cadherin was not able to 
concentrate in its well-defined apical zone of cells (Fig 2.3). The crisp, linear staining of E-cadherin 
was lost in ECT2 KD cells. A linescan analysis was performed in these cells, where a line is drawn 
across the contact and fluorescence intensity is measured along that line. In ECT2 KD cells, the 
cadherin fluorescence peak intensity was decreased by 50% (Fig 2.3 b, c); further strengthening the 
observation that ECT2 KD perturbs ZA integrity. 
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 Figure 2.3 ECT2 KD perturbs E-cadherin organization 
(a) E-cadherin immunostaining in control and Ect2 knockdown (Ect2 kd) cells imaged by wide- field 
deconvolution microscopy (b) Represented are Gaussian fit curves of contact profiles in control (black) and Ect2 
Kd cells (red) and peak fluorescence intensity at cell-cell contacts (c) Data represents mean ± S.E.M of three 
independent experiments (n=3, in each experiment, 25 contacts were analyzed; ** p=0.005; Student’s t-test) 
Scale bars = 10 µm 
 
 
A trypsin protection assay was performed to measure the surface levels of E-cadherin. It was 
observed that neither total nor surface level of E-cadherin (which is susceptible to trypsinisation in 
the presence of calcium) was changed in ECT2 KD cells, suggesting that the loss of apical E-
cadherin observed was because of the inability of the ECT2kd cells to locally concentrate E-
cadherin in the apical ring (Fig 2. 4), and not because of defects in transcription or trafficking. 
 
To further delineate whether ECT2 functions specifically at the ZA, the tight junctions component 
ZO-1 was studied in the ECT2 knockdown cells. The ZO-1 staining was comparable in both control 
and ECT2 KD cells (supported by linescan analysis and bar graphs), thus indicating that ECT2 
specifically acts on the ZA to maintain its integrity (Fig 2.5). 
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Fig 2.4 Trypsin protection assay 
 
Surface expression of E-cadherin was measured using surface trypsin protection assays in control (Ctrl) and 
Ect2 knockdown (Ect2kd) cells. Cells were lysed immediately (WCL) or after trypsinisation in the presence 
(+Ca) or absence (–Ca) of extracellular Ca2+ . Lysates were immunoblotted for E-Cadherin (E-Cad) and β-
tubulin (β-tub 
 
2.3.2 Identification of ECT2 effectors at junctions 
 
The Zonula adherens is a cellular structure composed of E-cadherin that is extensively regulated 
and supported by the actomyosin network. This actomyosin network comprises of the cytoskeleton 
component actin and motor protein Myosin. The Yap laboratory has previously identified that 
Myosin IIA supports E-cadherin clustering at junctions, and thus maintains ZA integrity (Smutny et 
al., 2011; Shewan et al., 2005; Smutny et al., 2010). 
 
So, to identify the molecules that ECT2 might utilize to preserve ZA architecture, I focussed on this 
actomyosin cytoskeleton. MCF-7 ECT2 KD cells were stained for F-actin and no change was 
observed in steady state junctional actin content in ECT2 KD cells compared to control (Fig 2.6). 
This suggests that ECT2 does not regulate the ZA by modulating junctional actin. 
 
The cadherin phenotype observed in ECT2 KD cells was similar to that of observed in Myosin IIA 
KD cells (Smutny et al., 2010), i.e. failure of E-cadherin to concentrate on the apical ring of the 
cells. So, Myosin IIA appeared to be a strong candidate for mediating ECT2 functions at the ZA.  
 WCL   +Ca   -Ca             WCL  +Ca    -Ca
E-cad
ǃWXEXOLQ
FWUO (FWNG
 50 
 
 
Fig 2.5 ECT2 KD does not perturb tight junctions. 
 
(a) ZO-1 immunostaining in Control and Ect2 knockdown (Ect2 Kd) cells imaged by confocal microscopy (b) 
Represented are Gaussian fit curves of contact profiles in control (black) and Ect2 Kd cells (red) and peak 
fluorescence intensity at cell-cell contacts (c) Data represents mean ± S.E.M of three independent experiments 
(n=3, in each experiment 20 contacts were analysed; Student’s t-test) Scale bars = 10 µm 
 
Accordingly, the Myosin isoforms, Myosin IIA and Myosin IIB were analysed for their junctional 
localization in ECT2 KD cells. A distinct loss of Myosin IIA (~50%) from junctions was observed 
in ECT2 KD cells, that was confirmed by line scan analysis (Fig 2.7). But interestingly there was no 
change in Myosin IIB staining at junctions in ECT2 KD cells (Fig 2.8), thus suggesting that Myosin 
IIA is the downstream effector of Rho-ECT2 pathway at ZA. This supports the previous 
observations from this laboratory (Smutny et al., 2010), suggesting that Myosin IIA and IIB 
respond to different upstream regulators, with Rho regulating IIA exclusively. 
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Fig 2.6 ECT2 KD does not perturb F-actin content.  
 
F-actin immunostaining in Control and Ect2 knockdown (Ect2 Kd) cells imaged by confocal microscopy (b) 
Represented are Gaussian fit curves of contact profiles in control (black) and Ect2 Kd cells (red) and peak 
fluorescence intensity at cell-cell contacts (c) Data represents mean ± S.E.M of three independent experiments 
(n=3, in each experiment 20 contacts were analyzed; Student’s t-test)  
Scale Bar=10µm 
 
The hypothesis that Myosin IIA is a downstream effector of ECT2 predicted further that the ECT2 
KD phenotype might be reverted if amount of junctional Myosin IIA is enhanced. To test this, 
Myosin IIA was overexpressed in ECT2 KD cells. ECT2 KD cells were transiently transfected with 
GFP-tagged Myosin IIA constructs and then studied for cadherin phenotype (Fig 2.9).  
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Fig 2.7 ECT2 KD perturbs Myosin IIA junctional localization 
 
(a) Myosin IIA immunostaining in Control and Ect2 knockdown (Ect2 Kd) cells imaged by confocal microscopy 
(b) Represented are Gaussian fit curves of contact profiles in control (black) and Ect2 Kd cells (red) and peak 
fluorescence intensity at cell-cell contacts (c) Data represents mean ± S.E.M of three independent experiments 
(n=3), in each experiment 25 contacts were analysed; ** p=0.005 Student’s t-test) 
Scale bar = 10 µm 
 
 
 
 
Fig 2.8 ECT2 KD does not affect Myosin IIB. 
(a) Myosin IIB immunostaining in Control and Ect2 knockdown (Ect2 Kd) cells imaged by confocal microscopy 
(b) Represented are Gaussian fit curves of contact profiles in control (black) and Ect2 Kd cells(red) and peak  
fluorescence intensity at cell-cell contacts (c) Data represents mean ± S.E.M of three independent experiments 
(n=3, in each experiment 20 contacts were analyzed; Student’s t-test) Scale bar = 10 µm 
 
 
Indeed, Myosin IIA expression led to the restoration of the 'dispersed cadherin phenotype' and well-
defined linear staining for apical E-cadherin was observed in the cells expressing GFP-tagged 
Myosin IIA. Moreover, this observation was specific for Myosin IIA as the ECT2 KD cells 
transiently transfected with GFP alone looked similar to ECT2 KD cells (Fig 2.9). Overall, these 
results suggest that ECT2 acts specifically via Myosin IIA pathway to support E-cadherin 
organization and zonula adherens biology. 
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Fig 2.9 Myosin IIA can rescue ECT2 KD phenotype 
 
Control and Ect2 knockdown (Ect2 kd) cells were transfected with p-EGFPC1 (GFP) or EGFP-Myosin IIA 
(GFP-IIA) and were fixed and stained for E-cadherin (magenta) and GFP (green). (a) Representative epi-
illumination images were taken from the apical junctions of Ect2 kd cells. (b) Changes in junctional E-cadherin 
was analyzed by line-scan analysis. Gaussian fit curves of contact profiles are shown.(c) Fluorescence intenisty at 
cell contacts were quantified and data represents mean ± S.E.M of three independent experiments (n=3, in each 
experiment, 25 contacts were analyzed; ***P<0.0001;  
One way Annova, Dunnett’s post hoc test.)Scale bars = 10 µm 
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2.3.3 ECT2-Rho signaling stabilizes E-cadherin at the apical junctions 
 
I then sought to understand the impact of ECT2-Rho signaling on zonula adherens in a more 
detailed fashion. Since ECT2 depletion led to the loss of cadherin-belt at ZA (a phenotype similar to 
Myosin IIA depletion), I postulated that the apical pool of cadherin is getting destabilized when Rho 
signalling is compromised. To test this, GFP-tagged E-cadherin was expressed in control and ECT2 
KD cells and FRAP (Fluorescence recovery after photobleaching) was performed on the apical 
cadherin pool. The recovery was monitored over a period of time and FRAP profiles were obtained 
using Image J and Prism softwares (see material and methods for details). 
 
 
 
Fig 2.10 ECT2-Rho signaling stabilizes E-cadherin at the apical junctions 
 
(a-b) E-cadherin GFP was expressed in MCF-7 cells (ctrl, Ect2 KD, IIA KD and c-3transferase treated) and the 
desired area of it was photobleached and observed for recovery over a period of time. Representative frames 
after photobleaching in the apical zones of an individual contact in the indicated conditions and the one-phase 
association curves corresponding to it. (d) Immobile fraction and (c) Half time of E-cadherin were extracted 
from the one-phase association curves. (n=11); ***p<0.001, **** p<0.0001 compared with controls (Student’s T-
test).  
 
    
Strikingly, compared to control, the turnover of apical cadherin pool was significantly higher in 
ECT2 KD cells as exemplified by a significant decrease in the immobile fraction and half time (Fig 
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2.10). Also, direct inhibition of Rho by the pharmacological inhibitor C3-T and depletion of its 
downstream effector Myosin IIA led to a similar phenotype, as there was marked increase in GFP-
E-cad mobility (Fig 2.10). This strongly supports the theory that ECT2-mediated activation of Rho 
leads to the stabilization of apical cadherin pool by the Myosin IIA pathway. Rho activates Myosin 
IIA by phosphorylating its regulatory light chain via ROCK.  This puts Myosin IIA in a pathway in 
which ECT2, a GEF, activates Rho, which drives Myosin activity. Myosin IIA in turns helps in 
clustering of E-cadherin and thus maintains ZA integrity.  
2.3.4 ECT2 is important for junctional tension 
 
Tension imparted by Myosin motors on actin filaments generates contractile forces inside the cells. 
This actomyosin-generated tension is necessary for morphogenesis and regulates cell-cell adhesion 
(Gomez et al., 2011; Liu et al., 2010). Myosin II appears to be important for the generation of this 
tension as when inhibited or depleted, it leads to a decrease in forces and also cadherin adhesion is 
compromised (Ladoux et al., 2010). Also, adherens junctions act to transmit this mechanical tension 
across neighbouring cells as integration of these forces is important for producing tissue level 
changes during morphogenesis (Maitre et al., 2012; Parsons et al., 2010; Kasza and Zallen, 2011).  
 
As ECT2 knockdown cells showed decreased Myosin IIA localization, I sought to test the 
hypothesis that junctional tension is compromised in these cells. For this a multi-mode tuneable 
Chameleon laser was used to ablate cell-cell contacts labelled with E-cadherin GFP (see Material 
and Methods for details). Instantaneous recoil of the contacts at its vertices was measured as an 
index of junctional tension(Fernandez-Gonzalez et al., 2009). 
 
Inside the cells, the actomyosin network ring beneath the contact imparts its tension and thus when 
ablated, this ring is disrupted and the tension is released which leads to the expansion of contact. 
This degree of expansion is correlated to the tension inherent to that contact. As evident, control 
cells showed a visible expansion in contact length after the ablation, but depletion of ECT2, Myosin 
IIA and inhibition of Rho signalling led to no change in contact length after ablation (Fig 2.11).   
 
This contact expansion was measured by determining the difference between the position of two 
vertices before and after ablation and the resulting values (vertex separation) were fitted in a one-
phase association curve (Fig 2.12). The value of initial recoil (parameter of junctional tension) was 
obtained from these curves and as shown, there was a decrease in junctional tension in ECT2 KD, 
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Myosin II KD and C3-transferase treated cells thus suggesting that ECT2 supports junctional 
tension via the Myosin IIA pathway (Fig 2.12). 
 
Fig 2.11 Contact expansion after laser-ablation in the indicated conditions 
 
 MCF-7 cells expressing (a) E-cadherin GFP (control) were infected with virus encoding (c) Myosin IIA KD 
shRNA, (d) Ect2 KD shRNA and were treated with (b) c3-trasnferase (500 ng/µl for 1 hour). A constant ROI was 
marked for each experiment and contacts marked with GFP-cadherin were ablated with 3 iterations  of 790 nm 
laser with 100 % transmission. Represented are the still from the movie at indicated time frames. 
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Fig 2.12 ECT2-Rho signaling is essential for junctional tension 
 
(a) The distance (d) between vertices that define the ablated contact was measured as a function of time (t). Then 
obtained values d(t) were subtracted from the average distance before the ablation step d(0) and the resulted 
values were fitted in an one-phase association curve.(b) Average Instantaneous recoil for 10-15 contacts was 
determined from the curve and then normalized to value according to control conditions 
 (n=10-15) ,  where * p< 0.03, Student’s t-test)  
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2.3.5 Functional implications of ECT2 knockdown on morphogenesis using cyst culture 
 
Cadherins mediate many aspects of morphogenesis and are dynamically regulated in response to 
developmental or physiological signaling pathways (Gumbiner, 2005). The above results suggest 
that ECT2 is important for E-cadherin organization at the ZA (Ratheesh et al., 2012). To further 
pursue this, I aimed to assess the functional relevance of this phenotype in a physiological relevant 
setting. So, to identify the importance of ECT2 for epithelial morphogenesis I used 3-D cyst culture 
of ECT2 knockdown cells. A lentivirus-mediated knockdown of ECT2 was performed in human 
colon carcinoma cell lines Caco-2. Caco-2 cells were chosen because, although derived from tumor 
cells, they polarize to form cysts in 3-D culture (Jaffe et al., 2008). Briefly, Caco-2 cells were 
trypsinized to form a single cell suspension and 2 X 10 4 cells were mixed in a solution containing 
RPMI and matrigel  (reduced growth factor, Becton Dickinson) to a final concentration of 2%. Then 
200 µl of above solution was added to each well of a chambered cover glass and placed in 37° C 
incubator. The cysts were ready in 10 days and then were stained for the relevant proteins. 
 
Recently two research articles from Toru Miki's group have suggested that ECT2 is important for 
polarity. Using highly polarized MDCK cell lines and the yeast two-hybrid system, they have 
shown that ECT2 interacts with the polarity component Par6, also associates with Par3 and 
PKCzeta, and is required for the Par3/Par6/aPKC polarity complex to be recruited to tight junctions 
(Liu et al., 2004; Liu et al., 2006).  Surprisingly, in the Caco-2 cyst cultures depleted of ECT2, loss 
of polarity was not observed, as assessed by the apical localization of aPKC, ZO-1, actin and lateral 
distribution of E-cadherin (Fig 2.13 a,b,c,d). However, ECT2 knockdown leads to certain defects in 
cysts formation. There were fewer cysts formed from ECT2 KD cells, and the ones formed were 
strikingly smaller in size and were generally devoid of lumens (Fig 2,13 e). Also, we observed less 
E-cadherin concentration at the intercellular contacts (Fig 2.13 f); in most of the cases the E-
cadherin organization was grossly disrupted or altogether reduced levels of E-cadherin was 
observed. E-cadherin has been shown to be essential for proper lumen formation in 3-D cysts 
cultures (Marciano et al., 2011; Jia et al., 2011). 
 
So, above results suggest an alternative role of ECT2 in morphogenesis by regulating the size of 
cysts and lumen formation and this may be via regulating the organization of E-cadherin. However, 
further experiments are needed to support and build up on this observation. Due to the time-
constraints of my PHD tenure, I was not able to pursue this further, but it remains an exciting 
possibility to be explored. 
 
 59 
 
 
Fig 2.13 ECT2KD does not affect polarity but perturbs E-cadherin distribution 
 
Ect2 KD does not affect polarity  (a,b,d) but leads to smaller cyst size (e), absence of lumen (e)  and disruption of 
E-cadherin (c,f). Caco-2 cysts were transduced with lentivirus encoding ECT2 shRNA or control shRNA, grown 
for 10-12 days, fixed with 4% PFA and stained for indicated proteins as shown.  
Scale Bar = 20 µm 
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2.4 Significance and outcomes 
 
Rho GTPases are the key regulators of epithelial cell junctions (Amano et al., 2010). They act in 
concert with various downstream effectors to dynamically organize various cellular structures like 
acto-myosin network, cell-adhesion proteins and microtubules (Bishop and Hall, 2000; Etienne-
Manneville and Hall, 2002). At a given time and space, the activity of Rho is very finely tuned to 
generate a proper biological response via its upstream regulators: GEFs, GAPs and GDIs (Etienne-
Manneville and Hall, 2002; Rossman et al., 2005). However, we still don’t understand the exact 
molecular pathway and relevant components required to generate a functional Rho circuit.  
 
The results presented in this study strengthen the notion that junctional Rho signaling is required to 
maintain a functional zonula adherens and detail the mechanism behind it. Also, it identifies ECT2 
as the prominent ‘functional’ Rho-GEF at ZA and implies its role in supporting ZA organization 
and junctional tension via the Myosin IIA pathway. These findings suggest a novel extra-mitotic 
role for ECT2 in supporting junctional biology. This is significant, as the general consensus is that 
ECT2 is mostly nuclear in interphase cells and functions mainly during cytokinesis (Fields and 
Justilien, 2010). However all these studies were done in single cells which cannot form intercellular 
junctions. Apart from the Yap laboratory, other groups have also confirmed that ECT2 can localize 
to junctions in epithelial cells and can perform junction specific functions like regulating cell 
polarity and interacting with junctional complexes (Liu et al., 2006)  
 
The work presented here establishes that ECT2 supports ZA architecture by stabilizing cadherin at 
the apical zone of the cells via Myosin IIA. ECT2 depletion led to loss of cadherin ring at the apical 
zone of cells and this could be restored back by the expression of Myosin IIA. Also, using FRAP 
analysis of GFP-E-cadherin, it was found that this Rho-ECT2 pathway is essential to constrain E-
cadherin mobility at the ZA, mostly by supporting Myosin IIA accumulation (as ECT2 depletion 
specifically perturbs Mysoin IIA, but not IIB). Strikingly, these functions of Rho-GEF ECT2 are 
specific for ZA, as ECT2 knockdown did not affect tight junctions marked by ZO-1. Interestingly, 
p115 Rho GEF has been demonstrated to specifically support tight junctions but not ZA, thus 
further re-enforcing the idea that spatio-temporal activity of Rho GTPase is tightly regulated by 
their regulators depending on the cellular context. Further, using a two-photon laser to cut junctions 
and by measuring the instant recoil as a measure of tension, I have shown that ECT2 acts in concert 
with myosin IIA to maintain the junctional tension, which is critical for epithelial remodeling 
during tissue organization. 
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Overall, these results uncover a novel role of Rho GEF ECT2; that is to promote ZA organization 
and cortical tension in interphase epithelial cells.  
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Chapter 3: E-cadherin supports steady-state Rho signaling at the 
epithelial zonula adherens 
 
3.1 Introduction 
 
The Zonula Adherens (ZA) is a cadherin based cell-cell adhesive structure found in epithelia. E-
cadherin forms the core component of ZA and maintains epithelial cell shape and morphology. The 
extracellular domain of E-cadherin mediates calcium-dependent adhesion while the cytoplasmic 
domain associates with actomyosin cytoskeleton (reviewed in (Niessen et al., 2011). This 
actomyosin cytoskeleton is mainly regulated by Rho family GTPases. These small GTPases (mainly 
Rho and Rac) localize to cadherin-based junctions and together with the actomyosin cytoskeleton, 
they ensure proper organization and functionality of these adhesive structures (Braga, 2000). In 
turn, the localization and activity of these small GTPases is regulated in a cadherin-dependent 
manner (Braga and Yap, 2005; Kovacs et al., 2002; Wheelock and Johnson, 2003). This hints that 
junctions and Rho GTPases act in a co-operative manner to achieve significant biological outcome 
but the exact nature of this interaction is not well-understood.  
 
One of the open questions in the field is how cadherin signaling regulates Rho GTPases.  By plating 
CHO cells expressing C-cadherin on the immobilized extracellular domain of C-cadherin, Noren et 
al showed that upon cadherin ligation, Rac1 gets activated but activity of Rho is diminished (Noren 
et al., 2001). They further proposed that cadherin engagement leads to activation of a Rho GAP, 
p190RhoGAP, that dampens Rho signaling (Noren et al., 2003). Rho and Rac are believed to 
occupy two distinct zones during nascent junction formation. As cells make contact with each other, 
Rac takes the centre stage along with its effectors and later on is replaced by Rho (Yamada and 
Nelson, 2007). However, these reports of Rho inhibition by cadherin adhesion are studied in a 
context that is different from steady-state homeostasis that we investigate. 
 
Recently we discovered a pathway that regulates Rho signaling at ZA. We have shown that ZA is a 
Rho zone and harbors a conserved molecular ensemble known to control Rho at the cytokinetic 
furrow (Ratheesh et al., 2012). This ensemble is comprised of ECT2, a GEF for Rho, and the 
centralspindlin (CS) complex (composed of MgcRACGAP and MKLP1). The CS complex supports 
junctional Rho signaling by concentrating ECT2 at ZA and also by interfering with the junctional 
localization of p190RhoGAP, a GAP for Rho (Ratheesh et al., 2012). Together, this pathway 
facilitates the downstream activation of Myosin IIA, which promotes E-cadherin concentration and 
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junctional tension. Interestingly, in our hands α-catenin was necessary for junctional Rho signaling 
as it supports CS and ECT2 retention at junctions (Ratheesh et al., 2012).  
 
In this chapter, I have taken a step further and aimed to study the direct impact of E-cadherin on 
steady-state Rho signaling and extended my previous observation that Rho signaling stabilizes 
cadherin at the apical junctions. 
3.2 Result 
 
This research chapter has been divided into sections: 
 
3.2.1 The results related to this chapter have been published as a research article in Differentiation, 
86 (2013) 133–140, May 2013, of which I am the first author. The article is attached here. 
Erratum: The images corresponding to MgcRacGAP for Control and E-cad GFP (Fig 3a) got swapped during 
the preparation of manuscript. This is an unwanted technical error and has no consequences on the meaning of 
the figure and/or the rest of the manuscript. 
 
 
3.2.2 An article published in www.bio-protocol.org, expanding on the FRAP experiments I 
performed in the research chapter 1 and 2. 
 http://www.bio-protocol.org/e937 
 The article is attached here. 
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In simple polarized epithelial cells, the Rho GTPase commonly localizes to E-cadherin-based cell–cell
junctions, such as the zonula adherens (ZA), where it regulates the actomyosin cytoskeleton to support
junctional integrity and tension. An important question is how E-cadherin contributes to Rho signaling,
notably whether junctional Rho may depend on cadherin adhesion. We sought to investigate this by
assessing Rho localization and activity in epithelial monolayers depleted of E-cadherin by RNAi.
We report that E-cadherin depletion reduced both Rho and Rho-GTP at the ZA, an effect that was
rescued by expressing a RNAi-resistant full-length E-cadherin transgene. This impact on Rho signaling
was accompanied by reduced junctional localization of the Rho GEF ECT2 and the centralspindlin
complex that recruits ECT2. Further, the Rho signaling pathway contributes to the selective stabiliza-
tion of E-cadherin molecules in the apical zone of the cells compared with E-cadherin at the lateral
surface, thereby creating a more defined and restricted pool of E-cadherin that forms the ZA. Thus,
E-cadherin and Rho signaling cooperate to ensure proper ZA architecture and function.
& 2013 International Society of Differentiation. Published by Elsevier B.V. All rights reserved.
1. Introduction
Classical cadherin adhesion receptors control morphogenesis and
tissue organization through close cooperation with the acto-myosin
cytoskeleton (Mason and Martin, 2011; Roh-Johnson et al., 2012).
Cadherin extracellular domains mediate adhesive binding, while
their cytoplasmic tails can functionally interact with the cytoskele-
ton through physical binding to actin filaments as well as regulation
of filament dynamics and organization (Ratheesh and Yap, 2012).
This apparatus integrates cell–cell adhesion and the cytoskeleton.
Indeed, cadherins may play a significant morphogenetic role by
mechanically coupling the tension-generating apparatuses of corti-
cal cytoskeletons in neighboring cells (Maitre et al., 2012). In simple
epithelia, this integration is exemplified by the zonula adherens (ZA)
(Meng et al., 2008; Otani et al., 2006), a specialized adhesive
junction where Myosin II is locally recruited to concentrate
E-cadherin and generate junctional tension (Ratheesh et al., 2012;
Smutny et al., 2010).
Rho family GTPases play important roles in supporting
cadherin–actin cooperation at junctions such as the ZA (Braga, 2000).
The canonical members of this family (Rho, Rac, and Cdc42) have
been identified at cadherin junctions. In particular, Rho and Rac may
play pivotal roles by regulating myosin II recruitment (Ratheesh et al.,
2012; Shewan et al., 2005; Smutny et al., 2010) and actin assembly
(Insall and Machesky, 2009; Kraemer et al., 2007; Yamazaki et al.,
2007), respectively. Further, disruption of Rho and/or Rac signaling
can perturb junctional integrity; therefore expression of these signals
may be important for junctional homeostasis. Rho GTPases are
molecular switches that shuttle between a GTP-bound active state
and a GDP-bound inactive state. The nucleotide status of GTPases is,
in turn, controlled by three sets of regulatory proteins: guanine
nucleotide exchange factors (GEFs) that activate GTPases by the
exchange of GDP for GTP; GTPase-activating proteins (GAPS) that
inhibit GTPases by accelerating the hydrolysis of GTP to GDP; and
GDP dissociation inhibitors (GDIs) that extract GTPases from mem-
branes and sequester them in the cytosol (Etienne-Manneville and
Hall, 2002). Potentially the interplay between these three sets of
regulators, or subsets of them, may determine the stringent expres-
sion of GTPase signaling (Miller and Bement, 2009).
Indeed, we recently identified a regulatory apparatus that
coordinates the balance between GEF and GAP activity to influ-
ence Rho signaling at the epithelial ZA (Ratheesh et al., 2012).
This apparatus involved the centralspindlin (CS) complex, com-
posed of MgcRacGAP and MKLP1, which is best-understood to
control Rho at the cytokinetic furrow of dividing cells. However,
we found that CS also localizes to the ZA of interphase epithelial
cells. There it supported Rho signaling by localizing a GEF, ECT2,
to activate Rho, and also by preventing the junctional localization
of p190B RhoGAP, a GAP for Rho (Ratheesh et al., 2012). Together,
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this pathway facilitates the downstream activation of Myosin IIA,
which promotes E-cadherin concentration and junctional tension.
An important cognate question is the role that the E-cadherin
adhesion system plays in the control of junctional GTPase signaling.
Ligation of E-cadherin can activate Rac (Kovacs et al., 2002; Kraemer
et al., 2007; Nakagawa et al., 2001; Yamada and Nelson, 2007)) and
Cdc42 (Kim et al., 2000; Kraemer et al., 2007), suggesting that these
may be directly downstream of E-cadherin. Further, we found that
the centralspindlin complex was localized to the ZA through an
interaction with the N-terminus of a-catenin (Ratheesh et al., 2012),
implying a supportive influence of E-cadherin on junctional Rho
signaling at established junctions. In contrast, ligation of Xenopus
C-cadherin caused an acute reduction in Rho-GTP levels (Noren et al.,
2001), apparently due to the activation of p190 RhoGAP (Noren et al.,
2003). This suggested that cadherin adhesion might inhibit Rho
signaling. Accordingly, in this paper we sought to test the impact of
E-cadherin on Rho signaling at mature zonulae adherente.
2. Materials and methods
2.1. Cell culture, antibodies, plasmids and shRNA reagents
MCF-7 cells were cultured in a Dulbecco’s modified Eagle’s
medium supplemented with 10% FBS, 2 mM glutamine,
non-essential amino acids, 100 units/ml penicillin, 100 mg/ml
streptavidin and 0.01 mg/ml bovine insulin. Lipofectamine RNAi-
MAX (Invitrogen) was used for transfection of RNAi oligonucleo-
tides according to the manufacturer’s instructions and cells were
analyzed 48 h after transfection.
A lentivirus-based shRNA system was used to deplete
endogenous E-cadherin, ECT2 and Myosin IIA (Rubinson et al.,
2003); it was also used to simultaneously deplete endogenous E-
cadherin and express mouse E-cadherin fused to GFP (Smutny
et al., 2011). The lentivirus expression vector LentiLox pLL5.0
(backbone pLL3.7) and the third-generation packaging constructs
pMDLg/pRRE, RSV-Rev and pMD.G were gifted from James Bear
(UNC Chapel Hill, USA) (Vitriol et al., 2007). E-cadherin, ECT2 and
Myosin IIA shRNA sequences and virus production and infection
methods have been described earlier (Ratheesh et al., 2012;
Smutny et al., 2010). pTriEx-RhoA Biosensor WT used for RhoA
FRET experiments was obtained from Addgene and has been
described previously (Pertz et al., 2006).
Primary antibodies used in this study were as follows: (1) mouse
monoclonal antibody (mAb) directed against the ectodomain of
human E-cadherin (HECD-1) (a gift from Peggy Wheelock,
University of Nebraska, Omaha, NE; with the permission of
M. Takeichi); (2) E-cad mouse IgG2a mAb against cytoplasmic tail,
BD Transduction Laboratories (cat #610182); (3) rabbit poly-
clonal Ab (pAB) against human E-cadherin (generated in-house)
(Helwani et al., 2004); (4) E-cadherin rat mAb (ECCD-2, Invitrogen,
cat #13-1900); (5) ECT2 rabbit pAb (Millipore, cat #07-1364);
(6) human ZO-1, rabbit pAb (Invitrogen, cat #61-7300); (7) MKLP1,
rabbit pAb (Santa Cruz, cat #22793); (8) MgcRacGAP, rabbit pAb
(Santa Cruz, cat #sc98617); (9) RhoA, mouse mAb (Santa Cruz, cat
#sc418); and (10) GAPDH, rabbit pAb (R&D systems). Secondary
antibodies were species-specific antibodies conjugated with Alexa-
Fluor 488, 594 or 647 (Invitrogen) for immunofluorescence, or with
horseradish peroxidase (Bio-Rad Laboratories) for immunoblotting.
Western Blots were performed as described previously (Mangold
et al., 2011).
2.2. Immunofluorescence, confocal microscopy, image acquisition
and processing
MCF-7 cells were fixed with 10% TCA on ice for 15 min for Rho
staining or with ice-cold methanol for 5 min on ice for ECT2/
MgcRacGAP/MKLP1 staining. To stain for cytoplasmic GFP, cells
were fixed with 4% Paraformaldehyde in PBS on ice for 20 min
and then permeabilized with 0.25% Triton-X100 in PBS for 5 min
at room temperature.
For immunofluorescence, confocal images were acquired with
a Zeiss 710 Meta laser scanning confocal microscope, with a
60" objective, 1.4 NA oil Plan Apochromat immersion lens with
0.6–1.0 mm optical sections. Contrast adjustment, background
corrections and z-projections of raw images were done by using
ImageJ software (National Institutes of Health), Imaris (Bitplane)
and Illustrator (Adobe). For quantitation of fluorescence intensity
at contacts of immunofluorescence images, the line scan function
of ImageJ was used as described in detail previously (Smutny
et al., 2010). For each experiment, up to 25 contacts were
analyzed. Data were processed using Prism.
The Z-stack profile of fluorescence intensity at cell–cell junc-
tions was determined as follows: Z-stacks of the entire lateral
region of cells stained for RhoA, E-cadherin and ZO1 were
acquired by confocal microscopy with 0.3 mm interval steps and
0.6 mm optical sections. Junctional average and background
intensities for each protein at different z-positions were deter-
mined in small regions located at the junctions and next to these.
After background subtraction and normalization along the Z-axis,
z-profiles of normalized fluorescence for multiple contacts
(n¼15) were aligned using the position of the maximum normal-
ized intensity of ZO1 as a reference (0 mm), where positive values
correspond to lower z-sections.
2.3. Fluorescence recovery after photobleaching (FRAP)
To address the issue of E-cadherin dynamics, E-cadherin GFP
was expressed in an endogenous E-cadherin knockdown back-
ground using lentivrus infection (Smutny et al., 2011). ECT2 and
Myosin IIA KD was performed by coinfecting the above cells with
either lentivirus encoding shRNA designed against the 30UTR
Fig. 1. Rho signaling at the zonula adherens requires E-cadherin. (a) RhoA (green), E-cadherin (red) and ZO-1 (magenta) immunostaining in confluent MCF-7 cells. Left;
Representative confocal sections of a 3D Z-stack showing E-cadherin (middle panel) and RhoA (top panel) distribution at the zonula adherens (Z¼1.2 mm) and ZO-1
(bottom panel) distribution at tight junctions (Z¼0 mm). The position of the tight junctions was used as reference. Right, Merge of E-cadherin and RhoA at the zonula
adherens and X–Z projection (taken at the horizontal line) showing the distribution of E-cadherin, RhoA and ZO-1. (b) Z-stack profile of fluorescence intensity for RhoA,
E-cadherin and ZO-1 at cell–cell junctions, data represent means7SEM. (c and d) MCF-7 cells were infected with lentivirus encoding GFP (Control) or lentivirus encoding
an shRNA for human E-cadherin (E-cad KD) and GFP, or virus encoding both an shRNA for human E-cad and a mouse E-cad GFP transgene (E-cadKDþrescue).
(c) Immunoblots were probed for endogenous human E-cadherin and mouse E-cad GFP using the same antibody directed against the cytoplasmic domain of E-cadherin
and GAPDH. (d) Infected cells were examined for GFP fluorescence, endogenous E-cadherin and ZO-1 by immunostaining. (e–g) Control, E-cad KD or E-cad KDþrescue (E-
cad GFP) MCF-7 cells co-stained for RhoA and E-cad. Representative confocal images acquired at apical junctions are shown and fluorescence intensity at cell junctions was
quantitated by linescan analysis (f). Represented are mean values7SEM of contact profiles in control (blue), E-cad KD (red) and E-cad GFP (green) cells and peak
fluorescence intensity at cell–cell contacts (g). Data represent means7SD of data pooled from three individual experiments (n¼25), Po0.001; One-way Anova, Dunnett’s
post hoc test. (h–j) E-cadherin depletion reduces junctional Rho-GTP. MCF-7 cells transfected with E-cad siRNA or scrambled siRNA and a RhoA biosensor were
immunoblotted for E-cadherin and GAPDH (h). (i) Cells were imaged live using confocal microscopy and representative images (YFP and ratio of FRET/CFP) are shown.
(j) Average emission ratios (FRET/CFP) were determined at the apical junctions. Data represent means7SEM pooled from three individual experiments (n¼35), Po0.0001;
Student’s t-test. Scale bars: (a) 5 mm and (d, e and i) 10 mm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of
this article.)
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region of ECT2 or lentivirus encoding shRNA against Myosin IIA
(MYH9) (Ratheesh et al., 2012; Smutny et al., 2010). Cells were
split into glass bottom dishes (N 1.5, MatTek corporation, MA)
48 h after infection and grown to full confluency. For image
acquisition, cells were washed and incubated in the presence of
imaging media (Hank’s balanced salt solution supplemented with
10 mM HEPES pH 7.4 and 5 mM CaCl2). For these experiments,
only cells co-expressing E-cadherin GFP and cherry were chosen
to ensure the presence of the knockdown phenotype. To inhibit
Rho signaling, cells were treated with 500 ng/ml of cell-permeant
C3 Transferase (Rho inhibitor I, Cytoskeleton, CO) in imaging
media for 1 h, washed and incubated in the same. Cells with en
face contacts were chosen, which allowed us to precisely identify
and photobleach the zonula adherens and the lateral contacts.
Image acquisition and analysis for FRAP experiments have been
described previously (Ratheesh et al., 2012). Briefly, time-lapse
images were acquired before and after photo bleaching with an
interval of 5 s per frame (total 280 s). Image analysis was performed
using ImageJ. Fluorescence intensities values F(t) in the bleached
area were normalized to prebleach values and fitted to the equation:
Fluorescence recovery¼ FðtÞ&Fð0Þ
Fð&tÞ ¼Mf ð1&e
ln 2t=t1=2 Þ
where F(t) is the average fluorescence of the bleached area during
the time series, Mf is the mobile fraction, t1/2 is the half time of
recovery and t is time in seconds.
2.4. Fluorescence resonance energy transfer (FRET) microscopy
MCF-7 cells were transiently transfected with the RhoA
biosensor and E-cadherin Dharmacon SMARTpool siRNA (50 nM)
directed against human CDH1 (NM_004360). Non-targeting
siRNA pools were used as controls (Dharmacon). FRET measure-
ments were performed 48 h after transfection as described pre-
viously (Ratheesh et al., 2012). Briefly, cells were imaged live at
37 1C by confocal microscopy and images acquired on a LSM710
Zeiss confocal microscope equipped with a 63" oil Immersion
objective (Plan Apochromat 63"1.4NA, Zeiss, Jena, GER). Donor
(D) and FRET (F) channels were recorded by scanning using a
458 nm laser line and collecting the emission in the donor
emission range (BP 470–490 nm) and acceptor emission range
(BP 530–590 nm), respectively. In addition, the acceptor
(A) channel was acquired using the 514 nm laser line for excita-
tion and collecting the emission in the acceptor emission range.
Images were acquired by sequential line acquisition.
[FRET/Donor] emission ratios calculated for pixels located at
the cell–cell junctions in every image were normalized to the
value corresponding to the average FRET emission ratio value
observed in control conditions. Data presented are mean FRET
emission ratios calculated across the different images and their
standard errors.
3. Results
3.1. E-cadherin is necessary for junctional Rho signaling
To investigate the impact of E-cadherin on RhoA signaling, we
first used immunofluorescence and confocal microscopy to char-
acterize the distribution of RhoA and E-cadherin at cell–cell
interfaces in confluent MCF-7 cells monolayers. We found that
RhoA concentrates with E-cadherin at the apical region of cells,
but below the tight junction marker ZO1 (Fig. 1a, and b), thus
reinforcing the idea that cadherin junctions, such as the ZA, are
sites that accumulate Rho (Ratheesh et al., 2012). In addition, our
detailed analysis of junctional RhoA distribution showed that it is
also present, though less prominent, with E-cadherin at the lateral
surface (Fig. 1a, and b).
To analyze if E-cadherin supports junctional RhoA, MCF-7
cells were infected with a lentivirus encoding E-cadherin shRNA.
A significant reduction in E-cadherin expression was detected by
both immunofluorescence ('80%, Fig. 1d) and western blot
analysis (50%, Fig. 1c) where the difference observed is mainly
due to the heterogeneity of lentiviral infection. In control cells,
RhoA staining was evident at the ZA (along with cytoplasmic
staining) and this junctional staining was diminished upon E-
cadherin depletion (E-cad KD), becoming more diffused and
punctated (Fig. 1e). This was not a consequence of the loss of
cell junctions as tight junctions, identified by ZO-1 staining,
remained intact in E-cad KD cells (Fig. 1d). We quantified the
reduction in RhoA junctional intensity in E-cadherin KD cells
using line scan analysis and confirmed the significant reduction
when compared to control cells (Fig. 1f, and g). Also, by
expressing a RNAi resistant mouse-E-cad-GFP transgene
(Fig. 1c), we were able to restore junctional RhoA, indicating
that the changes in RhoA localization were attributable to the
reduction in E-cadherin (Fig. 1e–g).
These results, together with our previous observations that its
active state was closely related to the junctional concentration of
RhoA (Ratheesh et al., 2012), suggested that E-cadherin is
required to maintain an active pool of Rho at the ZA. To confirm
if this was indeed the case, we used a RhoA-FRET biosensor to
analyze the impact of E-cadherin on RhoA activation at the ZA in
live cells (Pertz et al., 2006; Ratheesh et al., 2012). For these
experiments the RhoA biosensor was co-transfected with a
Dharmacon smartpool siRNA targeted against E-cadherin
(Fig. 1h) as the E-cadherin shRNA lentiviral system also expresses
GFP as an infection marker, which interferes with the detection of
CFP and YFP fluorescence. FRET measurements were performed
48 h after transfection (Ratheesh et al., 2012). Indeed, E-cad KD
reduced junctional Rho-GTP significantly compared to control
cells (Fig. 1i and j). Overall, these results imply that E-cadherin is
required to sustain Rho signaling at the ZA.
3.2. Junctional localization of Rho-GEF ECT2 and centralspindlin
requires E-cadherin
The spatial expression of RhoA activity can reflect tight
regulation by GEFs and GAPs. We recently demonstrated that
ECT2, a member of the Dbl family of Rho GEFs, supports Rho
signaling at the ZA in MCF-7 cells (Ratheesh et al., 2012). ECT2
localized to the ZA, in turn, through the action of the CS complex,
which binds to a-catenin. Accordingly, we hypothesized that Rho
signaling in E-cadherin KD cells might arise from loss of one or
both of these elements from junctions.
To test this notion, we first examined the effect of E-cad KD on
junctional ECT2. MCF-7 cells infected with lentivirus encoding
E-cad shRNA were methanol fixed and stained for ECT2 and E-cad.
In control cells, ECT2 accumulated at the cell–cell junctions,
preferentially at the ZA (not shown) (Ratheesh et al., 2012).
However, depletion of E-cadherin expression by shRNA caused a
significant reduction in the junctional ECT2 as shown in Fig. 2a
and further confirmed by line scan analysis (Fig. 2b and c). As
with junctional RhoA, the loss of junctional ECT2 in E-cad KD cells
was restored by expression of RNAi-resistant E-cad-GFP (Fig. 2b
and c). Then we tested the impact of E-cadherin depletion on
junctional CS, by co-staining E-cadherin either with MgcRacGAP
(Fig. 3a–c) or MKLP1 (Fig. 3d–f), the components of the CS
complex. Whereas MgcRacGAP and MKLP1 localized at the ZA in
confluent control MCF7 cells, their junctional levels were sub-
stantially reduced by E-cadherin shRNA, and this was restored by
expression of RNAi-resistant E-cad GFP (Fig. 3). Overall, these
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findings suggest that E-cadherin may support Rho signaling at ZA
by maintaining ECT2 and CS at these junctions.
3.3. The ECT2-Rho signaling pathway specifically stabilizes apical,
rather than lateral, E-cadherin
A major target for Rho signaling at the ZA is non-muscle
myosin II, especially the myosin IIA isoform (Smutny et al., 2010),
which promotes junctional integrity by stabilizing mobility of
E-cadherin at the ZA (Ratheesh et al., 2012). Further, elements of
the CS-Rho signaling pathway also limit cadherin mobility,
indicating that this whole pathway serves to stabilize E-
cadherin at the ZA (Ratheesh et al., 2012).
However, E-cadherin can also be found elsewhere at cell–cell
junctions. Notably, it often forms dispersed clusters and strands at
the lateral junctions, below the ring-like structure of the apical ZA
(Kametani and Takeichi, 2007; Klingelhofer et al., 2002; Meng and
Takeichi, 2009). We therefore asked whether molecular mobility
might differ between the apical (ZA) and lateral pools of cadherin.
E-cadherin-GFP was expressed in MCF-7 cells depleted of endo-
genous E-cadherin by shRNA (Fig. 1c, Ratheesh et al., 2012;
Smutny et al., 2011) and fluorescence recovery after photobleach-
ing (FRAP) was monitored in small foci at the ZA and lateral
regions of the same junctions. We found that the apical and
lateral E-cadherin in control cells showed strikingly different
patterns of fluorescence recovery (Fig. 4a and b). The lateral
cadherin displayed a significantly shorter t1/2 and greater mobile
fraction than did the apical cadherin pool (Table 1). Thus, even
within individual contacts, E-cadherin in the apical pool is
relatively more stable and less mobile than that in the lateral
pool.
We then asked whether E-cadherin stabilization in the ZA pool
might reflect the action of the CS-ECT2-Rho signaling pathway and
its effectors (Fig. 4c and e). We compared apical and lateral
E-cadherin turnover in cells where ECT2 or Rho was perturbed by
RNAi or C3-transferase, respectively. In both cases, the regional
difference in E-cadherin turnover seen in control cells was abolished,
and the FRAP curves largely coincided. In particular, the mobile
fractions were indistinguishable in the apical and lateral zones from
both ECT2-KD and C3-transferase-treated cells, although regional
differences in t1/2 persisted (Table 1). Further, the difference
between apical and lateral turnover was also lost in Myosin IIA
shRNA cells (Fig. 4d). Overall, these findings support the notion that
local activation of myosin IIA by the ECT2-RhoA pathway creates a
pool of E-cadherin at the ZA whose mobility is more restricted than
that in the lateral pool.
4. Discussion
E-cadherin-based cell–cell junctions and Rho family GTPase
signaling pathways interact cooperatively. Not only can GTPases
Fig. 2. E-cadherin is necessary for the junctional localization of Rho-GEF ECT2. (a) Control, E-cadherin KD or E-cad KDþrescue (E-cad GFP) MCF-7 cells co-stained for ECT2
and E-cadherin. Representative confocal images acquired at apical junctions are shown and fluorescence intensity at cell junctions was quantitated by linescan analysis.
Represented are mean values7SEM of contact profiles in control (blue), E-cad KD (red) and E-cad GFP (green) cells (b) and peak fluorescence intensity at cell-cell contacts
(c). Data represent means7SD of data pooled from three individual experiments (n¼20), Po0.001; One way Anova, Dunnett’s post hoc test. Scale bars: (a) 10 mm.
(For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
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and their downstream effectors influence junctional integrity and
dynamics (commonly described as ‘‘inside-out’’ signaling) (Fukata
and Kaibuchi, 2001; Wheelock and Johnson, 2003) but cadherin
adhesion can itself regulate the localization and function of these
GTPases (‘‘outside-in signaling’’) (Braga, 2000; Wheelock and
Johnson, 2003; Yap and Kovacs, 2003). In this report we sought to
investigate both aspects of this signaling nexus.
Our analysis indicated that although Rho localizes throughout
lateral cell–cell contacts, it preferentially concentrates at the zonula
adherens with E-cadherin. Our results also suggest that E-cadherin
is required to maintain active Rho signaling at established cell–cell
junctions, especially at the specialized zonula adherens that we
studied. Thus, both RhoA protein and RhoA-GTP signals at the
junctions were significantly reduced in E-cadherin RNAi cells,
although some degree of cell–cell contact was preserved
(as indicated by the persistence of ZO-1 staining). This implied that
the presence of E-cadherin, rather than simply cell–cell contact, was
necessary for steady-state Rho signaling at the ZA. Further, Rho
signaling at the ZA is regulated by the centralspindlin complex,
which localizes by directly or indirectly binding to a-catenin
(Ratheesh et al., 2012). This suggested that cadherin might
ultimately influence Rho signaling through CS. Indeed, we now find
that E-cadherin depletion displaced both CS and its effector, ECT2,
from junctions. Together, these findings support the notion that
E-cadherin supports RhoA signaling at the ZA by controlling the
junctional localization of CS and, thereby, the RhoA activator, ECT2.
The apparently preferential localization of CS and ECT2 to the
ZA implies that this pathway regulates Rho signaling in this
spatially restricted region of the apical junction. Such spatial
selectivity might, in turn, locally regulate downstream effectors
and their potential impact on E-cadherin. One such effector is
myosin IIA, which is necessary for ZA integrity (Ratheesh et al.,
2012; Smutny et al., 2010) and selectively stabilizes E-cadherin
in the apical (ZA) pool. Thus, our FRAP analysis indicates that
E-cadherin at the ZA has a significantly restricted mobility
compared with that found at the lateral surface of cell–cell
contacts below the ZA. However, this difference was largely
abolished in myosin IIA RNAi cells. Further, the spatial difference
in mobility patterns was also abolished when elements of the
upstream regulatory pathway, Rho and its apically confined
activator ECT2, were perturbed. Overall, this suggests that the
spatially confined localization of upstream Rho regulators, such as
Fig. 3. E-cadherin supports junctional localization of the Centralspindlin complex. Control E-cadherin KD or E-cad KDþrescue (E-cad GFP) MCF-7 cells co-stained for
E-cadherin and either MgcRacGAP (a–c) or MKLP1 (d–f). Representative confocal images acquired at apical junctions are shown (a, d) and fluorescence intensity at cell
junctions was quantitated by linescan analysis (b, c, e, and f). (b and e) Represented are mean values7SEM of contact profiles for MgcRacGAP (b) or MKLP1 (e) in control
(blue), E-cad KD (red) and E-cad GFP (green) cells. (c and f) peak fluorescence intensity at cell–cell contacts for MgcRacGAP (c) or MKLP1 (f) pooled from three individual
experiments (n¼20). Data are means7SD, Po0.001; One-way Anova, Dunnett’s post hoc test. Scale bars: (a and d) 10 mm. (For interpretation of the references to color in
this figure legend, the reader is referred to the web version of this article.)
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ECT2 ultimately affects local E-cadherin mobility through myosin
IIA. One potential mechanism for this to happen might be via
myosin IIA-induced clustering of E-cadherin (Smutny et al., 2010).
It should be noted that our current findings contrast with
earlier work, which demonstrated that homophilic ligation of
Xenopus C-cadherin acutely inhibited Rho signaling (Noren et al.,
2001). The experimental systems used are not readily comparable.
One important difference is the distinction between long-term
contributions of cadherin, as studied in our experiments, compared
with the acute stimulation used by earlier (Noren et al., 2001). As
well, E-cadherin may act with other forms of junctional signaling
when studied at native cell–cell contacts (Yap and Kovacs, 2003),
whereas ligation with recombinant ligands isolates the influence of
homophilic cadherin adhesion. More generally, these discrepancies
may highlight the complex network of signals that determine the
expression of Rho GTPase signaling at junctions. For example,
whereas the inhibition of Rho by acute C-cadherin ligation involved
cross-talk mediated by p190 RhoGAP (Noren et al., 2003) that can be
downstream of Rac (Wildenberg et al., 2006), CS at the established
ZA inhibited Rac signaling (Ratheesh et al., 2012). Such cross-talk
between Rac and Rho signaling pathways implies that the functional
outcome may be very sensitive to cellular context.
Finally, our current and recent findings (Ratheesh et al., 2012)
suggest that Rho signaling at the ZA arises from the input of
multiple cellular factors. In addition to E-cadherin, these include
dynamic microtubules, which can be recruited to cadherin adhe-
sions (Mary et al., 2002; Stehbens et al., 2006), which in turn
control the junctional localization of CS (Ratheesh et al., 2012).
Thus, rather than being the product of a linear signaling pathway,
junctional Rho signaling may be better conceived as the product
Fig. 4. Rho signaling differentially stabilizes two E-cadherin pools. Fluorescence recovery after photobleaching (FRAP) was performed with mouse E-cadherin-GFP
expressed in MCF-7 cells depleted of endogenous E-cad by shRNA. (a) Representative frames after photobleaching in the apical and lateral zones of an individual contact.
(b–e) FRAP profiles of apical (black) and lateral (red) E-cad-GFP in control MCF-7 cells (control, b) and cells treated with ECT2 RNAi (ECT2KD) (c), Myosin IIA RNAi (IIA KD)
(d) or with C3-T (C3-transferase and (e) solid lines represent means7SEM. Mobile fraction and half time values obtained from the best-fit single exponential curves of
FRAP profiles and expressed as ratios of apical vs lateral values (f and g). Data represent means7SEM of data pooled from three individual experiments (n¼10), Po0.001;
One way Anova, Dunnett’s post hoc test. Scale bars: (a) 1 mm. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of
this article.)
Table 1
Half life and mobile fraction values obtained from non-linear regression analysis
of FRAP profiles of E-cadherin GFP in control, Ect2KD, IIA KD and C-3 trasnferase
treated cells. Data are presented as mean7SEM (n¼10). Statistical significance of
the difference between apical vs lateral FRAP parameters for each condition was
assessed by Student’s t-test and is indicated in the brackets.
Conditions Half life (s) Mobile fraction
Control apical E-cadherin 65.6274.476 0.403870.01046
Control lateral E-cadherin 40.40072.71nnn 0.628470.01135nnnn
ECT2 KD apical E-cadherin 49.9873.77 0.501870.012
ECT2 KD lateral E-cadherin 34.9172.71nn 0.495370.00148 (ns)
IIA KD apical E-cadherin 53.3674.736 0.47670.01401
IIA KD lateral E-cadherin 41.3172.81n 0.469470.00883 (ns)
C3-transferase apical E-cadherin 38.3172.71 0.588470.0087
C3-transferase lateral E-cadherin 25.572.33nnn 0.581170.010 (ns)
n po0.05.
nn po0.01.
nnn po0.001.
nnnn po0.0001.
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of coincidence detection (Carlton and Cullen, 2005) where multi-
ple factors must be spatially and temporally coordinated for
productive signaling to occur. From this perspective, it might be
useful to consider that, at the ZA, the E-cadherin molecular
complex serves as a cortical platform to coordinate the multiple
upstream elements that regulate Rho, thereby facilitating
coincidence detection.
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3.2.2 Results presented as accepted manuscript 
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[Abstract] Fluorescence Recovery After Photobleaching (FRAP) (Lippincott-Schwartz et al., 2003; Reits and Neefjes, 
2001) was employed to determine dynamic properties of proteins localized at the ephitelial zonula adherens (ZA) 
(Kovacs et al., 2011; Otani et al., 2006). The proteins of interest were expressed in cells using a knockdown and 
reconstitution approach in which endogenous proteins were depleted by RNA interference (RNAi) and replaced by 
expression of an RNAi-resistant gene fused to GFP (Priya et al., 2013; Smutny et al., 2010; Smutny et al., 2011; Vitriol 
et al., 2007). By choosing expression levels of GFP-tagged proteins that were comparable to endogenous levels, we 
minimized transient overexpression artifacts due to overcoming regulatory mechanisms that directly affect protein 
dynamics (Goodson et al., 2010). Using this approach, junctional E-cadherin-GFP or GFP-Ect2 were subjected to 
FRAP analysis in small areas corresponding to the ZA using confocal microscopy (Priya et al., 2013; Ratheesh et al., 
2012; Gomez et al., 2005; Trenchi et al., 2009). Although in principle this approach is similar in every case, bleaching 
conditions, acquisition parameters and analysis details might differ depending on the time scale of the recovery process 
(Lippincott-Schwartz et al., 2003). In this protocol we will describe the experimental procedure to perform FRAP 
experiments and how to optimize bleaching and acquisition conditions for optimal measurements of protein dynamics at 
cell-cell junctions. 
  
Materials and Reagents 
 
1. MCF-7 cells, mammary carcinoma epithelial cells derived from metastatic site (ATCC® HTB22™) 
2. HEK293T cells 
3. Plasmids. 
• pLL5.0 lentiviral vector (Fig1) and packaging plasmids pMDLg/pRRE, pMD2.G (VSV G) and pRSV-Rev. 
pLL5.0 is a modified version of pLL3.7 and it was generously provided by Jim Bear, Department of Cell 
and Developmental Biology, University of North Carolina, Chapel Hill, NC 27599 (Vitriol et al., 2007; 
Rubinson et al., 2003). 
• pLL5.0 containing both a shRNA against the ORF of human CDH1 (NM_004360) (5′-
GGGTTAAGCACAACAGCAA -3′) cloned downstream of the U6 promoter (HpaI and XhoI) (Fig1) and a 
mouse E-Cadherin(NM_009864)-GFP fusion construct cloned at SacII and SbfI sites. The E-cadherin-
EGFP fusion protein expression was driven by a 5’LTR promoter to facilitate lower expression levels of 
GFP fusion proteins for imaging (Smutny et al., 2011 ). 
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• pLL5.0 containing both a shRNA against the 3’UTR of human ECT2 (NM_001258315) (5'-
GCTGTTTCAAAGTGTGATA-3') and cloned downstream of the U6 promoter (HpaI and XhoI) (Fig1) in 
a modified version of pLL5.0. In this modified pLL5.0 the GFP reporter was replaced by the sequence that 
encompasses both the coding region for GFP and the multiple cloning site of pEGFP-C1 (Clontech) using 
EcoRI and SbfI sites. These restriction sites were not preserved after this cloning step. Then the human 
ECT2 coding sequence (NM_001258315) was cloned into the vector using EcoR1 and BamH1 sites 
(pLL5.0 GFP–shRNA resistant ECT2). 
4. Dulbecco’s Modified Eagle’s Medium High glucose with stable L-glutamine (DMEM) (Gibco/Life 
Technologies, catalog number: 11995-073) 
5. Foetal Bovine Serum (FBS) (Gibco/Life Technologies, catalog number: 26140079) 
6. PBS without Ca2+ and Mg2+ (Astral Scientific, catalog number: 09-8912-100) 
7. 16% Paraformaldehyde (formaldehyde) aqueous solution (ProScitech, catalog number: C004) 
8. Hank’s balanced salt solution (HBSS) (Sigma, catalog number: H8264) 
9. In-Fusion cloning kit (Clontech, CA, catalog number: 638909) 
10. Sodium butyrate (Sigma, catalogue number: B5887). A 1M stock solution of Sodium butyrate is prepared in 
water, filter sterilized and stored at 4°C previous to use.  
11. Hexadimethine bromide (polybrene), (Sigma, catalog number: H9268). A stock solution of polybrene is made 
by diluting it into water to a final stock concentration of 8 mg/mL and sterilizing by filtering trough a 0.2 µm 
filter). 
12. Hank’s Balanced Salt Solution (Sigma, catalogue number: H8264) 
13. Imaging media (see Recipes) 
14. 4% Paraformaldheyde in PBS (see Recipes) 
15. 175 cm2 and 25 cm2 Nunclon Delta Flasks (Nunc, ThermoScientific, cat# 159910 (175cm2 flask) and 
cat#156367 (25 cm2 flasks). 
16. Trypsin, 2.5% (10X) Liquid (Life Technologies, cat#15090046). NOTE: this solution is diluted to 0.25% final 
concentration with PBS. 
 
 
Figure 1. Schematic of pLL5.0 vector. Sites HpaI and XhoI are used for the subcloning of shRNA 
sequences desired to knockdown endogenous levels of the protein of interest. The U6 promoter drives 
the expression of this shRNA sequence. Contrarily, a shRNA resistant version of the same protein can 
be subcloned downstream of the 5’LTR promoter and fused to GFP. Thus, it is possible to achieve 
endogenous levels of expression for a fluorescent-tagged protein and preventing effects associated to its 
overexpression. MCS=Multiple cloning site 
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17. Poly(vinylidene difluoride) spin columns (Amicon Ultra Centrifugal filters. UltraCel-100K, Millipore 
Catalogue number: UFC910024) 
Equipment 
 
1. Laser scanning confocal microscope equipped with acousto-optic tunable filters (AOTF) for bleaching of 
selected areas and heated chamber (37 °C) for live cell imaging. The microscope must also be equipped with 
dichroic and emission filter for the use of the 405 and 488 nm laser lines and detection of GFP fluorescence. 
The experiments shown were performed on LSM510 Meta or LSM710 inverted confocal microscopes (Zeiss, 
Jena, Germany) 
2. 30 mW Argon (458, 488 and 514 nm laser lines) and 25 mW (405 nm) diode lasers (Lasos, Lasertechnik, 
GMbH) 
3. Plug-in FRAP profiler (McMaster University, Canada) 
4. Glass bottom dishes (#1.5 MatTek Corp, catalog number: P35G-1.5-20-C or Shengyou Biotechnology Co. Ltd, 
catalog number: D29-10-1.5-N) 
 
Software 
 
1. Image J software. 
2. Prism, GraphPad. 
3. Matlab, MathWorks. 
 
Procedure 
 
I Cell preparation 
1. Expression of GFP-tagged proteins in a knockdown background 
We have used this approach in our recent article published in Nature Cell Biology (Ratheesh et al., 2012) to 
characterize the dynamic properties of the adhesion molecule E-cadherin and the RhoA GEF, Ect2. For the 
expression of these proteins at endogenous levels, we used the pLL5.0 lentiviral vector (Vitriol et al., 2007; 
Rubinson et al., 2003). This vector contains two promoters, a U6 promoter that drives the expression of 
shRNA and a 5’LTR promoter that drives the expression of a shRNA-resistant gene (Fig.1). 
2. Lentivirus preparation and viral transduction 
a. HEK293T cells were cultured in 20 mL DMEM supplemented with 10% FBS at 37°C and maintained 
under these condition during the following steps.  
b. Constructs made in the pLL5.0 vector were simultaneously transfected with packaging vectors into HEK-
293T cells by CaCl2 precipitation. 
c. 48 h after transfection, cells were treated with sodium butyrate (10 mM final concentration) to increase 
gene induction.  
d. Virus-like particles (VLPs) were harvested 48–72 h after transfection and concentrated on poly(vinylidene 
difluoride) spin column as follows: 
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• Collect media of cells and spin down in 50 mL conical tube. 
• Filter the supernatant into new tubes using 0.2 µm syringe filters. 
• Add 10 mL filtrate to the poly(vinylidene difluoride) spin column and centrifuge at 3200 rpm on a 
bench top centrifuge for 20 min  at room temperature. This will reduce the volume of the suspension 
of VLPs to ~800 µL per tube). 
• Discard the flow trough and add the remaining supernatant (~10mL) to the the poly(vinylidene 
difluoride) spin column and repeat the above step. 
• Aliquots of virus were subsequently used for titration or stored at −80 °C. Titers were determined as 
described before (Smutny et al., 2010). 
3. Preparation of the cells for image acquisition 
a. For FRAP experiments, MCF-7 cells were cultured in DMEM supplemented with 10% FBS and 
infected with lentiviral particles at a multiplicity of infection of 10 per cell on 25 cm2 flasks.  
b. Cells were incubated at 37 °C with the lentivirus in DMEM + FBS and Polybrene (8 µg ml−1) and 
harvested by trypsinization three days after infection.  
c. Single-cell suspensions were seeded on glass bottom dishes at 80% confluence and allowed to 
grow for 48 h (or until they reach full confluence) for FRAP experiments.  
d. Prior to image acquisition, cells were washed with imaging media and incubated with 1.5 mL of it 
for the duration of the experiment. 
 
II Image Acquisition 
1. FRAP experiments were performed on a LSM 510 Meta or LSM 710 Zeiss confocal microscope for E-
cadherin-GFP or GFP-Ect2, respectively. Microscopes were equipped with a heated stage maintained at 37 °C 
and a 30 mW Argon laser (458, 488 and 514 nm laser lines). The LSM 710 Zeiss confocal microscope was 
also equipped with a 405 nm (25 mW) diode laser. Images (pre and post-bleach, Figure 1) were acquired using 
60x objective, 1.4 NA oil Plan Apochromat immersion lens at 4x digital magnification with 0.7 µm optical 
section. A 488 nm laser line of an argon laser (30 mW) was used for fluorescence excitation at 1-3% 
transmission. 
2. For E-cadherin-GFP dynamics, time-lapse images (416 x 416 pixels, 0.086 µm/pixel) were acquired before and 
after photobleaching with an interval of 5 seconds per frame for the total time of 280 seconds (Figure 1A). A 
constant region of interest (ROI) of 2.8 x 1.7 µm with the longer axis parallel to the cell-cell contact was 
marked for each experiment and E-cadherin-GFP was bleached with 50 iterations of the 488 nm laser with 
100% transmission. This resulted in maximum bleach of approximately 70%.  
3. Ect2 dynamics was assessed using GFP-Ect2 co-expressed with Ect2 shRNA by lentiviral infection. A constant 
circular ROI (1.4 µm diameter) in approximately the center of the cell-cell contact was bleached to ~ 70% with 
both the 488 and the 405 nm lasers turned on simultaneously at 100% transmission. Time-lapse images of the 
same region were acquired before (20 frames, 5 seconds) and after (210 frames, 50 seconds) photobleaching 
with an interval of ~ 250 m per frame (Figure 1B).  
4. For these experiments, cells with slanted contacts were chosen which allowed us to precisely identify and 
photobleach the ZA. 
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Special considerations 
a. For any experimental setup, it is important to consider that the bleaching process and the frequency of 
acquisition has to match the dynamics of the protein of interest (Lippincott-Schwartz et al., 2003; Weiss 
2004). The above technical details should be first be tested to achieve the optimal conditions for FRAP 
experiments of specific proteins or for different subcellular compartments. Bleaching and acquisition 
conditions can be optimized by doing FRAP in fixed cells. We routinely grow cells on glass bottom 
dishes and fix using 4% paraformaldehyde (PFA) in phosphate buffered buffer saline (PBS) for 15 min at 
room temperature. After fixation, PFA solution is replaced by imaging media and the FRAP protocols 
tested on this set of cells. Following this approach, optimization can be achieved in conditions that match 
the real experimental setup. 
The major aims of these optimization experiments are to: 
i. Determine the best conditions suitable for a fast and efficient photobleaching of molecules in a 
region of interest that would be used in the real experiments. 
ii. Optimize the time-lapse settings for acquisition during pre- and, more importantly, post- bleaching 
regimes. The main aim is to acquire images without causing photobleaching (< ~5%) of the sample at 
a given frequency that does not compromise FRAP analysis. 
b. Following the optimization steps, a FRAP test is performed in living cells. There are two important points 
that that needs to be considered that are related to the half time of the observed recovery process (Weiss, 
2004). Firstly, if the half time is comparable to the bleaching step, then there is a high chance that 
recovery is underestimated as bleached molecules can diffuse away from the bleached area during the 
bleaching step (Weiss, 2004). If so, it is necessary to optimize the bleaching protocol to make this step 
faster (~< 3 times the half time of recovery). This can be achieved for example, by reducing the area of 
the region that is wanted to be bleached or, by increasing the laser power and reducing the number of 
iterations during the bleaching step or, by increasing the number of laser lines activated during the 
bleaching step or, by reducing the scan speed of the bleaching step at the same time the number of 
iterations it is also reduced. The conditions mentioned for the bleaching step of E-cadherin and Ect2 are 
good standard initial conditions to perform FRAP experiments on proteins that exhibits very distinctive 
dynamics. Secondly, slow post acquisition frames can compromise recovery measurements. As the half 
time of a FRAP curve is calculated with the information acquired during the first 1.5 half times of the 
recovery process, confident estimation of FRAP parameters requires that acquisition be fast enough to 
accurately sample this early period. To satisfy this requirement, increasing scan speed or reducing the 
area of sampling during pre and postbleaching acquisition can increase the speed of acquisition. This 
second option was chosen in order to capture the fast dynamics of Ect2 mobility. 
c. After these conditions are set, it is essential to consider that the optimized protocol does not compromise 
the viability of cells. Normally, UV irradiation causes toxicity, which is evident by changes in the 
morphology of the cell and membrane blebbing (Frigault et al., 2009). Acquisition of phase contrast or 
Differential interference contrast (DIC) images before and after FRAP acquisition is a complementary 
test to assess cell viability. Of note, UV irradiation can cause membrane damage that often results in an 
unexpectedly high immobile fraction. For this, it has been suggested to perform 2 consecutive FRAP 
experiments on the same cells and on the same region, in order to determine that recovery occurs even 
after two consecutive rounds of photobleaching (Lippincott-Schwartz et al., 2003). 
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III Image analysis 
1. E-cadherin Turnover 
Image analysis was performed using Image J software. Noise on images was reduced by applying a median 
filter of 2 pixels radii. As E-cadherin dynamics at the ZA is relatively slow (in our experience, a FRAP 
experiment takes ~10 min to plateau), it is inevitable that some cell movements and/or drift occur during image 
acquisition. If these movements really compromise the measurements, then the experiment is discarded. 
However, those experiments with slight cell movements can be corrected and/or eliminated by aligning 
consecutive frames using Turbo-reg (http://bigwww.epfl.ch/thevenaz/turboreg/) plug-in of Image J. After that, 
FRAP profiles were calculated using a ROI marked at the bleached area and use the plug-in FRAP profiler to 
obtain fluorescence intensity profiles. Fluorescence intensities in the ROI immediately after bleaching (F(0) ) 
were subtracted from fluorescence intensities at all times (F(t) ) and results were then normalized to pre-
bleaching values (Eq.1, Figure 2A). Results were then imported into Prism software for statistics analysis. Data 
from 11 replicates (3 independent experiments) were pooled and fluorescence intensity at time points after the 
bleaching step were fitted to the equation: 
Fluorescence Recovery=
F(t)−F(0)
F(−t)−F(0) =Mf ⋅ (1− e
ln2⋅t
t1/2 )                               (Eq.1) 
where F(t) , F(−t) and F(0)  are the average fluorescence of the ROI at any time, before bleaching and, 
immediately after bleaching, respectively. Mf is the mobile fraction, t½ is the half time of recovery and t is 
time in seconds. In Prism, this fitting is achieved by using non-linear regression and the exponential one-phase 
association model using Y0=0 and where Mf corresponds to the plateau value. Data then are presented as the 
average ± SEM and the statistical significance assessed by t-test. 
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Figure 2. Examples of E-cadherin-GFP and GFP-Ect2 FRAP experiments. A. Left, Representative images 
using MCF-7 cells of the subcellular distribution of E-cadherin-GFP and GFP-Ect2 expressed in E-cadherin 
and Ect2 knockdown backgrounds, respectively. Center, details of acquisition frames during pre (shown) and 
post bleaching (not shown) stages during a FRAP experiment. Right, Fluorescence recovery plots for E-
cadherin-GFP (top graph) and GFP-Ect-2 (bottom graph). Note the difference in time scales. B. Details of non-
linear regression of GFP-Ect2 recovery plot using either mono-exponential (Eq.1) or double exponential (Eq.2) 
functions. This shows that a mono exponential function does not adjust properly to the experimental curve. 
 
2. Ect2 Turnover 
Image analysis was also performed using Image J software. It is worth to mentioning that an Ect2 FRAP 
experiment takes ~1 min, therefore no significant drifts or cell movements were observed. To calculate FRAP 
profiles, a ROI at the bleached GFP-Ect2 area was marked and its average fluorescence determined at every 
time point using the measure stack plugin in Image J software. Fluorescence intensities were treated as 
described above for E-cadherin-GFP to obtain recovery plots and data fitted to the double exponential equation 
(Figure 2B): 
Fluorescence Recovery=
F(t)−F(0)
F(−t)−F(0) =Mf ⋅ f fast ⋅ (1− e
ln2⋅t
t1/2fast )
#
$
%
%
&
'
(
(
+Mf ⋅ fslow ⋅ (1− e
ln2⋅t
t1/2slow )
#
$
%
%
&
'
(
(
 (Eq.2) 
 F(t) is the average fluorescence of the ROI, Mf  is the mobile fraction, 
€ 
f fast  and 
€ 
fslow  are weighting factors 
for fast and slow mobile components, 
€ 
t1/ 2fast  and 
€ 
t1/ 2slow  their respective half times and t is time in seconds. In 
 80 
Prism, this fitting is achieved by using non-linear regression and the exponential two-phase association model 
using Y0=0 and where the plateau value corresponds to Mf . 
For this case, a numerical solution to obtain the t value at which Fluorescence Recovery= 0.5 was applied to 
obtain the global half time for Ect2 recovery. This was performed in Matlab (MathWorks, Australia) as 
follows. Values from fitting can be introduced as: 
 
>> Parameters=[M f  f fast  t1/2
fast  fslow  t1/2
slow ]  (In the brackets real values are introduced) 
And then calculate the global t
1/2
using  the FRAPtwo function (see below) and the following sentence: 
>> t
1/2
= fzero(@(t) FRAPtwo(Parameters,t),7); 
Data are then presented as the average ± SEM and the statistical significance assessed by t-test. 
 
The following is the description of the Matlab function used for calculation of t
1/2
. 
 
 
 
Recipes 
 
1. Imaging media 
Hank’s balanced salt solution supplemented with 10 mM HEPES pH 7.4 and 5 mM CaCl2 
2. 4% Paraformaldehyde in PBS 
Prepare by dilution of the stock solution (16% formaldehyde). Adjust pH to 7 with HCl or NaOH if necessary 
using pH indicator papers. Aliquot dilutions and store at -20 °C. 
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Chapter 4: Myosin II anchors a novel feedback loop to sustain 
junctional Rho zone 
 
 
In this chapter, I have illustrated a novel feedback loop mediated by Myosin II that is necessary to 
maintain junctional Rho zone. This chapter has been divided into two sections: 
 
4.1 Here I am presenting the results as a manuscript, which has been submitted to the journal Nature 
Cell Biology and is under revision. 
Please refer to the Author Contributions section of the manuscript, where each author has been acknowledged. 
 
4.2 Here I have expanded the findings from section 4.1 and sought to understand the contribution of 
Rho pathway in a physiologically relevant system of oncogenic extrusion. 
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Abstract 
 
Actomyosin contractility at the epithelial zonula adherens (ZA) generates junctional 
tension for tissue integrity and morphogenesis. This requires the Rho GTPase, which 
establishes a strikingly stable active zone at the ZA. Mechanisms must then exist to 
confer robustness on junctional Rho signaling, buffering it against noise to preserve 
its stability. We now identify a feedback network that allows a stable mesoscopic Rho 
zone to be generated out of dynamic elements. The key is scaffolding of ROCK-1 to 
the ZA by Myosin II. Junctional ROCK-1 then phosphorylates Rnd3 to antagonize the 
Rho suppressor, p190B RhoGAP. This ultimately sustains junctional Rho and 
contractile tension. Combining predictive modelling and experimentation, we show 
that this network constitutes a bistable dynamical system that is realized at the 
population level of the ZA. Thus, stability of the Rho zone is an emergent 
consequence of the network of interactions that allow Myosin II to feedback to Rho. 
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Introduction 
 
Apical actomyosin networks are characteristic features of simple epithelia, often 
found as medial-apical networks or as circumferential apical bundles juxtaposed to 
cell-cell junctions 1-4. When coupled to E-cadherin adhesion they generate contractile 
tension at the junctions to drive epithelial morphogenesis and support homeostatic 
tissue integrity 1, 5, 6. Commonly, apical actomyosin couples to a distinct cadherin 
junction, the zonula adherens (ZA), which typically appears as an apical ring where 
E-cadherin is stabilized relative to cadherin found in the lateral junctions below the 
ZA 2, 7, 8. The ZA is the dominant site for junctional tension, which is substantially 
greater there than in the lateral junctions 8. This is teleologically attractive, as it would 
allow adhesion to be reinforced precisely where it has to bear the greatest contractile 
stresses. 
 However, the biogenesis of contractility at the ZA does not simply reflect 
physical association of the cadherin molecular complex with the actin filaments of the 
actomyosin apparatus. Instead, multiple mechanisms interact to generate the 
contractile ZA. For example, non-muscle myosin II (NMII), which is necessary for 
contractile tension, also stabilizes E-cadherin to form the ZA 2, 7. Similarly, actin 
regulators are necessary for ZA integrity, biogenesis of actomyosin, and for 
contractile tension 9. Many of these regulatory molecules are recruited to the apical 
junctional cortex by E-cadherin 7, 9-11, suggesting that adhesion plays an active role in 
establishing junctional contractility. Thus, the specialized junction that is the ZA can 
be regarded as the emergent product of a complex, dynamical system that integrates 
adhesion, signaling and actomyosin. The challenge is to understand how salient 
features of this system are organized to establish effective apical contractility in 
coherent epithelia. 
 One key element is signaling by the Rho GTPase. Rho stabilizes E-cadherin 
to generate the ZA 2, 5, 7; recruits NMII to the ZA, notably its myosin IIA (NMIIA) 
paralog 2; and can influence actin modulators, such as mDia1 12. Active Rho is found 
at the apical ring of the ZA 5, 13, forming a zone of signaling akin to that of the 
cytokinetic furrow. Indeed, the activation of Rho at the ZA during interphase is 
mediated by the centralspindlin-ECT2 complex 5, which also supports Rho signaling 
during cell division 14. This spatial concentration of Rho is plausibly located to 
coordinate adhesion and contractility at the ZA. Consistent with this, inhibiting the 
Rho pathway, including its upstream regulation by centralspindlin/ECT2, disrupts 
actomyosin and reduces junctional tension at the ZA 5. 
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 Therefore, the mechanisms responsible for the Rho zone at the ZA likely play 
an important role in sustaining junctional tension for morphogenesis and tissue 
homeostasis. However, Rho can be influenced by many upstream inputs 15-17. To 
establish a stable Rho zone at the ZA implies that mechanisms must exist that confer 
robustness on Rho signaling, i.e. which would buffer Rho at the ZA against small 
stochastic changes from other inputs that can impinge on the Rho pathway. 
Robustness in dynamical control systems often involves feedback loops 18-21, but 
whether this is so at the ZA is not yet understood. We now identify a bistable 
feedback system, anchored by Myosin II, that confers robustness to generate a 
stable Rho signaling zone at the ZA.  
 
Results 
 
Myosin II supports a stable Rho zone at the ZA. We used two approaches to 
evaluate endogenous Rho signaling at the ZA. First, we immunostained for Rho 
protein in TCA-fixed cells, as its steady-state localization at junctions requires that 
Rho be active 5. Junctional localization thus serves as a useful proxy for the 
integration of stimulatory and inhibitory signals that impinge upon Rho at the ZA. As 
observed earlier 5, 7, Rho stained prominently at the ZA of confluent MCF-7 cells 
(Supplementary Fig 1a), a pattern that is rapidly reduced by C3-transferase 5.  
We complemented this by using a location biosensor derived from the C-
terminal fragment of anillin (GFP-AHPH) to characterize the spatiotemporal 
distribution of endogenous GTP-Rho 22, 23. Confocal stacks revealed that GFP-AHPH 
concentrated in a narrow zone at the ZA, constituting the most prominent site for 
GTP-Rho in the cells (Fig. 1a, Supplementary video 1), and in puncta in the 
perijunctional regions (Supplementary video 2). Junctional concentration of GFP-
AHPH was effectively blocked with C3-T, confirming that the reporter was sensitive 
to the location of GTP-Rho (Supplementary Fig 1b). Further, the tight ring-like pattern 
detected by GFP-AHPH persisted for the 30+ min duration of our movies 
(Supplementary video 2). Kymographs revealed that the Rho zone remains sharply 
defined (Fig 1b) and its intensity stable throughout the movies, despite minor cyclic 
fluctuations (Fig 1b,c). Therefore, mechanisms must exist that concentrate and 
sustain GTP-Rho at the ZA, to thereby establish a stable junctional Rho zone. 
One possible factor was E-cadherin adhesion itself, as junctional Rho is 
reduced when E-cadherin is depleted 7. To investigate this possibility, we expressed 
GFP-AHPH in E-cadherin RNAi cells (Supplementary Fig 1d). E-cadherin depletion 
abolished the ZA, but allowed cells to remain in contact with one another and 
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assemble tight junctions (Supplementary Fig 1c). Despite this, GFP-AHPH failed to 
concentrate in a focused peak at apical junctions in E-cadherin knock-down (KD) 
cells (Fig 1d), as confirmed by measurement of fluorescence intensity (Fig 1e). 
Instead, GFP-AHPH appeared to redistribute into the apical puncta (Fig 1d). Total 
cellular GTP-Rho levels, detected by pull-down with the Rho-binding domain of 
rhotekin, were not altered by E-cadherin KD (Supplementary Fig 1e). Thus, E-
cadherin constitutes a major factor that maintains the apical junctional region as a 
site of concentrated Rho signaling.  
 In considering candidates that might mediate this impact of E-cadherin, we 
focused on NMII, which is recruited by E-cadherin adhesion to co-accumulate with 
GTP-Rho at the ZA 2, 5 and can interact with Rho GEFs 24-26. First, we inhibited 
Myosin II activity with blebbistatin (100μM, 2 hr), which reduced NMIIA staining at 
cell-cell junctions (Supplementary Fig 1f) 2. In contrast to control cells, junctional Rho 
was reduced by >70% in MCF-7 cells treated with blebbistatin (Fig 1 f,g). Similar 
effects were observed in Caco-2 and MDCK monolayers (Supplementary Fig 1g). As 
both NMIIA and Myosin IIB (NMIIB) accumulate at the ZA in MCF7 cells, we then 
used lentiviral shRNA to selectively deplete each of these proteins by ~ 90% 
(Supplementary Fig 1 h,i). Junctional Rho was substantially reduced in NMIIA KD 
cells, consistent with the effect of blebbistatin, but not significantly decreased in cells 
depleted of NMIIB (Fig 1 f,h). 
The loss of steady state Rho protein was paralleled by degradation of the 
stable GTP-Rho zone at the junctions. As we had seen with E-cadherin KD, GFP-
AHPH failed to concentrate in a focused region at contacts between cells treated with 
blebbistatin or NMIIA RNAi (Fig 1 i, j). None of these manoeuvres altered the total 
levels of Rho or GTP-Rho (Supplementary Fig 1 e), implying that NMII principally 
affected the stable subcellular distribution of active Rho. To test whether the apical 
redistribution of GTP-Rho might reflect an altered localization of residual NMII itself, 
we co-expressed mCherry-MRLC with GFP-AHPH and treated the cells with 
blebbistatin. However, mCherry-MRLC did not redistribute apically with GFP-AHPH 
(Supplementary Fig 1j). Altogether, these findings led us to conclude that NMIIA was 
necessary to generate a stable Rho zone at the ZA.  
  
p190B RhoGAP degrades the junctional Rho zone when NMII is inactivated. 
Formally, junctional Rho signaling might be compromised either through loss of the 
GEF activity that is responsible for its activation and/or by the action of a GAP that 
promotes GTP hydrolysis. Rho signaling at the ZA of MCF7 cells is activated by the 
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ECT2 GEF and inhibited by p190B RhoGAP (p190B) 5. However, junctional staining 
for ECT2 was not affected by blebbistatin or NMIIA shRNA, examined under the 
exact conditions when Rho was reduced (Supplementary Fig 2a). Nor did we detect 
changes in hSyk-4/MgcRacGAP (Supplementary Fig 2 b), a component of the 
centralspindlin complex, which recruits ECT2 to the ZA 5, 14. Therefore, loss of ECT2 
did not readily explain how the Rho zone was compromised when NMII was inhibited.   
 We then examined whether inhibiting myosin affected the junctional 
accumulation of the RhoGAP, p190B. Scant staining for p190B was detected at the 
junctions and apical poles of control cells, but apical junctional staining was 
increased ~5-fold by blebbistatin (Fig 2 a,b). p190B also increased at the apical 
junctions in NMIIA KD cells but not NMIIB KD cells (Fig 2 a,c), exactly the conditions 
which compromised the junctional Rho zone. None of these conditions affected 
cellular p190B expression (Supplementary Fig 2 f,g ), indicating that inactivating NMII 
allowed p190B to become recruited to the ZA. In contrast, p190A RhoGAP did not 
localize to junctions under control or NMII-inhibited conditions (Supplementary Fig 2 
c-e). 
p190B was thus a potential candidate to disrupt Rho signaling at the ZA when 
myosin II was blocked. To test this, we asked how myosin inhibition affected the 
integrity of the junctional Rho zone when p190B was depleted by RNAi (~ 90% 
reduction, Fig 2d,e). Whereas blebbistatin substantially decreased junctional Rho in 
wild-type (WT) cells, it had no detectable impact on Rho in p190B KD cells (Fig 2 d,f). 
Similarly, stable concentration of GFP-AHPH at the apical junctions was preserved 
(Fig 2 g,h) when blebbistatin was added to p190B KD cells. Therefore, p190B was 
responsible for degrading the Rho zone at the ZA when myosin II was perturbed.  
 
Rnd3 recruits p190B to the ZA. These findings implied that NMII might support Rho 
signaling by antagonizing the junctional accumulation of p190B. To understand how 
this could be achieved, we then turned to identify the mechanism that recruited 
p190B to junctions when myosin was inhibited. One potential candidate was Rac, 
which can be activated when myosin is disabled 25, 27 and can also induce the cortical 
recruitment of p190B 5, 28. However, inhibiting NMII did not alter either Rac 
(Supplementary Fig 3 a-c) or GTP-Rac levels at the ZA (Supplementary Fig 3g). Nor 
was the ability of p190B to accumulate at junctions in blebbistatin-treated cells 
affected by inactivating Rac (Supplementary Fig 3 d-f) or blocking Src 29 
(Supplementary Fig 3h). 
 Alternatively, the Rnd3 GTPase can also directly bind p190B to activate and 
recruit it to the cell cortex 30, 31. We found that GFP-Rnd3 localized clearly with E-
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cadherin at the ZA (Fig 3a) and this was increased by treatment with blebbistatin (Fig 
3 b,c), without any change in total expression levels (Supplementary Fig 4 d). Thus, 
Rnd3 showed a suitably responsive pattern of localization to mediate the junctional 
recruitment of p190B. Nor did p190B recruit Rnd3, as Rnd3 T55V, which cannot bind 
p190B 30, 31, also translocated to junctions when myosin was blocked (Fig 3 b,c). 
 However, p190B failed to recruit to junctions in blebbistatin-treated cells when 
Rnd3 was depleted by siRNA (Fig 3 d,e, Supplementary Fig. 3 i-k). Junctional p190B 
was restored by expression of RNAi-resistant Rnd3 (Fig 3 d,e, Supplementary Fig. 
3l), confirming the specificity of the effect, but depletion of the related Rnd1 had no 
effect (Supplementary Fig. 3 j,k). As well, blebbistatin did not inhibit junctional Rho in 
Rnd3 KD cells; but its effect was restored by reconstitution of WT Rnd3 (Fig 3 f, 
Supplementary Fig. 3m). This implied that Rnd3 was necessary to recruit p190B to 
junctions when myosin was inhibited. Confirming this, Rnd3 T55V failed to restore 
either p190B recruitment or Rho inhibition at junctions when Rnd3 KD cells were 
treated with blebbistatin (Fig 3 d-f, Supplementary Fig. 3m). Thus, Rnd3 and p190B 
constituted the functional module responsible for inhibiting junctional Rho when 
myosin was inactivated. 
 
Protein phosphorylation regulates Rnd3 recruitment to the ZA. Serine/Threonine 
phosphorylation plays a critical role in regulating the cortical localization of Rnd3 31. 
When phosphorylated, Rnd3 binds to 14-3-3ζ, which sequesters it in the cytosol. 
Effectively, phosphorylation antagonizes Rnd3 signaling by blocking its association 
with the plasma membrane. We therefore asked if this might influence whether Rnd3 
localizes at the ZA.  
To test this, we reconstituted Rnd3 KD cells with transgenes lacking key 
phosphorylation sites that affect its cortical recruitment (Supplementary Fig. 3 l): 
Rnd3 AllA, which lacks all the known phosphorylation sites, and Rnd3 S240A, which 
cannot bind 14-3-3ζ 31. Strikingly, we found that even under basal conditions Rnd3 
AllA showed strong junctional staining, comparable to that seen in myosin-inhibited 
control cells (Fig 3b,c). Moreover, this was not further increased by blebbistatin, 
suggesting that Rnd3 became constitutively localized to the ZA when it could no 
longer be phosphorylated (Fig 3b,c). Similarly, Rnd3 S240A showed strong baseline 
localization that was not enhanced by blebbistatin (Fig 3b,c). Consistent with what 
we had already found, the apparently constitutive localization of both these 
phosphodeficient mutants increased the basal levels of p190B (Fig 3d,e), and 
decreased Rho levels (Fig 3f, Supplementary Fig. 3m) at junctions; nor were these 
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further altered by blebbistatin. Thus phosphorylation of Rnd3 is a key determinant of 
Rho signaling at the ZA. 
 
Rnd3 negatively regulates ZA tension. These findings provided the opportunity to test 
whether Rnd3 could ultimately influence contractility at E-cadherin junctions. The 
constitutively-localized phosphodeficient Rnd3 mutants allowed us to assess 
contractility without the need to inhibit myosin, which was otherwise necessary to 
recruit Rnd3/p190B to junctions. Using laser nanoablation assays, we found that 
apical junctional tension was conspicuously reduced in Rnd3 KD cells reconstituted 
with either Rnd3 AllA or Rnd3 S240A compared with those expressing WT Rnd3 (Fig 
3 g,h), exactly the conditions where junctional Rho was decreased. Altogether, then, 
the Rnd3/p190B module constitutes a potent suppressor of junctional contractility. 
 
ROCK phosphorylates Rnd3 to support junctional Rho signaling. These findings 
suggested that NMII at the ZA might ultimately act through a protein kinase to 
antagonize Rnd3. Here, ROCK-1 presented an interesting candidate as it is a Rnd3 
kinase that can localize to cell-cell junctions 32-34. Indeed, we found that ROCK-1 (Fig 
4a), but not ROCK2 (Supplementary Fig. 4a), concentrated at the ZA of MCF7 cells. 
Immunoprecipitation analysis confirmed Rnd3 as a ROCK target in these cells, as its 
Ser-phosphorylation was reduced by the ROCK inhibitor, Y-27632 (Fig 4b). ROCK-1 
therefore had the potential to antagonize junctional Rnd3 in epithelial cells. 
Consistent with this hypothesis, Y-27632 increased the amount of GFP-Rnd3 
found at junctions without affecting its overall expression (Fig 4c, Supplementary Fig. 
4b and 4d). Turnover studies suggested that this was due to stabilization of GFP-
Rnd3 at the ZA (Fig 4d). Protein phosphorylation of Rnd3 was necessary for ROCK 
to antagonize its junctional accumulation, as Y-27632 did not enhance the already 
elevated baseline levels of either GFP-Rnd3 AllA or GFP-Rnd3 S240A (Fig 4c, 
Supplementary Fig. 4b). The recruitment of Rnd3 to junctions in ROCK-inhibited cells 
was accompanied by increased junctional p190B (Fig 4e, Supplementary video 3) 
and suppressed junctional Rho (Fig 4f). Y-27632 also decreased the ability of Rho to 
be activated, as measured with a FRET activity biosensor (Supplementary Fig 4c) 
and degraded the ability of cells to concentrate GFP-AHPH in the apical junction 
region (Fig 4g, h), exactly as we had observed when either E-cadherin or NMII were 
directly disrupted. 
Given its junctional localization (Fig 4a), we then tested how Rho signaling 
was affected when we depleted ROCK-1 by siRNA (Supplementary Fig 4e). Under 
baseline conditions ROCK-1 KD cells displayed elevated junctional p190B (Fig 4i, 
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Supplementary Fig. 4f) with concomitantly depressed junctional Rho (Fig 4j, 
Supplementary Fig. 4f), consistent with a dominant effect on the junctional 
recruitment of p190B. Moreover, neither of these parameters were further affected by 
blebbistatin (Fig 4 i,j, Supplementary Fig. 4f), suggesting that the impact of inhibiting 
NMII on Rho regulation was principally mediated through ROCK-1. Together, these 
findings identified ROCK-1 as responsible for antagonizing Rnd3-p190B to support 
Rho signaling at the ZA. 
 
Myosin II scaffolds ROCK-1 at the epithelial ZA. We then entertained the possibility 
that Myosin II might serve to localize ROCK-1 at the ZA. Consistent with this, the 
conspicuous junctional ROCK-1 staining was substantially reduced by blebbistatin 
(Fig 5 a,b) or NMII RNAi (Fig 5c, Supplementary Fig. 5 a and b). Interestingly, 
junctional ROCK-1 was reduced by NMIIA KD to a greater extent than by NMIIB 
depletion (Fig 5c, Supplementary Fig. 5 a and b), paralleling the impact of their 
selective depletion on junctional Rho.  
We then performed co-immunoprecipitation analyses to further characterize 
how NMII localized ROCK-1 to the ZA. GFP-ROCK-1 expressed in HEK 293 cells 
associated with endogenous NMIIA, but not with NMIIB, and this was not affected by 
blocking motor activity with blebbistatin (Fig 5d). Conversely, GFP-NMIIA 
immunoprecipitated endogenous ROCK-1 (Fig 5e). This implied that Myosin IIA can 
interact, directly or indirectly, with ROCK-1. The rod domain of NMIIA was sufficient 
to associate with ROCK-1 and this was independent of kinase activity, being 
unaffected by Y-27632 (Fig 5e). 
 NMIIA mutants were then reconstituted in NMIIA KD MCF7 cells in order to 
assess what properties of this molecule were required to localize ROCK-1 at the ZA 
(Fig 5 f,g). Expression of WT NMIIA restored junctional ROCK-1, confirming the 
specificity of this effect. Interestingly, ROCK-1 was restored as effectively by 
reconstitution with NMIIA N93K, a mutant which localizes to the ZA 2 and retains the 
ability to bind F-actin, but is an ineffective filament slider 35. The Rod domain also 
localized to junctions, as it does to the contractile furrow in dividing cells 36, and this 
was sufficient to restore junctional ROCK-1 (Fig 5 f,g). Together, these data 
suggested that the ability to generate contractile force, and hence junctional tension, 
might be dispensible for Myosin IIA to recruit ROCK-1 to junctions. Consistent with 
this, depleting either Cdc42 or N-WASP (Supplementary Fig 5 d,e), manoeuvres that 
decrease apical junctional tension 8, 37 (M.Michael, not shown), did not affect 
junctional ROCK-1, Rho or p190B (Supplementary Fig 5 f-h). Altogether, these 
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findings suggested that Myosin II acted as a cortical scaffold to localize ROCK-1 to 
the ZA. 
 
Myosin-Rho feedback represents a bistable control system. We then developed a 
numerical model to explore the potential dynamical properties of the regulatory 
network that we had identified. This network can be represented by a minimal 
architecture that consists of two interlocked feedback loops that intersect at ROCK-1 
(Fig 6a; discussed in detail in the Computational modelling section of the 
Supplementary Information). In the first loop, activated ROCK-1 supports Rho by 
antagonizing Rnd3/p190B. In the second loop Myosin II is activated by ROCK-1 and 
feeds back to concentrate ROCK-1 at the ZA. We used first-order differential 
equations to model the kinetics of each step and analysed the variable space of 
activation coefficients to identify regions distinguished by different levels of active 
Rho. We focused especially on how Myosin might be necessary to generate a stable 
Rho zone at the ZA. 
The behaviour of the model is illustrated in Fig 6b, where all constituents 
began with equal initial concentrations and feedback from NMIIA to ROCK-1 was 
present. We found that the system initially showed dynamic behaviour but then 
evolved to a stable state with high concentrations of active Rho/ROCK and 
concomitantly  low  levels  of  Rnd3/p190B  (consistent  with  a  “Rho-ON”  state).  Strikingly,  
however, if the feedback from NMIIA to ROCK-1 was disabled without any other 
parameter  change,  then  the  system  reversed  to  a  “Rho-Off”  state  distinguished  by  
low levels of Rho/ROCK, but high concentrations of p190B and Rnd3. This implied 
that the presence or absence of feedback from myosin to ROCK could profoundly 
affect the signaling output of the system. 
We pursued this by investigating the dynamical implications of systematically 
varying the strength of feedback from NMIIA to ROCK-1; in the model this 
corresponds to the association constant between NMIA and ROCK1 (1/𝐾ேெூூ஺ோை஼௄ଵ), 
reflecting the affinity of association between these two proteins. We found that at low 
values of feedback, i.e. low affinity interactions, the system persisted in a Rho-OFF 
state that was insensitive to the specific concentrations of the components at the 
start of the simulation (Fig 6c, Supplementary Fig. 6a). Conversely, for high affinities 
of association between NMIIA and ROCK-1, the system stably locked in a Rho-ON 
state. Interestingly, for intermediate affinities, the system could achieve either a Rho-
OFF state or an Rho-ON state, depending on the initial concentrations of the 
components. However, even within this intermediate zone, for any specific 
association constant between NMIIA and ROCK-1, the system evolved to establish 
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only one level of Rho-ON activity; it did not establish other levels of stable activity. 
Thus, our numerical analysis showed that the architecture of the system that we 
studied has the capacity to generate bistability, a property that might confer 
robustness on the system 18-20. 
Then we sought to test the predictions of this model. We reasoned that, while 
individual Rho molecules can only be active or inactive, there was no a priori reason 
why, at the population level, different junctions might not have different 
concentrations of active Rho molecules. If bistability were to manifest at the 
population level, we predicted that junctions would fall into either of two categories: 
those with some level of Rho signaling – which would trend towards a single level of 
activity - and those where Rho signaling was inactive. Further, our model predicted 
that myosin was essential for the active state to be achieved. To test this, we 
measured Rho intensity in a large cohort of junctions (Fig 6d), as the level in each 
junction would reflect the steady-state integration of Rho activation and inactivation 
over populations of Rho molecules. Control junctions showed a non-Gaussian profile 
with two apparent inflections (Fig 6e, e’). This profile could be well-fit to two separate 
Gaussians, one centred on zero intensity, consistent with an inactive state (as Rho 
delocalizes from junctions when it is inhibited 5), and a positive signal corresponding 
to an active state. Furthermore, only a single population centred on zero intensity 
was seen in blebbistatin-treated cells (Fig 6e, e’), exactly in agreement with the 
prediction of the model. This suggested that the bistability predicted by dynamical 
analysis of the regulatory network that we have identified is manifest at the 
population level of junctional Rho signaling. 
Finally, we extended the model to test how this feedback system can 
influence the spatial expression of Rho signaling. As a test of principle, the model 
was expressed in 3-dimensions as a sphere where the GEF was globally distributed 
and therefore unable to confer spatial information (Fig 6f). We found that when NMII 
was unstable throughout the cortex, the system evolved to establish a stable state 
where GTP-Rho was uniformly low and p190B uniformly high (Fig 6f). In contrast, if 
we stabilized NMII at the equator, the system generated a stable zone of high Rho 
activity at the equator, with a complementary pattern of p190B distribution elsewhere 
(Fig 6f). Thus, even without spatial localization of the Rho activator, the minimal 
feedback architecture that we had identified has the capacity to support spatial 
organization of Rho signaling that is directly analogous to the Rho zone that we had 
characterized. 
 
Discussion 
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Rho signaling is necessary for junctional contractility to support adhesion and 
morphogenesis 2, 38. Consistent with this, in mammalian epithelial cells GTP-Rho 
concentrates prominently at the ZA itself 5, which is a major site where adhesion and 
actomyosin cooperate to generate junctional tension 1, 8. Our live-cell imaging now 
reveals that this zone displays a striking stability: GTP-Rho is confined to a narrow 
zone with an average intensity that is constant for tens of minutes. This stability 
contrasts with many other signaling pathways, which are intrinsically transient or lead 
to state changes that ultimately limit the signal itself. For example, the Rho zone of 
the cytokinetic furrow, which shares many molecular similarities with the ZA 5, 39, is 
terminated by cell division 14, 40. Teleologically, the stability of the Rho zone at the ZA 
may allow junctional tension to be sustained during epithelial homeostasis. Indeed, 
we found that constitutive localization of Rnd3 to inhibit Rho at the ZA profoundly 
reduced junctional tension. Therefore, cells must have a strategy to sustain Rho 
signaling in the spatially defined region of the ZA and buffer it against stochastic 
noise in the many pathways that can converge upon Rho.  
 We propose that robust stability is conferred by feedback that couples a 
canonical Rho effector, NMII, to Rho itself (Supplementary Fig. 6c). The key to the 
network that we have identified lies in the localization of ROCK-1 at the ZA through 
its interaction with NMIIA. This allows ROCK-1 to antagonize p190B by opposing the 
cortical association of Rnd3. One predicted consequence is to increase the lifetime of 
GTP-loaded Rho, potentially from ~ 0.5 sec to ~ 30 min 41, a time scale consistent 
with that which we observed for the stable Rho zone. We cannot exclude the 
possibility that other GAPs influence Rho signaling at junctions. Nonetheless, p190B 
appears to be a dominant influence, since it was necessary for the junctional Rho 
zone to be compromised when NMII was inhibited. While individual Rho molecules 
will eventually inactivate, stochastic activation by GEFs such as ECT2 5 may be 
sufficient to sustain signaling at the population level of the junction. Antagonism of 
p190B would then allow the intrinsically slow GTPase activity of Rho to confer 
temporal stability on the Rho signal at the ZA. 
 Our analysis further revealed that this feedback system can confer bistability 
on Rho signaling outcomes. Bistability represents a dynamical feature that can 
support robustness by buffering the system against noise 18-20. Computationally, we 
found that the system was resistant to changes in the values of inputs for individual 
parameters, as might be represented by noise impinging on Rho. This translated to 
the population level of signaling at junctions, as we found that the Rho content of the 
junctions  fell  into  either  of  only  two  populations,  consistent  with  a  “Rho-off”  state  and  
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a  single  “On”  state. Note that we deliberately used the coarse-grained metameter of 
junctional Rho content for two reasons. It allowed us to assess endogenous Rho, 
providing a proxy for the integration of the many inputs that may affect it at junctions. 
It also allowed us to survey Rho at the population level, which was the scale at which 
stability of the Rho zone was evident. 
 A key feature in any bistable signaling network is the presence of positive 
feedback in the system. Our analysis identified the loop between ROCK-1 and NMII 
as a central factor. Ablating feedback from NMII to ROCK-1, either computationally 
or experimentally, caused the system to be incapable of sustaining stable Rho 
signaling at the ZA. How, then, might NMII support positive feedback to ROCK-1? 
ROCK signaling promotes the accumulation of NMIIA at the ZA 2, 42, where we now 
find that it serves to also localize ROCK. Such localization would allow NMIIA to 
recruit inactive ROCK to the apical junctions, where it could be activated by GTP-
Rho. Further, scaffolding to NMII might also serve to retain ROCK at the ZA so that it 
can be reactivated by Rho. Of note, the biochemical interaction between ROCK-1 
and NMIIA did not appear to require either the motor activity of NMII or kinase activity 
of ROCK1, as it was resistant to both blebbistatin and Y-27632. Effectively, 
localization of ROCK in proximity to GTP-Rho at the ZA would allow NMIIA to close a 
loop that promotes ROCK activity.  
 Local feedback can also contribute to spatially defining the Rho zone of the 
ZA. Spatial patterning can be generated by the combination of short-range positive 
feedback combined with long-range inhibition 43, 44. Here we envisage that scaffolding 
of ROCK-1 by NMII at the ZA represents the local activatory feedback element, 
whereas Rnd3/p190B may constitute a long-range inhibitory component. Indeed, 
p190B was extensively distributed at the cortices of cells (not shown), likely reflecting 
the ability of Rnd3 to localize at the plasma membrane through its C-terminal farnasyl 
group 31, 32. At the ZA, however, myosin-localized ROCK-1 would antagonize the 
cortical association of Rnd3, yielding complementary patterns for ROCK and 
Rnd3/p190B. Therefore, in this model localization of the NMII-ROCK-1 network 
would not only define the site of positive feedback, but also influence the patterning 
of a potential antagonist. Consistent with this, extension of our numerical model to a 
spatial form revealed that local stabilization of NMII was sufficient to generate a 
stable Rho zone and a complementary distribution of p190B, even when the 
activatory GEF was uniformly distributed. Interestingly, for a stable Rho zone to be 
established it was also necessary for the cortical dynamics of NMII to be significantly 
slower than those of Rho (see also Supplementary Experimental Procedures). 
Indeed, the scale of this predicted difference was comparable to that which we have 
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measured by FRAP for junctional Rho (T1/2 ~ 0.5 sec) and NMIIA (T1/2 ~ 5 sec at 
the ZA, unpublished). This implies that the spatial stability of the Rho zone at the ZA 
would reflect the effective local time scale of NMII dynamics.  
Our findings add to the increasing appreciation that NMIIA can exert 
biological functions through an ability to scaffold signaling molecules (Lee, 2010; Wu, 
2006; Kuo, 2011; Shin, 2014) that can be separated from its ability to exert 
contractile force. Thus, we found that ROCK-1 could be restored at the ZA when 
NMIIA KD cells were reconstituted with mutants (N93K, Rod) which are themselves 
unable to generate high levels of contractility 45. Although blebbistatin inhibits NMII-
dependent contractility, it also causes NMIIA to be lost from junctions 2. Similarly, 
ROCK-1 localization was resistant to alternative manoeuvres that inhibited tension. 
However, these findings are consistent with our earlier observation that NMIIA N93K 
could restore the integrity of the ZA to NMIIA-depleted cells 2.  
Overall, we propose that NMIIA establishes a cortical landmark for a 
feedback network that confers the stability and robustness necessary to sustain 
contractility at the ZA. It is attractive to postulate that the junctional recruitment of 
GEFs, such as ECT2 5, defines where Rho is activated, while the NMII-ROCK 
network that we have identified serves to sustain the activated Rho and confine it to 
the region of the ZA. However, it should be noted that NMIIA is found in many other 
parts of the cell 46, including the lateral junctions located below the ZA 8. Despite this, 
NMIIA principally localized ROCK-1 to the ZA. Therefore, factors other than the 
presence of NMIIA alone must also contribute to scaffolding ROCK at these junctions. 
One possibility is that proteins, such as Shroom 38, 47, contribute to localizing ROCK. 
Nevertheless, they did not appear to be sufficient to compensate for loss of NMII in 
our experiments. Alternatively, the apparently privileged location of ROCK-1 at the 
ZA may reflect local differences in the cortical dynamics of NMII (not shown) that can 
result in advective flows of NMII at the cell cortex towards the sites of more stable 
myosin 48. This may ultimately cause the distribution of ROCK-1 to be influenced by 
active cortical mechanics 48-50, in addition to passive reaction-diffusion patterning. 
Exploring the dynamical properties of these possibilities, both at the theoretical and 
experimental level, may then provide a fruitful approach to understanding the 
systems cell biology that controls contractile tension at cell-cell junctions. 
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Figure Legends 
 
Figure 1: Myosin II supports a stable Rho zone at the ZA.  
 (a) GFP-AHPH and cortical F-actin (RFP-UtrCH) localization in live MCF-7 cells 
monolayers at the apical (z=0μm) vs. sub-apical (z= -3μm) junctions imaged by 
spinning disc confocal microscopy. 
(b-c) Kymograph (b) and fluorescence intensity (FI) (c) of GTP-Rho (GFP-AHPH) at 
the ZA, (30 min, Supplementary video 1) imaged by spinning disc confocal 
microscopy). 
(d, e) MCF-7 cells were transfected with control siRNA (Ctrl) or E-cadherin siRNA (E-
cad KD) along with GFP-AHPH and imaged for GTP-Rho distribution by spinning 
disc confocal microscopy. Representative images acquired at the apical junctions of 
the cells (d) and junctional/cytoplasmic fluorescence intensity ratio of GTP-Rho (e).  
(f-h) RhoA immunostaining in TCA-fixed MCF-7 cells transduced with lentivirus 
encoding control shRNA (Ctrl), NMIIA (IIAKD), NMIIB (IIB KD) shRNA or treated with 
blebbistatin (BLB) (100μM, 2 hours). Representative confocal images were acquired 
at the apical junctions (f) and fluorescence intensity at cell junctions was quantitated 
by linescan analysis (g, h).  
(i, j) Junctional/cytoplasmic fluorescence intensity ratio of GTP-Rho measured in 
MCF-7 cells treated with blebbistatin (BLB) (100μM, 2 hours) (i) or transduced with 
lentivirus encoding non-targeting control shRNA (Ctrl), NMIIA (IIAKD) or NMIIB (IIB 
KD) shRNA (j).  
Data represent mean  S.E.M. of three individual experiments (n=3), **P<0.01, 
****P<0.0001;;  Student’s  t-test (e,g, i); **P<0.01, ***P<0.001 one-way ANOVA, 
Dunnett's multiple comparisons test (h,j). 
Scale bars: 10 μm 
 
Figure 2: p190B RhoGAP degrades the junctional Rho zone when NMII is 
inactivated.  
(a-c) Junctional p190B Rho GAP (p190B) in MCF-7 cells transduced with lentivirus 
encoding non-targeting control shRNA (Ctrl); NMIIA (IIAKD) and NMIIB (IIB KD) 
shRNA or treated with blebbistatin (BLB) (100μM, 2 hours). Representative confocal 
images were acquired at the apical junctions (a) and fluorescence intensity at cell 
junctions was quantitated by linescan analysis (b, c).  
(d-f) RhoA localization in TCA-fixed MCF-7 cells transfected with non-targeting 
control siRNA (Ctrl) or siRNA against p190B Rho GAP (p190B KD), then treated with 
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blebbistatin (100μM, 2 hours). Representative confocal images were acquired at the 
apical junctions (d) and fluorescence intensity at cell junctions was quantitated by 
linescan analysis (f).(e) Lysates from MCF-7 cells transfected with non-targeting 
control siRNA (Ctrl) or siRNA against p190B Rho GAP (p190B KD were 
immunoblotted for p190B RhoGAP and β-tubulin (loading control) (e). 
(g,h) GFP-AHPH distribution imaged by spinning disc confocal microscopy (g) in 
MCF-7 cells transfected with non-targeting control siRNA (Ctrl) or siRNA against 
p190B Rho GAP (p190B KD) along with GFP-AHPH and treated with blebbistatin 
(BLB) (100μM, 2 hours). Junctional/cytoplasmic fluorescence intensity ratio of GTP-
Rho was calculated using line-scan function of ImageJ.  
Data represent mean  S.E.M. of three individual experiments (n=3), **P<0.01 
Student’s  t-test (b) and **P<0.01 (c,h), ****P<0.0001 (f) one-way ANOVA, Dunnett's 
multiple comparisons test. 
Scale bars: 10 μm 
 
Figure 3: Rnd3 recruits p190B to the ZA. 
(a) MCF-7 cells transfected with GFP-Rnd3 and E-cadherin-tdTomato were imaged 
by spinning disc confocal microscopy. Merged image shows co-localisation of GFP-
Rnd3 with E-cadherin-tdTomato at the apical junctions. 
(b,c) MCF-7 cells transfected with Rnd3 siRNA and reconstituted with mCherry 
tagged WT Rnd3 (WT), AIIA Rnd3 (AIIA), S240A Rnd3 (S240A) and T55V Rnd3 
(T55V) were treated with either DMSO (Ctrl) or blebbistatin (100μM, 2 hours) and 
the transgenes imaged by confocal microscopy. The ratio of mean fluorescence 
intensity from junctions and cytoplasm were obtained using ImageJ (c).  
(d,e) p190B Rho GAP immunolocalization in MCF-7 cells transfected with non-
targeting siRNA (Ctrl) or Rnd3 siRNA and GFP, WT Rnd3 (WT), AIIA Rnd3 (AIIA), 
S240A Rnd3 (S240A), T55V Rnd3 (T55V) were treated with either DMSO (Ctrl) or 
blebbistatin (BLB) (100μM, 2 hours). Representative confocal images were acquired 
at the apical junctions (d) and fluorescence intensity at cell-junctions was quantitated 
by linescan analysis (e). Asterisks mark the transfected cells. 
(f) Fluorescence intensity of RhoA at cell junctions (corresponding to representative 
images shown in Supplementary Fig. 3m) measured in MCF-7 cells transfected with 
non-targeting siRNA (Ctrl) or Rnd3 siRNA and GFP, WT Rnd3 (WT), AIIA Rnd3 
(AIIA), S240A Rnd3 (S240A), T55V Rnd3 (T55V) treated with either DMSO (Ctrl) or 
blebbistatin (BLB) (100μM, 2 hours).  
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(g,h) Junctional tension at the ZA of MCF-7 cells expressing E-cadherin-GFP, 
transfected with Rnd3 siRNA and reconstituted with WT Rnd3 (WT), AIIA Rnd3 
(AIIA) or S240A Rnd3 (S240A). Represented are the best-fit single exponential 
curves from one of the experiments (g) and tension (initial recoils) measured after 
ablation (h).  
Data represent mean  S.E.M. for at least three individual experiments (n=3) (c,e,f)  
*p<0.05; **p<0.01, ***P<0.001, ****P<0.0001, one-way ANOVA, Dunnett's multiple 
comparisons test (c,e,f) and Student’s  t-test (h). 
Scale bars: 10 μm 
 
Figure 4:  ROCK-1 phosphorylates Rnd3 to support junctional Rho signalling. 
(a) Confluent MCF-7 cells were fixed with methanol and stained for ROCK-1, NMIIA 
and E-cadherin. Representatives are confocal images acquired at the apical 
junctions of the cells. 
(b) HEK293T cells expressing GFP-Rnd3 were treated with either PBS or Y-27632 
(30 μM, 1 hour). Rnd3 was immunoprecipitated by GFP-trap and lysates were 
immunoblotted for GFP and phospho-serine. 
(c) MCF-7 cells transfected with Rnd3 siRNA and reconstituted with GFP-tagged WT 
Rnd3 (WT), AIIA Rnd3 (AIIA), S240A Rnd3 (S240A) were treated with either PBS or 
Y-27632 (30 μM, 1 hour). The ratio between mean fluorescence intensity at 
junctions and cytoplasm was obtained using ImageJ.  
(d) MCF-7 cells were transfected with GFP-Rnd3 and treated with either PBS (Ctrl) 
or Y-27632 (30 μM, 1 hour). Fluorescence recovery after photobleaching was 
performed on the junctional pool of GFP-Rnd3.  Solid lines are best-fit mono-
exponential curves and vertical lines represent the S.E.M. Mobile fraction (Mf) values 
were obtained by non-linear regression analysis.  
(e-f) Confluent MCF-7 cells were treated with either PBS (Ctrl) or Y-27632 (30 μM, 1 
hour), fixed with methanol and stained for p190B Rho GAP (e) or fixed with TCA and 
stained for RhoA (f). The fluorescence intensity at cell junctions was quantitated by 
linescan analysis.  
(g,h) GFP-AHPH distribution in MCF-7 cells treated with either PBS (Ctrl) or Y-27632 
(30 μM, 1 hour), and imaged by spinning disc confocal microscopy (g). 
Junctional/Cytoplasmic fluorescence intensity ratio of GTP-Rho was calculated by 
line-scan analysis (h).  
(i) MCF-7 cells were transfected with non-targeting control siRNA (Ctrl) or with 
ROCK-1 siRNA (ROCK-1KD) and 48 hours post-transfection, treated with either 
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blebbistatin (100μM, 2 hours) alone (BLB) or in combination with ROCK-1 siRNA 
(ROCK-1 KD+BLB). Fluorescence intensity of p190B Rho GAP at cell junctions was 
quantitated by linescan analysis.  
(j) MCF-7 cells were transfected with non-targeting control siRNA (Ctrl) or with 
ROCK-1 siRNA (ROCK-1KD) and 48 hours post-transfection, treated with either 
blebbistatin (100μM, 2 hours) alone (BLB) or in combination with ROCK-1 siRNA 
(ROCK-1 KD+BLB). Fluorescence intensity of RhoA at cell junctions was quantitated 
by linescan analysis.  
Data represent mean  S.E.M. of at least three individual experiments; **P<0.01, 
***P<0.001, ****P<0.0001, one-way ANOVA, Dunnett's multiple comparisons test (c, 
i,j)  and  Student’s  t-test (d,e,f,h). 
Scale bars: 10 μm 
 
Figure 5: Myosin II scaffolds ROCK-1 at the epithelial ZA. 
(a-b) Confluent MCF-7 cells were treated with either DMSO (Ctrl) or blebbistatin 
(BLB) (100μM, 2 hours), fixed with methanol and stained for 
ROCK1.Representatives are confocal images acquired at the apical junctions of the 
cells (a). The fluorescence intensity at cell junctions was quantitated by linescan 
analysis (b).  
(c) Fluorescence intensity of ROCK-1 at cell junctions measured in MCF-7 cells 
transduced with lentivirus encoding non-targeting control shRNA (Ctrl), NMIIA 
(IIAKD) and NMIIB (IIB KD) shRNA.  
(d) HEK293T cells were transfected with GFP-ROCK-1 and treated with blebbistatin 
(BLB) (100μM, 2 hours). ROCK-1 was immunoprecipitated using GFP-TRAP and 
lysates were immunoblotted for NMIIA, NMIIB and GFP. 
(e) HEK293T cells were transfected with GFP-FL NMIIA (full-length) or GFP-NMIIA-
ROD and treated with Y-27632 (30 μM, 1 hour). Immunoprecipitation was performed 
using GFP-TRAP and lysates were immunoblotted for ROCK-1 and GFP.  
(f-g)  MCF-7 cells were depleted of NMIIA using siRNA and then transfected with 
GFP only, GFP-full-length NMIIA (FL IIA), GFP-N93K mutant of NMIIA (N93K), or 
GFP-NMIIA-ROD (ROD). Methanol-fixed cells were stained for GFP and ROCK-1. 
Representatives are confocal images acquired at the apical junctions of the cells (g). 
The fluorescence intensity at cell junctions was quantitated by linescan analysis (f).  
Data represent mean  S.E.M. of three individual experiments (n=3),  **P<0.01 and 
****P<0.0001  Student’s  t-test (b) or one-way ANOVA, Dunnett's multiple 
comparisons test (c,f). 
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Scale bars: 10 μm 
 
Figure 6: Bistable properties of RhoA activation at cell-cell junctions. 
(a) Activation and repression network model of GTP RhoA, ROCK-1, Rnd3, p190B 
RhoGAP and NMIIA. Arrows represent activation, T-junctions represent repression.   
(b) Switching between states in the network model. The network shown in (a) was 
mathematically modelled as a system of pairwise activations and repressions. A 
NMIIA to ROCK-1 activation coefficient (K୒୑୍୍୅ୖ୓େ୏ଵ), equivalent to the dissociation 
constant of NMIIA/ROCK-1 in a Hill model, of 0.5 was used with all other model 
constants as given in Table 1 in Materials and Methods. All concentrations were 
initialised to 1 at time t=0. In the figure active concentrations of all elements of the 
model are shown across time. At time t=200, the activation of ROCK-1 by Myosin IIA 
is turned off in the model.  
(c) Effect of feedback from NMIIA to ROCK-1 on stable signaling outcomes from the 
network. Steady state levels of RhoA were determined in simulations in which the 
activation coefficient  K୒୑୍୍୅ୖ୓େ୏ଵ was varied in the range 0 to 5, equivalent to a variation 
in the association constant (feedback strength) between >10 to 0.25 between these 
two molecules in a Hill model and all other constants as in Table 1 in Supplementary 
experimental procedure. For each model, a number of distinct initial concentrations 
of RhoA in the range 0 to 3.5, Rnd3 in the range 0 to 3.5, and all other 
concentrations 1 were run for t=0 to t=5000. Each was found to lead to one of two 
stable states, that is RhoA, ROCK-1 and NMIIA high and Rnd3 and p190B low or 
RhoA, ROCK-1 and NMIIA low and Rnd3 and p190B RhoGAP high. In the figure, the 
stable state (t=5000) concentrations of RhoA found for each 𝐾ேெூூ஺ோை஼௄ଵ are shown.  
(d-e’) Immunofluorescence analysis of junctional RhoA localization in control and 
blebbistatin treated MCF-7 cells (d) and frequency distribution of junctional RhoA 
intensity under the same conditions (e). (e’) Histograms were fitted to a double 
Gaussian function for control (p<0.01 double peak vs. single peak non linear 
regression; extra-sum-of squares F-test) and with a single Gaussian curve for 
blebbistatin treated cells (n.s. for  double peak vs single peak non linear regression; 
extra-sum-of squares F-test). Scale bars: 50 μm 
(f) Computer simulations of the network in 3-dimension. A cell was modelled as a 
sphere of 5 μm radius where the surface represents the cell cortex and the interior 
volume the cytoplasm. The top panels correspond to the steady state distribution at 
the cortex for NMIIA, RhoA, ROCK-1, Rnd3 and p190B and a RhoGEF under 
conditions where myosin is unstable throughout the cell cortex. The bottom panels 
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correspond to a similar simulation but a ring of stable NMIIA was created at the 
equator of the sphere. 
 
Supplementary Figure Legends 
 
Supplementary Figure 1: Myosin II supports a stable Rho zone at the ZA 
(a) Confluent MCF-7 cells fixed with TCA and stained for RhoA (green) and E-
cadherin (red). Shown are representative confocal images acquired at the apical 
junctions of the cells and the corresponding merged image. 
(b) Confluent MCF-7 cells transfected with GFP-AHPH and RFP-UtrCH, treated with 
vehicle control (Ctrl) or with Rho-inhibitor C3 Transferase (C3T, 1 µg/ml) for 3 hours 
and then imaged for GFP-AHPH and RFP-UtrCH distribution using a spinning disc 
confocal microscope. 
(c) MCF-7 cells were co-transfected with GFP-AHPH and a ctrl siRNA (Ctrl) or a 
siRNA against E-cadherin (E-cad KD) and fixed 24 hours later with TCA. Cells were 
immunostained for GFP (GFAHPH), E-cadherin (E-cad) and ZO-1.Representative 
confocal images were acquired at the apical junctions of the cells. 
(d) Lysates from MCF-7 cells transfected with control siRNA or E-cadherin siRNA 
were immunoblotted for E-cadherin and β-tubulin (loading control). 
(e) MCF-7 cells were transfected with siRNA against E-cadherin (E-cad KD), NMIIA 
(NMIIA KD) or treated with blebbistatin (100μM, 2 hours) (BLB) were lysed and 
GTP-Rho was isolated using beads coated with the RBD domain of Rhotekin (as 
described in the supplementary experimental procedure). The lysates were 
immunoblotted for RhoA and β-tubulin (loading control). 
(f) MCF-7 cells were treated with blebbistatin (100μM, 2 hours), fixed with methanol 
and immunostained for NMIIA or E-cadherin. Representative confocal images were 
acquired at the apical junctions of the cells. 
(g) Caco2 and MDCK cells were grown till confluent, treated with blebbistatin (100μ
M, 2 hours), fixed with TCA and stained for RhoA. Representative confocal images 
were acquired at the apical junctions of the cells. 
(h, i) Lysates from MCF-7 cells transduced with lentivirus encoding an empty vector 
control (Ctrl), shRNA-directed against NMIIA (h) or shRNA-directed against NMIIB (i) 
were immunoblotted for NMIIA, NMIIB and β-tubulin (loading control). 
(j) GFP-AHPH and MRLC-mCherry localization at the apical junctions in live MCF-7 
cells treated with blebbistatin (100μM, 2 hours) and imaged by spinning disc 
confocal microscopy. 
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Scale bars: 10 μm 
 
 
Supplementary Figure 2: p190B RhoGAP degrades the junctional Rho zone 
when NMII is inactivated. 
(a-e) MCF-7 cells transduced with lentivirus encoding non-targeting control shRNA 
(Ctrl), NMIIA (IIAKD) or NMIIB (IIB KD) shRNA, or treated with DMSO (Ctrl) or 
blebbistatin (100μM, 2 hours) were fixed with methanol and stained for ECT2 (a), 
MgcRacGAP (RacGAP) (b) p190A Rho GAP (p190A), Myosin IIA and Myosin IIB (c-
e). Representative confocal images were acquired at the apical junctions of the cells. 
Scale bars: 10 μm 
(f-g) Lysates from MCF-7 cells transduced with lentivirus encoding an empty vector 
control (Ctrl) or an shRNA-directed against NMIIA or an shRNA-directed against 
NMIIB (f) or treated with DMSO control (Ctrl) or blebbistatin (BLB, 100μM, 2 hours),  
(g) were immunoblotted for p190B Rho GAP and β-tubulin (loading control). 
Scale bars: 10 μm 
 
Supplementary Figure 3: Rnd3 recruits p190B to the epithelial Zonula 
Adherens 
(a-c) MCF-7 cells transduced with lentivirus encoding non-targeting control shRNA 
(Ctrl), NMIIA (IIAKD) or NMIIB (IIB KD) shRNA, and treated with DMSO (Ctrl) or 
blebbistatin (100μM, 2 hours) were fixed with TCA and stained for Rac1. 
Representative confocal images were acquired at the apical junctions.  
(d) Lysates from wild type MCF-7 (Ctrl) and MCF-7 cells transfected with siRNA 
against Rac1 were immunoblotted for Rac1 and β-tubulin (loading control). 
(e) Wild type MCF-7 and MCF-7 cells transfected with Rac siRNA were treated with 
DMSO (Ctrl) or with blebbistatin (BLB; 100μM, 2 hours) and fixed and stained for 
p190B Rho GAP. 
(f) MCF-7 cells were left untreated (Ctrl) or treated with blebbistatin (BLB; 100μM, 2 
hours) alone or in combination with Rac inhibitors EHT1864 (10 μM,  12  hours)  or  
NSC23766 (50 μM,  12  hours),  fixed  with methanol and stained for p190B GAP. 
(g) MCF-7 cells transduced with lentivirus encoding non-targeting control shRNA 
(Ctrl), NMIIA (IIAKD) or NMIIB (IIB KD) shRNA were transfected with the Raichu-Rac 
FRET biosensor and FRET measurements were performed as described in 
supplementary experimental procedure. Average emission ratios were calculated at 
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the apical junctions. Data represent mean  S.E.M. of 60 contacts and the result is 
the representative of two independent experiments. 
(h) MCF-7 cells were left untreated (Ctrl) or treated with blebbistatin (BLB) (100μM, 
2 hours) alone or in combination with Src inhibitors SU6656 (10 μM) or PP2 (10 μM))  
for 4 hours. Cells were fixed with methanol and stained for p190B GAP. 
(i) Lysates from MCF-7 cells transfected with control siRNA or siRNA targeted 
against Rnd3 were immunoblotted for Rnd3 and β-tubulin (loading control). 
(j,k) Control MCF-7 cells or MCF-7 cells transfected with siRNA against Rnd3 or 
Rnd1 and treated with blebbistatin (BLB; 100μM, 2 hours) were fixed with methanol 
and stained for p190B Rho GAP and E-cadherin. Representative confocal images 
were acquired at the apical junctions (j) and fluorescence intensity at cell junctions 
was quantitated by linescan analysis (k). Data represent mean  S.E.M. of three 
individual experiments (n=3); ****P<0.0001, one-way ANOVA, Dunnett's multiple 
comparisons test 
(l) Lysates from MCF-7 cells transfected with Rnd3siRNA along with GFP-tagged 
Rnd3 constructs (WT, AIIA, S240A, T55V) were immunoblotted for GFP and β-
tubulin (loading control). 
(m) MCF-7 cells transfected with Ctrl siRNA or Rnd3 siRNA and GFP, WT Rnd3 
(WT), AIIA Rnd3 (AIIA), S240A Rnd3 (S240A), T55V Rnd3 (T55V) were treated with 
either DMSO (Ctrl) or blebbistatin (100μM, 2 hours), fixed with TCA and stained for 
RhoA. 
Scale bars: 10 μm 
 
Supplementary Figure 4: ROCK-1 phosphorylates Rnd3 to support junctional 
Rho signaling. 
(a) Confluent MCF-7 cells were fixed with methanol and stained for ROCK-2 and E-
cadherin. Representative images were acquired at the apical junctions of the cells by 
confocal microscopy. 
(b) MCF-7 cells transfected with Rnd3 siRNA and reconstituted with GFP tagged WT 
Rnd3 (WT), AIIA Rnd3 (AIIA), S240A Rnd3 (S240A) were treated with either PBS 
(Ctrl) or Y-27632 (30 μM, 1 hour). Representatives images were acquired at the 
apical junctions of the cells by confocal microscopy. 
(c) MCF-7 cells were transfected with ctrl siRNA (ctrl) or p190B Rho GAP siRNA and 
RhoA-FRET biosensor and then treated with Y-27632 (30 μM, 1 hour). Average 
emission ratios were quantified at the apical junctions. Data represent mean  S.E.M. 
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of three individual experiments (n=3), **P<0.01, one-way ANOVA, Dunnett's multiple 
comparisons test. 
(d) Lysates from MCF-7 cells treated either with DMSO (ctrl) or Y-27632 (30 μM, 1 
hour), or blebbistatin (BLB) (100μM, 2 hours) and blotted for Rnd3 and β-tubulin 
(loading control). 
(e) Lysates from MCF-7 cells transfected with control siRNA (ctrl) or ROCK-1 siRNA 
(ROCK-1 KD) and immunoblotted for ROCK-1, ROCK-2 and β-tubulin (loading 
control) 
(f) MCF-7 cells were transfected with Ctrl siRNA or ROCK-1 siRNA (ROCK-1KD) and 
48 hours post-transfection, treated with either blebbistatin (100μM, 2 hours) alone 
(BLB) or in combination with ROCK-1 KD (ROCK-1 KD+BLB). Cells were fixed with 
methanol and stained for p190B Rho GAP or fixed with TCA and stained for Rho. 
Representative images were acquired at the apical junctions of the cells by confocal 
microscopy. 
Scale bars: 10 μm 
 
Supplementary Figure 5: Myosin II scaffolds ROCK-1 at the epithelial Zonula 
Adherens 
(a-b) MCF-7 cells wild type (ctrl) and transduced with lentivirus encoding NMIIA 
(IIAKD) or NMIIB (IIB KD) shRNA were fixed with methanol and stained for ROCK-1, 
NMIIA and NMIIB. Representative images were acquired at the apical junctions of 
the cells by confocal microscopy. 
(c-e) Lysates from MCF-7 cells transfected with non-targeting control siRNA (Ctrl) or 
NMIIA siRNA (c), Cdc42siRNA (d), or N-WASP siRNA (e) and immunoblotted for 
NMIIA, Cdc42 or N-WASP, respectively and β-tubulin (loading control) 
(f) MCF-7 cells transfected with siRNA targeted against Cdc42 or N-WASP were 
fixed with methanol and stained for ROCK-1 and ZO-1. Representative images were 
acquired at the apical junctions of the cells by confocal microscopy. 
(g) MCF-7 cells transfected with siRNA targeted against Cdc42 or N-WASP were 
fixed with TCA and stained for RhoA. Representative images were acquired at the 
apical junctions of the cells by confocal microscopy. 
(h) MCF-7 cells transfected with siRNA targeted against Cdc42 or N-WASP were 
fixed with methanol and stained for p190B Rho GAP, E-cadherin or ZO-1. 
Representative images were acquired at the apical junctions of the cells by confocal 
microscopy. 
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Supplementary Figure 6: Bistable properties of RhoA activation at cell-cell 
junctions 
(a) NMIIA to ROCK-1 activation coefficient and stable states. Using the activation 
and repression model and constants as described in Table 1 (Supplementary 
Information), time course plots for Rnd3 against RhoA are shown for three values for 
K୒୑୍୍୅ୖ୓େ୏ଵ: (left) K୒୑୍୍୅ୖ୓େ୏ଵ = 2.3; (center) K୒୑୍୍୅ୖ୓େ୏ଵ = 1.4; (right) K୒୑୍୍୅ୖ୓େ୏ଵ=0.5. In each, initial 
concentrations of RhoA and Rnd3 were set in a range between 0 to 3.5 and all other 
concentrations equal to unity. Simulations were run for t=0 to t=5000, with each line 
corresponding to a time course. Arrows denote the direction of increased time and 
red circles denote stable points. 
(b) Convergence behaviour of Rnd3 and RhoA for varying NMIIA initial values. Using 
the model described in Experimental Procedures and constants as in Table 1 of 
Supplementary experimental procedures, the convergence behaviour for initial 
values of Rnd3 and RhoA in the range 0 to 3.5 were examined, with all other initial 
concentrations set to 1 apart from NMIIA which was allowed to take values 0, 1, 2, 3, 
4 in distinct simulations. The red circles show the stable point concentrations for 
Rnd3 and RhoA that all initialisations converge towards. Each point in the plane then 
corresponds to an initialisation for Rnd3 and RhoA that will converge to one of the 
stable circles. Each line then denotes the boundary, for a given initial value of Myosin 
IIA, between those points in the plane that will converge to either the RhoA low/Rnd3 
high state and the RhoA high/Rnd3 low state. For instance, the points above the red 
line correspond to those initial values of RhoA and Rnd3 that for an initial 
concentration of NMIIA of 4 will converge toward the RhoA low / Rnd3 high state 
over time (upper left red circle). Similarly, the points below the red line are those 
initial values of RhoA and Rnd3 that will converge to the RhoA high / Rnd3 low state 
(lower right red circle) given an initial NMIIA of 4. Note how increasing NMIIA initial 
concentration leads to a larger proportion of initial RhoA and Rnd3 values that will 
converge to the RhoA high / Rnd3 low state.  
(c) A model for the sustenance of robust Rho zone at the epithelial Zonula Adherens.  
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Supplementary Information 
 
Methods 
 
Cell culture, Transfection: 
MCF-7, MDCK and HEK293T and Caco2 cells were grown in DMEM and RPMI media, 
respectively, supplemented with 10% FBS, 1% L-glutamine, 1% penicillin/streptomycin. All cell 
lines were maintained in low-doses of plasmocin (Invivogen) and routinely tested for the presence 
of mycoplasma. Cells were seeded at 30-40% confluency 48 hours before transfection with 
plasmids and siRNA, using Lipofectamine 2000 (Invitrogen) or RNAimax (Invitrogen), respectively 
according to manufacturer’s recommendations. For live-cell experiments, cells were cultured on 29 
mm glass-bottom dishes (Shengyou Biotechnology) and imaged in clear Hank’s balanced salt 
solution supplemented with 5% FBS, 10 mM HEPES (pH 7.4) and 5mM CaCl2. 
 
 
siRNA and shRNA: 
NMIIA and NMIIB were depleted using lentiviral shRNA, produced and transduced as described 
previously 1, 2. For reconstitution experiments with human Rnd3 and NMIIA, siRNA sequences were 
designed against their UTR regions using Invitrogen Block-iT RNAi designer. Smartpool siRNA 
(Dharmacon) were used to deplete Rac1, p190BRhoGAP, ROCK-1, Rnd1, E-cadherin and N-
WASP. Cdc42 siRNA (#sc-29256) has been described previously 3. The relevant sequences of 
siRNA are shown in Supplementary Table 1.  
 
Antibodies and Inhibitors: 
Primary antibodies used in this study were: (1) mouse monoclonal antibody (mAb) HECD-1 against 
the ectodomain of E-cadherin (1:50; a gift from Peggy Wheelock, University of Nebraska, Omaha, 
NE; with the permission of M. Takeichi);  (2) rabbit polyclonal antibody (pAb) for non-muscle 
myosin IIA heavy chain (1:1000; #PRB-440P, Covance); (3) rabbit pAb for non-muscle myosin IIB 
heavy chain (1:1000; #PRB-445P, Covance); (4) rabbit pAb (1:2000; #A-6455) and mouse mAb 
(1:200; #A-1120) against GFP (Molecular Probes/Invitrogen); (5) rabbit pAb (1:300; #61-7300, 
Invitrogen) and (6) mouse mAb against human ZO-1(1:300, #33-9100, Invitrogen); (7) mouse 
mAbs against RhoA (1:100; Santa Cruz Biotechnology, #sc418), (8) rabbit pAb against Ect2 (1:50; 
Millipore; #07-1364), (9) MKLP1(#sc: 22793, 1:50) and (10) RacGAP1(cat #sc:98617, 1:50) 
(SantaCruz Biotechnology Inc); mouse mAbs against (11) p190A (cat #610150, 1:50) and (12) 
p190B (#611612, 1:50) (BD Biosciences); (13) mouse mAb against β-tubulin (1:500, #T4026, 
Sigma-Aldrich); (14) rabbit pAb against ROCK-1 (1:300, Abcam ,#AB134181); (15) rabbit pAb to 
ROCK-2 (1:100, Abcam, # AB71598); (16) mouse anti-ROCK-2 mAb (1:300,BD Biosciences, 
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#610623,); (17) mouse mAb Anti-Rac1 (1:200, Millipore, #05-389); (18) mouse mAb against GFP 
(1:1,000; Roche; #11814460001, mixture of clones 7.1 and 13.1); (19) mouse mAb against actin 
(1:100; Millipore; # MAB1501, clone number C4); (20) rabbit mAb antibody 30D10 against N-
WASP (1:50; Cell Signaling Technologies; #4848; (21) rat mAb E-Cadherin (ECCD-2) (1:500, 
Invitrogen, #13-1900,); and (22) mouse mAb Anti-Cdc42 (1:300, BD biosciences, # 610928).). 
 Secondary antibodies were species-specific antibodies conjugated with AlexaFluor 488, 
594 or 647 (Invitrogen) (1:500) for immunofluorescence, or with horseradish peroxidase (Bio-Rad 
Laboratories) (1:5000) for immunoblotting.  
 Cells were treated with Blebbistatin (#US1203390-5MG, Merck; 100 μM, 2 hours) or Y-
27632 (# Y0503, Sigma; 30 μM, 1 hour). To inhibit Rac activity, cells were treated with 10 μM 
EHT1864 (#3872, Bio-Scientific) or 50 μM NSC23766 (#2161, Bio-Scientific) for 12 hours. To 
inhibit Src activity, cells were treated with 10 μM SU6656 (#572635, MERCK) or 10 μM PP2 
(#529573, MERCK) for 4 hours 4.For inhibition of Rho activity, cells were treated with 1 μgm/μl of 
cell permeable Rho Inhibitor (C3T based; #CT04-A, Jomar Bioscience) for 2-3 hours 5.  
 
Plasmids: 
FLAG-tagged RND3 mutants (WT, AIIA, S240A, T55V) were a kind gift from Anne Ridley, (King’s 
College London) and were described previously 6.These constructs were used as template for 
PCR-amplification and were subsequently cloned into pEGFP-C1 (Clontech) using EcoR1 and 
Kpn1 restriction sites.  To generate mCherry-tagged version of these Rnd3 constructs, the GFP tag 
was replaced in this vector by mCherry from pmCherry-C1 (Clontech) using Age1 and BsrG1 
restriction sites. GFP-p190BRhoGAP was generated by PCR from cDNA obtained from MCF-7 
cells and cloned into pEGFP-C1 using EcoR1 and Kpn1 sites. GFP-Myosin IIA ROD was a kind gift 
from Thomas Egelhoff (Cleveland Clinic, USA). GFP-ROCK1 construct was generated by PCR-
amplifying mouse ROCK1 using FLAG-tag mouse ROCK1 (a kind gift from Michael Samuel, 
Centre for Cancer Biology, Uni of South Australia) as a template and cloned into pEGFP-C1 
(Clontech) using Sac1 and Kpn1 restriction sites. Raichu- Rac FRET biosensors was a kind gift 
from  M. Matsuda (Kyoto University, Japan). pTriEx–RhoA biosensor WT was obtained from 
Addgene (#12150 ). GFP-AHPH location Rho biosensor was a kind gift from Michael Glotzer (Uni 
of Chicago, USA) 7, 8. GFP-Myosin IIA (#11347, Addgene) and GFP-Myosin N93K have been 
described previously 2.E-cad-EGFP and E-cad-tdTomato have been described previously 2, 9 10. 
MRLC1-mCherry was obtained by cloning MRLC1 (# 35680, Addgene) into pLL5.0 cherry 1 by 
PCR using SacI and BamHI restriction sites.  
 
Immunofluorescence microscopy and live-cell imaging: 
Cells were fixed with ice-cold methanol in -20 °C for 5 minutes or with 4% paraformaldehyde in 
cytoskeleton stabilization buffer (10 mM PIPES at pH 6.8, 100 mM KCl, 300 mM sucrose, 2 mM 
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EGTA and 2 mM MgCl2) on ice for 15 minutes or with freshly-prepared 10% TCA on ice for 15 
minutes (for Rho staining). TCA fixed cells were subsequently washed three times with 30mM 
glycine. Both PFA and TCA fixed cells were permeabilized with 0.25% triton X-100 for 5 minutes at 
room temperature. Confocal images were acquired with a Zeiss 510 or a Zeiss 710 Meta laser-
scanning confocal microscope. Background correction, contrast adjustment and Z-projections of 
raw data images were performed with ImageJ.  
 Live cell imaging (of GFP- and mCherry-Rnd3) was performed with cells incubated in 
movie-media (Hank’s balanced salt solution supplemented with 5% FBS, 10 mM HEPES pH 7.4 
and 5mM CaCl2) on a Zeiss 510 Meta laser-scanning confocal microscope. The mean grey values 
of fluorescence intensity from junctions and cytoplasm were obtained using ImageJ and their ratio 
was used for statistical analysis. 
 For representation purpose, images were processed in ImageJ by using the function 
smooth, applying a median filter of one pixel radius, or despeckle, as appropriate. Where 
necessary, background subtraction was performed using rolling-ball background subtraction 
function in Image J. Control and test images were processed identically. 
 
RhoA location biosensor (GFPAHPH) image acquisition and analysis: 
Cell grown on glass bottom dishes and expressing GFP-AHPH were imaged in a Zeiss inverted 
spinning disk confocal microscope equipped with a 63x 1.3 NA multi-immersion immersion 
objective (Zeiss), a CSU=X1-A Yokogawa spinning disk unit, and two Roper Evolve EMCCD 
512x512 cameras. Z-stacks were acquired with a Z-displacement of 0.2 μm and images were 
acquired with a digital resolution of 0.2 μm. Quantitative analysis of fluorescence intensity at 
contacts was performed using the line scan function of ImageJ. A line of ~20 μm in length (15 
pixels thick) was drawn starting from a cell-cell contact and orthogonal to it. Numerical values for 
the fluorescence intensity profile along this line were obtained for at least 100 contacts per 
condition per experiment using the Multiplot Plot feature of ImageJ and plotted in. Profiles were 
then averaged and fitted to the equation: 
𝑌 𝑥 = 𝑌! + (1 − 𝑌!) ∗ 𝑒(!!∗!!) 
where α was chosen as a shared parameter for the different conditions that were evaluated. To 
measure GTP-Rho accumulation at junctions the ratio at the ZA [Y(x=0 μm)] and its adjacent 
cytoplasmic region [Y(x=1 μm)] away was calculated for at least three independent experiments 
and the average values together with the standard errors of means were reported as indicated in 
the corresponding figure legends. 
 
Frequency analysis of RhoA intensity at junctions: 
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To acquire a large dataset of cell-cell junctions, wide-view Z-stacks (300x300x10 μm) of cells 
immunolabeled for RhoA and E-cadherin were acquired using a PLAN-Apochromat 40x Oil 
Objective. Then, quantitative analysis of fluorescence intensity at contacts was performed using 
the line scan function of ImageJ. A line of 10 μm in length (0.6 μm thick) was positioned orthogonal 
to, and centered upon, each cell-cell contact labeled with E-cadherin in every field of view. 
Numerical values for the RhoA fluorescence intensity profile along this line were obtained using the 
Plot Profile feature of ImageJ. Average profiles were then fitted to a Gaussian curve centered at 
zero. For each line scan profile, average intensities for pixels at a distance -1.2<x<1.2 μm from the 
center (junction) were calculated. In order to correct for background, we subtracted the 
corresponding average Rho fluorescence in the apical pole of cell (its average intensities for pixels 
located at distances X<-1.2 μm and x>1.2 μm). Corrected intensities (background subtracted) were 
then plotted as an histogram and fitted to a single or double peak Gaussian functions using the 
Peak Fitter function in Matlab 11. This approach allowed us to identify Rho labelling at the junctions 
that is higher than elsewhere in the apical region. As Rho staining at the apical pole of cells was of 
variable intensity, corrected intensities for single junctions could also acquire negative values, 
especially when their Rho content was reduced. 
 
GFP-TRAP pull-down assays: 
HEK293T cells growing on 10cm dishes were transfected with relevant constructs using 
Lipofectamine 2000 and processed for immunoprecipitation analysis 48 hours post-transfection. 
Cells were scrapped in pre-chilled tubes in 1 ml 1X TBS and centrifuged for 2 minutes for 1500xg 
to remove the TBS. Lysis buffer (600 μl) containing 50mM Tris, pH 7.5, 1% NP-40, 300 mM Nacl, 
Protease inhibitor cocktail (#138467, Roche), 1 mM Sodium orthovanadate, 20 mM Sodium 
Fluoride, 3mM EDTA, 10mM ATP, 5mM MgCl2 was added to the cell pellet.  Cells were incubated 
on ice for 30 minutes, with a brief vortex once every 10 minutes, and then centrifuged at 15,000xg 
for 30 minutes. The cleared 550 μl of supernatants were loaded with pre-blocked GFP-TRAP 
beads (GFP-Bond, Protein Expression facility, The University of Queensland, Australia) (50ul of 
50% bead-slurry) and allowed to incubate on a rotating wheel overnight in 4°C. The beads were 
then washed three times with wash buffer (50mM Tris pH 7.5, 1% NP-40, 500 mM NaCl) and 
protease inhibitor cocktail. The samples were eluted in 1X Laemmli buffer and processed for 
western blotting. For detection of Rnd3 phosphorylation levels, a phosphatase inhibitor cocktail 
(Cell Signaling, #5872) was added to the lysis and wash buffers and all the steps were performed 
as mentioned above. The samples were resolved on a 8-12% polyacrylamide gel, transferred to 
nitrocellulose membranes, and then blocked with 5% milk in TBST. The blots were washed thrice 
with TBST, incubated with anti-Phosphoserine Antibody (#AB1603, MERCK) in 3% BSA. This was 
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followed by three washes with TBST and incubation with secondary antibody in 5% milk (TBST) for 
1 hour.  
 
GTP-Rho Pull down assays: 
GTP-Rho pulldown assays were performed with RhoA Pulldown Activation Assay Kit (#BK036, 
Cytoskeleton Inc ) according to the manufacturer’s instructions. MCF-7 cells were grown in 10cm 
dishes for 4-5 days and transfected with siRNA against E-cadherin or siRNA against NMIIA. The 
cells were then incubated in DMEM with 0.5% FBS for 24 hours followed by serum-starvation for 
another 24 hours.  On the day of lysis, cells were treated with blebbistatin (100 μM, 2 hrs) followed 
by stimulation with 20% serum for 30 minutes. The cells were then washed with ice-cold PBS, 
lysed quickly and processed for pulldown assay according to the manufacturer’s instructions. 
 
FRET microscopy 
MCF-7 cells transduced with lentivirus encoding NMIIA shRNA and NMIIB shRNA were grown on 
29 mm glass-bottom dishes and transiently transfected with Raichu-Rac biosensor or pTriEx–RhoA 
biosensor as indicated in the corresponding figure legend. FRET measurements and analysis were 
performed 48 hours after transfection as described previously5.Briefly, live-cell imaging was 
performed at 37 °C on a LSM710 Zeiss confocal microscope equipped with a 63x oil Immersion 
objective (Plan Apochromat 63x 1.4 NA, Zeiss, Jena, GER). Images were acquired by sequential 
line acquisition. The acceptor (A) channel was imaged using 514 nm laser line for excitation and 
emission was collected in the acceptor emission range (BP 530-590 nm). Donor and FRET 
channels were acquired using 458nm laser line and emission was collected in the donor emission 
region (BP 470-490 nm) and acceptor emission region (BP 530-590 nm), respectively. When 
needed, mCherry fluorescence signal was collected using a 561 nm laser line and a 580-620 nm 
band pass emission filter. 
 
Laser Nanoscissors: 
MCF-7 cells transduced with lentivirus encoding E-cadherin-EGFP 2 were transfected with 
mCherry-Rnd3 WT, AIIA and S240A. Cells were processed for experiments twenty-four hours post 
transfection. Laser nanoscissors experiment was performed on a LSM 510 meta Zeiss confocal 
microscope equipped with a 37◦ C heating stage. Images (95.1 x 95.1 μm) were acquired with a 
63X objective (1.4 NA oil Plan Apochromat immersion lens) with 1.5X zoom. A constant ROI, with 
the longer axis parallel to the cell-cell contact was ablated with a Ti:sapphire laser (Chameleon 
Ultra, Coherent Scientific) tuned to 790nm, 30 iterations, and 25% transmission. Time-lapse 
images were acquired before (2 frames, 5.28 sec) and after (7 frames, 43.6 sec) ablation. Image 
analysis was done as described previously 12. 
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FRAP:  
MCF-7 cells were co-transfected with GFP-Rnd3 and with siRNA targeted against the UTR region 
of Rnd3. Images (47.5x47.5 μm) were acquired on a LSM 510 meta Zeiss confocal microscope 
equipped with a 37 °C heating stage, with a 63X objective (1.4 NA oil Plan Apochromat immersion 
lens) and 3X zoom. A constant ROI was drawn in the center of cell-cell contact and was bleached 
to 70-80% with a 790nm laser at 33%, 1 iteration. Time-series images were acquired before (3 
frames, ~311 ms) and after (247 frames, 38.8 s). To obtain FRAP profiles; a constant ROI at the 
bleached region of GFP-Rnd3 was drawn and the mean grey value were obtained at each time 
point. The fluorescence intensities obtained were normalized to the average pre-bleach values and 
fitted to a monoexponential function in the GraphPad Prism software.  
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Supplementary Table 1: 
 
Sequences of siRNA used in the study 
 
Target gene 
  
   
Vendor, Catalogue 
number 
siRNA sequences 
Human ROCK1 
 
Thermo Scientific, 
HumanROCK1 (6093) 
SMARTpool siRNA 
sequences 
5'-GCCAAUGACUUACUUAGGA-3' 
5'-GAGAUGAGCAAGUCAAUUA-3' 
5'-GAAGAAACAUUCCCUAUUC-3' 
5'-GGACACAGCUGUAAGAUUG-3' 
Human P190B 
Rho GAP  
 
Thermo Scientific,  ON-
TARGETplus Human 
ARHGAP5 (394) 
SMARTpool siRNA 
sequence 
5'-GUACGAAUUUGCAACCAUA-3' 
5'-GCUGAUACAACCACAAUUA-3' 
5'-GAUCAUGGCCGCUUAAGAU-3' 
5'-GGAAUCAGUUAAACACAAU-3' 
Human RND1 
 
Thermo Scientific, ON-
TARGETplus Human 
RND1 (27289) 
SMARTpool siRNA 
sequence 
5'-GGAUCUCCCUACUACGAUA-3' 
5'-GAGCUUAGUCUCUGGGAUA-3' 
5'-AGACAGACCUGCGAACAGA-3' 
5'- CAGAAGAGCCCUGUCCGAA-3' 
Human RAC1  
 
Thermo Scientific,  ON-
TARGETplus Human 
RAC1 (5879) SMARTpool 
siRNA sequence 
5'-GUGAUUUCAUAGCGAGUUU-3' 
5'-GUAGUUCUCAGAUGCGUAA-3' 
5'-AUGAAAGUGUCACGGGUAA-3' 
5'-GAACUGCUAUUUCCUCUAA-3' 
RND3 siRNA 
 
Invitrogen, Custom siRNA 
 
5'-UAAGCCUCUGGUAUACAUGACUUUG-3' 
5'-AUGAGUAUCCUCUCAAACGCCUCCU-3' 
Myosin IIA UTR  Invitrogen, Custom siRNA 
 
5'-UAUAGCCAGGACCUGAACCUGGAUC-3' 
5'-UUUAGAAUCAGGAGGGAGACAGCGG-3' 
Human N-
WASP 
 
Thermo Scientific,  ON-
TARGETplus Human N-
WASP(NM003941) 
SMARTpool siRNA 
sequence 
5’-CCAGAAAUCACAACAAAUA-3′ 
5’-CAGCAGAUCGGAACUGUAU-3 
5’-UAGAGAGGGUGCUCAGCUA-3′ 
5’-GGUGUUGCUUGUCUUGUUA-3′ 
Human E-
cadherin 
 
Thermo Scientific, ON-
TARGETplus Human 
CDH1 (NM_004360) 
SMARTpool siRNA 
sequence 
5’-GGCCUGAAGUGACUCGUAA-3′ 
5’-GAGAACGCAUUGCCACAUA-3′ 
5’-GGGACAACGUUUAUUACUA-3′ 
5’-GACAAUGGUUCUCCAGUUG-3′ 
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Supplementary Videos: 
 
Video 1:  
GFP-AHPH localizes at the zonula adherens of epithelial cells.  
AZ-stacks of GFP-AHPH and RFP-UtrCH acquired by spinning disc confocal microscopy. 
 
Video 2:  
GFP-AHPH exhibits stability on the time scale of minutes. 
 Time-lapse imaging of GFP-APHPH (transfected in MCF-7 cells) acquired over a span of 30 
minutes. 
 
Video 3:  
ROCK-1 inhibition causes accumulation of p190B Rho GAP at the cell-cell junctions. 
MCF-7 cells were transfected with GFP-p190B RhoGAP and time-lapsed imaging was performed 
briefly before and after addition of Y-27632 (30 μM) (20-minutes post-treatment).  
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4.2 Dissecting the role of Rho signaling in oncogenic epithelial extrusion 
 
The results presented in the previous section establish that in epithelial monolayers, Rho signaling 
exhibits bistability. Also, it implies that, by exploiting the myosin-ROCK feedback loop, cells can 
actually tune Rho activity (either ON or OFF) efficiently depending on the physiological cues.  This 
gives rise to an important question: at cellular levels, when and why does Rho need to be turned 
OFF? There is enough evidence in the literature supporting the role of active Rho in cellular 
processes (Bement et al., 2006; Burkel et al., 2012; Miller and Bement, 2009; Piekny et al., 2005; 
Ratheesh et al., 2012; Tse et al., 2012; Wolfe and Glotzer, 2009). However, epithelial 
morphogenesis relies on the extensive rearrangement of actomyosin cytoskeleton, of which Rho is a 
prime modulator. So to facilitate these dynamic changes, Rho activity must be downregulated at 
certain stages, probably by exploiting the balance between upstream Rho regulators, GEFs and 
GAPs. 
 
In order to understand the relevance of Rho inactivation, I used apical epithelial cell-extrusion as a 
model system, as described previously (Hogan et al., 2009; Slattum et al., 2009; Wu et al., 2014b). 
It is a process utilized by epithelial cells to preserve epithelial homeostasis, maintain barrier 
functions and modulate morphogenetic events (Eisenhoffer and Rosenblatt, 2013; Gu and 
Rosenblatt, 2012; Katoh and Fujita, 2012). The process involves expulsion of   a minority of cells 
from the monolayer, driven by apoptosis (Rosenblatt et al., 2001; Eisenhoffer et al., 2012; Kuipers 
et al., 2014), over-crowding (Eisenhoffer et al., 2012) or expression of an oncogene (Hogan et al., 
2009; Leung and Brugge, 2012; Wu et al., 2014b) The molecular pathways required for cell-
extrusion have been the focus of intense studies. Strikingly, actomyosin generated junctional 
contractility plays a decisive role in this process of epithelial oncogenic extrusion (Wu et al., 
2014b). Epithelial cells establish disparate regions of tension within their cell-cell junctions: the ZA 
acts as a site of high contractile tension, while lateral junctions display a much lower tension (Wu et 
al., 2014b). This higher apical tension is essential for epithelial integration as when this is depleted, 
cells tend to leave the monolayer and extrude (Wu et al., 2014b). Of note, it’s established that an 
active Rho is required to maintain apical junctional tension in epithelial monolayers (research 
chapter 2).  
 
Given above observations, I hypothesized that inhibition of Rho activity via p190B Rho GAP at the 
apical cadherin junctions leads to loss of apical tension and thus facilitates oncogenic extrusion (Fig 
4.2.1). To test this hypothesis, I performed mosaic expression of oncogenic Ras (HRasV12) in the 
 132 
MCF-7 cells and asked whether depleting p190B GAP can affect this process. Expression of 
HRasV12 leads to a significant increase in the percentage of extruding cells (Fig 4.2.2 a). 
 
 
Fig 4.2.1 Schematic indicating the proposed role of Rho signaling in apical oncogenic extrusion. 
 
  
 
Fig 4.2.2 p190B is essential for oncogenic extrusion. (a) MCF-7 cell monolayer with mosaic expression of  control 
(GFP  only) and HRasV12 cells, stained for E-cadherin and GFP. Arrow indicates the extruding cells. (b) 
Quantification of HRasV12-expressing cells undergoing extrusion in control or p190B depleted cell. Data 
represent mean ± S.E.M calculated from n = 3 independent experiments; ns, not significant; ∗∗  P < 0.01, 
Student’s t-test. Scale bar =10 µm 
 
 
Interestingly p190B GAP is required for this process as depletion of p190B GAP led to a sharp 
decrease in the number of Ras-transformed extruding cells (Fig 4.2.2 b. This suggests that p190B 
GAP activity is critical for cells to extrude. One way to envisage how this might happen is that the 
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GAP activity of p190B will suppress Rho signaling at the ZA, apical junctional tension will 
consequently be reduced, thus enabling cells to extrude. 
 
 
To test this hypothesis, I used laser-ablation to measure junctional tension along the interface of 
WT-WT vs. WT-HRasV12 transfected cells. Junctional tension was significantly less at the 
heterologous contacts between WT-HRasV12 cells compared to WT-WT cells (Fig 4.2.3). This 
indicates that indeed apical junctional tension is compromised at contacts of presumptive extruding 
cells, as observed earlier (Wu et al., 2014b). Strikingly, depletion of p190B GAP abolished this 
phenotype and junctional tension at the heterologous contacts was similar to the WT-WT cells (Fig 
4.2.3). These results strongly establish that p190B GAP is required to reduce the apical tension 
during oncogenic extrusion.  
 
Fig 4.2.3 p190B reduces apical tension at the interface of WT-HRas cells (a) Best-fit single exponential curves of 
apical junctions recoil (a) and tension (b) at the interface of heterologous contacts in the indicated conditions. 
Data represent mean ± S.E.M calculated from n = 3 independent experiments; ns, not significant; ∗∗  P < 0.01, 
Student’s t-test. 
 
Since p190B GAP function is crucial for oncogenic extrusion, it indicates that the HRasV12-
transfected cells might exploit its activity/localization to decrease Rho activity and thus exhibits 
reduced apical tension. So, to further dissect this, I aimed to characterize the distribution of p190B 
GAP and Rho at the heterologous contacts between WT-HRasV12 transfected cells. For this, I 
performed mosaic expression of HRasV12 in MCF-7 cells monolayer, fixed them and studied for 
Rho and p190B GAP localization.  
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Fig 4.2.4 Rho and p190B GAP localization in the extruding cells. Confluent MCF-7 cells with mosaic expression 
of GFP only or HRasV12, fixed with methanol and stained for p190B GAP (a) fixed with TCA and stained for 
Rho along with E-cadherin, and GFP. Scale bar=10 µm 
 
 
As shown in Fig 4.2.4, preliminary results indicate that at the heterologous contacts, Rho 
localization appeared to get disrupted (arrows) (Fig 4.2.4 b) and this was accompanied by an 
increase in the junctional accumulation of p190B GAP (Fig 4.2.4 a). However, the experiment 
proved to be technically challenging to reproduce the results because of the heterogeneous 
phenotype of the extruding cells. When studied closely, I found out that the process of HRasV12 
oncogenic extrusion in epithelia can be broadly characterized into three stages, and each stage is 
identified by a distinct shape of the presumptive extruding cell (Fig 4.2.5). The initial stage where 
the transformed cell is still in monolayer (stage 1); the middle stage in which the HRasV12 cell 
slightly lifts up from the monolayers and appears to be elongated (stage 2); and finally stage 3, 
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where the cell is completely extruded from the monolayer. Also, other studies have illustrated that 
epithelial cells extrusion is a multi-step complex process, with each step exhibiting distinct 
phenotype (Kuipers et al., 2014) 
 
Fig 4.2.5 Different stages of oncogenic extrusion identified in MCF-7 cells. Confluent MCF-7 cells with mosaic 
expression of HRasV12, fixed with methanol and stained for E-cadherin, Myosin IIA, GFP and DAPI. 
Representative are confocal images from different stages of extrusion. 
  
 
It is entirely possible that the component of Rho signaling pathways might get re-distributed only at 
a certain stage of oncogenic extrusion, but the sheer heterogeneity of the cells makes it hard to 
isolate that particular stage. Thus to better characterize the modulation of Rho-signaling elements 
during oncogenic extrusion, it will be useful to exploit an inducible system to control Ras 
expression, as used by other (Hogan et al., 2009). These are exciting possibilities and are part of on-
going work. 
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Chapter 5: Discussion and Future Implications 
 
 
Epithelial cells are tightly interlinked to each other via specialized adhesive structures called 
intercellular junctions. These junctions can display the dual properties of plasticity and stability: at 
steady state they provide strong cohesive strength to the cells, while during morphogenetic events, 
they transform into highly dynamic entities (Takeichi, 2014; Niessen et al., 2011). This enables 
epithelia to adopt various shapes and sizes and undergo extensive rearrangement like bending and 
constriction (Guillot and Lecuit, 2013; Takeichi, 2014). The adherens junction is a prominent 
feature of many epithelia. It is a cadherin-based cell-cell adhesion junction, supported by an 
extensive actomyosin network. At the apical zone of the cells, it organizes itself into a tight ring like 
structure, referred as the zonula adherens (ZA). This ring-like structure of the ZA accumulates 
dense clusters of E-cadherin decorating the actomyosin cables (Meng and Takeichi, 2009; Takeichi, 
2014). The intracellular domain of E-cadherin associates with this actomyosin network via linkers 
like α-catenin (Meng and Takeichi, 2009; Takeichi, 2014). This actomyosin network is an 
intrinsically dynamic highly contractile structure, which acts in concert with the E-cadherin 
complex to dictate various morphogenetic events (Brieher and Yap, 2013; Guillot and Lecuit, 2013; 
Munjal and Lecuit, 2014).  The coordinated action of ZA and actomyosin network in response to 
developmental cues is an outcome of many signaling events, primarily modulated by a class of 
powerful molecular switches called Rho GTPases (Braga and Yap, 2005; McCormack et al., 2013; 
Niessen et al., 2011; Ratheesh et al., 2013; Ratheesh and Yap, 2012). 
 
Rho GTPases are master regulators of cell physiology which, depending on the cellular context, are 
capable of fine-tuning their activity in a defined spatio-temporal manner (McCormack et al., 2013; 
Ratheesh et al., 2013). This is facilitated by a subset of upstream regulators: GEFs promote the 
exchange of GDP to GTP thus activating Rho; GAPs inactivate Rho by catalyzing the GTP 
hydrolysis; and GDIs sequester the GDP-bound Rho. Once activated, they initiate actomyosin 
remodeling via downstream effectors like ROCK and formins, which ultimately translate into a 
relevant biological outcome like migration, epithelial polarity or sustained adhesion (Bishop and 
Hall, 2000; Etienne-Manneville and Hall, 2002; Jaffe and Hall, 2005). Indeed, Rho GTPases have 
been shown to influence almost every aspect of junctional biogenesis; e.g. formation, maturation 
and disassembly (McCormack et al., 2013). 
 
We have come a long way since the initial studies suggesting that Rho GTPases support cadherin-
junctions. However, cadherin junction assembly and maintenance is a multi-step complex process, 
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utilizing a plethora of cytoskeletal regulators, not all of which respond to the same GTPase. Also, 
complexity lies in the fact that the same GTPase at a given point in time can coordinate opposing 
cellular processes by switching its activation state, by indulging in cross-talk or by exploiting 
different downstream effectors, depending on the cellular context (Braga and Yap, 2005; 
McCormack et al., 2013; Niessen et al., 2011; Ratheesh et al., 2013). The challenge lies in 
understanding how these multiple events are organized to ensure physiological interplay between 
cadherin and Rho. 
 
The work presented here aimed to address some of the above issues by unraveling very basic 
important questions pertaining to Rho signaling at junctions: how Rho GTPase supports cadherin 
junctions and what are the upstream factors required to maintain this GTPase cycle. Accordingly, I 
have dissected the precise molecular pathways by which RhoA supports the overall architecture of 
ZA and maintains junctional tension (Research chapter 2). Also, I have documented that E-cadherin 
facilitates junctional Rho activity by orchestrating the upstream Rho activators: ECT2 and 
centralspindlin complex (Research chapter 3). Finally, I have identified a novel feedback regulation 
anchored via ROCK and myosin-IIA; which ensures sustained production of GTP-Rho, thus 
ensuring the robustness of junctional Rho signaling (Research chapter 4). These findings advance 
our understanding of the interplay between Rho GTPase and cadherin junctions. 
 
In this chapter, I will discuss my research findings pertaining to each chapter in detail, with a 
perspective on existing literature and the future implications 
5.1 A novel role for Rho-GEF ECT2: from cell-division to cell-adhesion 
 
The last two decades has seen an increasing number of studies that outline the significance of Rho 
GTPases for epithelial integrity and junctional biology in various model systems (Ratheesh et al., 
2012; Simoes Sde et al., 2014; Smith et al., 2012; Smutny et al., 2011; Terry et al., 2011). Despite 
that, a great deal of knowledge is lacking about the upstream regulatory elements and downstream 
pathways, which determine the outcome of junctional Rho signaling.  
 
Given the above literature, I aimed to precisely dissect the functional impact of Rho signaling on 
the zonula adherens (Research chapter 2). By the time that I embarked upon these studies, 
preliminary data in the laboratory had already strongly suggested that ECT2 might be the relevant 
GEF for Rho at ZA. However, this was not a mainstream observation in the literature. Instead, 
multiple studies had confirmed its role as a Rho-GEF at the cytokinetic furrow and suggest that it 
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principally localizes in the nucleus during interphase and is found at the cortex only during cell 
division (Fields and Justilien, 2010; Hara et al., 2006; Yuce et al., 2005). 
 
So, I started with characterizing the location of ECT2 in monolayers of breast epithelial cells during 
interphase. Using immunofluorescence and live-cell imaging, I observed that ECT2 does get 
recruited to junctions, along with a prominent nuclear localization. This was in contrary to previous 
reports suggesting that ECT2 exclusively resides in the nucleus during interphase. The discrepancy 
can be because most of those studies were done on single cells or embryos and not on the 
monolayer of cells. Indeed, others have also reported junctional association of ECT2 (Liu et al., 
2004) Also, the fact that ECT2 harbors a PH domain known to have affinity for membrane-lipids, 
suggested that it might directly associate with plasma-membrane, as shown elsewhere 
(Chalamalasetty et al., 2006; Su et al., 2011).  
 
Further by using a lentivirus mediated knockdown approach, I demonstrated that ECT2 depletion 
led to the dispersion of E-cadherin at the apical zone of the cells and a significant reduction in the 
junctional cadherin staining. Also, I measured FRAP of GFP E-cadherin and found out that ECT2 
depletion or treating the cells with a pharmacological inhibitor of Rho led to significant reduction in 
the mobile fraction and half-time of recovery, indicating faster turnover of apical E-cadherin. Thus, 
Rho-ECT2 signaling maintains the stability of cadherin at apical junctions. These deleterious effects 
of ECT2 KD on the ZA were mediated specifically by myosin IIA (not by IIB), as junctional actin 
and myosin IIB remain unperturbed in these cells. ECT2 KD led to reduction in junctional myosin 
IIA and GFP-myosin IIA could rescue the E-cad phenotype. Also, depletion of myosin IIA led to 
destabilization of E-cadherin as assessed by FRAP. Of note, the effect of ECT2 KD on ZA was very 
much similar to myosin IIA KD (Smutny et al., 2010). These results indicate that ECT2 support 
cadherin organization by indirectly recruiting myosin IIA at the ZA via activation of Rho. Myosin 
IIA then supports E-cadherin clustering and stabilization. This is in agreement with previous 
findings from our lab suggesting that the Rho-ROCK pathway supports ZA integrity by specifically 
regulating junctional myosin IIA localization while myosin IIB is modulated by Rap1 GTPase.  
(Shewan et al., 2005; Smutny et al., 2010).  
 
Strikingly, in these studies, inhibition of Rho activity by ECT2 depletion perturbed the ZA, but not 
tight junctions. However, Rho GTPases have been implicated in the organization of tight junctions 
(McCormack et al., 2013; Terry et al., 2011). This discrepancy can be explained by the increasingly 
evident notion that Rho GTPases can modulate specific junctions by exploiting unique upstream 
activators, in this case GEFs. Indeed, Terry et al have shown that p114 Rho GEF is required for 
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tight junction assembly and its barrier function by activating Rho. Junctional protein cingulin 
directs the association of p114 Rho GEF with tight junctions and loss of p114 Rho GEF led to 
warped staining of ZO-1 without affecting adherens junctions (Terry et al., 2011). In contrast to 
this, ECT2 associates with α-catenin to localize specifically at zonula adherens and support its 
functions, with insignificant impact on tight junctions (Ratheesh and Yap, 2012). Thus, these 
finding contribute to the growing understanding that a common Rho GTPase can exploit the action 
of specific GEFs to generate a spatially restricted Rho signaling and functional outcomes. 
 
Myosin, along with actin, generates tensile forces at the cell junctions, which act in concert with 
cadherin to modulate epithelial patterning during disease and development (Gomez et al., 2011). 
Since ECT2 depletion led to the loss of cortical myosin IIA, I questioned whether the ECT2-Rho 
pathway affects junctional tension. Indeed, using a femtosecond laser to cut the junctions and 
measuring instantaneous recoil as a measure of tension, I have demonstrated that an active ECT2-
Rho signaling is required to maintain functional tension.  Depletion of ECT2 or its downstream 
target by C3-T or myosin RNAi led to significant reductions in tension. 
 
Further, using a 3-dimensional cyst culture that allows formation of polarized cysts, I have shown 
that ECT2 is required for morphogenesis. As compared to controls, Caco2 cells depleted of ECT2 
were unable to form fully formed cysts with proper lumen in the center. Also, E-cadherin 
organization in these structures was grossly disrupted with less concentration at the junctions. This 
suggests that the Rho-ECT2 pathway is indeed required for cadherin organization in a more 
physiologically relevant model like cyst culture. ECT2 has been implicated in establishing epithelial 
polarity by interacting with Par6/Par3 complex (Liu et al., 2004; Liu et al., 2006), but interestingly I 
could not observe any dominant alteration in polarity upon ECT2 depletion in Caco2 cells. This 
inconsistency can be explained by the type of model system used (MDCK vs CaCO2) and the kind 
of maneuver used. Liu et al relied on the use of dominant negative and constitutively forms of 
ECT2 (compare to the shRNA mediated knockdown of ECT2 employed here) for their studies, 
which has its own limitation of off-target effects and bypassing the endogenous regulatory 
mechanisms. Nonetheless, both studies speak to the argument that ECT2 supports morphogenesis in 
3-D cyst cultures, probably via different pathways depending on the cellular context. Due to the 
limited time frame of my thesis, I was not able to expand more on the cyst-study, but it remains an 
exciting possibility in the future. 
 
Overall, these results have identified a novel role for Rho-GEF ECT2 out of the ‘small cytokinetic 
window’. Multiple studies have established its importance as a Rho-GEF for cell division. But the 
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work presented here suggests that ECT2 is essential for the overall architecture and function of ZA 
in tinterphase epithelial cells. I have demonstrated that ECT2 specifically localizes to ZA and 
signals to myosin IIA (the downstream effector of Rho) to support ZA integrity and junctional 
tension.  
 
With this perspective, an important issue is what determines ECT2 localization at the ZA? Our lab 
has shown that α-catenin can act as a cortical anchor for MgcRacGAP (upstream activator of 
ECT2), thereby supporting ECT2 junctional association. However, α-catenin extensively co-
localizes with E-cadherin throughout the lateral surface of the cell, while ECT2 localization was 
found to be mostly apical. This suggests that alternate mechanisms might exist to spatially restrict 
ECT2 at the apical junctions. One of the most favorable candidates is Anillin, a multidomain 
protein that acts as an anchor to orchestrate Rho-signaling during cell-division (Piekny and 
Maddox, 2010). It was initially identified as an actin-binding protein and has been shown to 
regulate the localization of ECT2, CS, myosin and Rho, almost all the components of the junctional 
Rho-pathway during cell-division. Whether Anillin regulates ECT2 localization at junctions 
remains an interesting question. 
 
Also, at steady-state ECT2 remains in an inactive auto-inhibited form by interaction of its c-
terminus with N-terminus. During cytokinesis, binding to MgcRacGAP relieves this in a 
phosphorylation dependent manner (discussed in detail in section 1.8.2). We still don’t know 
whether some of these modifications are relevant for ECT2 activity at junctions. This will require 
the identification of junctional ECT2 modifications by exploiting phospho-specific antibodies. 
Also, kinases like CDK1 and Plk1 control the GEF activity/localization of ECT2 during cell 
division. Since these kinases are very tightly regulated in a cell-cycle dependent manner, this 
warrants the search for  ‘new’ regulator of ECT2 phosphorylation in interphase cells.  
 
5.2 E-cadherin and Rho signaling: a reciprocal interaction 
 
 
Cadherin based junctions are required to maintain the overall integrity of epithelial tissue. They 
regulate a variety of cellular processes like establishment of polarity, junctional biogenesis, cell 
sorting, and tissue formation (Brieher and Yap, 2013). Given these varied and profound outcomes, a 
key issue has been to understand how classical cadherins exert these functions. Indeed, cadherin-
based receptors have been established to act as a spot for the convergence of various signal 
transduction pathways (Braga, 2002; Niessen et al., 2011; Wheelock and Johnson, 2003; Yap and 
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Kovacs, 2003). By virtue of being adhesion receptors, they can directly initiate signaling reactions 
by homophilic ligation of cadherin ectodomain or drive juxtacrine signaling by bringing two 
plasma-membranes together. The signaling pathways emanating from cadherin-based junctions 
involve kinases (e.g Src, MAPK) and Wnt signaling and Rho family GTPases.  
 
Rho GTPases are known to influence cadherin-based junctions. Interestingly, cadherins also can 
modulate the spatiotemporal activity and localization of these GTPases (Braga and Yap, 2005; 
Wheelock and Johnson, 2003). This functional cooperativity enables these junctions to modulate a 
variety of cellular processes and thus needs to be understood in detail. So, using a combination of 
lentivirus mediated knockdown and rescue approaches, I aimed to address the impact of E-cadherin 
on GTP-Rho at junctions (Research chapter 3). 
 
In breast epithelial monolayers (MCF-7), depletion of cadherin displaces Rho from junctions, which 
can be restored by expression of a RNAi resistant GFP-E-cadherin. Of note, in a recent publication 
we have shown that treating with pharmacological inhibitor C3-T significantly reduced the amount 
of junctions Rho, implying that junctional Rho staining can be used as proxy for its activity 
(Ratheesh et al., 2012). Given this, my observation hints that E-cadherin supports GTP-Rho. In fact, 
using an activity-based Rho FRET biosensor, I found that cadherin depletion leads to loss of 
junctional Rho activity. How could cadherin support Rho GTPase? One immediate hypothesis will 
be by modulating its upstream regulators, GEF or GAP, as these molecules are largely responsible 
for the activity state of Rho. Indeed, cadherin depletion led to the loss of junctional Rho-GEF ECT2 
and its upstream activator centralspindlin complex. Further, in all these maneuvers cell-cell contacts 
remained intact as identified by ZO-1 staining, suggesting that the Rho signaling at junctions 
require the presence of cadherins.  
 
Strikingly, the findings reported here contrast with the earlier observation where it was shown that 
the assembly of cadherin junctions suppress Rho signaling while triggering Rac1 and Cdc42 (Noren 
et al., 2001). However, the discrepancy in the outcomes can by explained by the fact that the 
experimental maneuvers employed by those study are different from ours. Noren et al used acute 
methods like calcium switch and ‘artificial’ cadherin ligation (which broadly mimics ‘de novo’ 
junction assembly), while our studies were performed on steady-state mature junctions. Noren et al 
further proved that cadherin engagement dampens Rho signaling by the activation of p190RhoGAP 
(Noren et al., 2003). Rac GTPase, in response to cadherin signaling, has been shown to trigger 
p190RhoGAP activity and its localization at ZA via p120 catenin (Wildenberg et al., 2006). 
However a recent study from our lab indicates that at steady-state ZA, α-catenin can anchor 
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centralspindlin, which inhibits Rac activity and prevents p190BRhoGAP from junctional 
association (Ratheesh et al., 2012). These conflicting observations highlight the complexity of Rho 
signaling and strengthen the notion that a common GTPase can exist in alternate states by utilizing 
different effectors during various stages of junctional biogenesis (in this case formation vs. 
maintenance). 
 
Further to this, careful analysis of Rho localization at junctions revealed that apart from its 
distribution at the lateral cell surface, it selectively concentrates with cadherins at the ZA. Also, 
ECT2 and centralspindlin showed preferential localization at the apical junctions. What is the 
functional relevance of this ‘restricted’ Rho zone at ZA? I hypothesized that this spatially 
constrained zone of Rho signaling locally activates its downstream effectors (e.g. myosin IIA) and 
generates high concentration of cadherin at the apical zone (vs. lateral), thus generating the ZA. By 
performing FRAP studies on the apical vs. lateral pool of GFP-E-cadherin, I observed that indeed 
these two pools of cadherin are distinct and show different recovery patterns. Apical E-cadherin 
recovered to a lesser extent, with a low speed of recovery while basal E-cadherin recovered to 
greater extent and the recovery speed was higher than the apical (as reflected in the half time and 
mobile fraction values). This was a very intriguing novel observation, which suggests that E-
cadherin organizes itself into two differentially stabilized pools.  Strikingly, these regional 
differences in the apical vs. lateral pool of cadherin was largely abolished when Rho signalling was 
perturbed by various maneuver; by inhibiting GTP-Rho, by deleting upstream activator ECT2 or by 
removing the downstream effector myosin IIA.  These results affirm that local activation of myosin 
IIA via ECT2-Rho pathways is necessary to generate a stabilized and restricted pool of cadherin at 
the apical zone, referred as ZA. 
 
Recently we have shown that the cadherin-catenin complex can biochemically associate with 
upstream Rho regulators like ECT2 and centralspindlin as they were found to be present in the same 
complex (Ratheesh et al., 2012). This led me to ask that can E-cadherin directly influence the 
recruitment of Rho and its upstream activator at the ZA? I attempted to address this issue by 
exploiting ‘receptor-clustering’ mechanism. For this I used a fusion protein consisting of the IL2 
receptor α-subunit ectodomain (also called TAC) fused to the transmembrane and cytoplasmic 
domains of E-cadherin (Miranda et al., 2001) and induced E-cadherin clustering using TAC 
antibody. However, the results were not conclusive as the experiment had many technical 
limitations, mostly pertaining to the fixation methods used for Rho and ECT2. Due to the time-
constraints of my candidature, I was not able to further trouble-shoot this experiment, but it remains 
an exciting possibility for the future. 
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Fig 5.1 Signaling nexus between Rho and E-cadherin at epithelial zonula adherens. ECT2-Rho mediated 
activation of myosin IIA leads to cadherin clustering, stabilization and generates junctional tension. In-turn E-
cadherin anchors upstream Rho activators ECT2 and centralspindlin to maintain the GTPase cycle. 
 
Overall, the findings presented here speak to the notion that cadherins and Rho GTPase interacts 
cooperatively to generate a signaling nexus comprised of ‘inside-out’ signaling (e.g. Rho GTPase 
supports adhesion by modulating actomyosin cytoskeleton) and ‘out-side-in’ signaling (cadherins 
influence spatiotemporal activity of Rho GTPase) (Fig 5.1). 
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5.3 A myosin-mediated feedback loop ensure robustness of junctional Rho 
signaling 
 
The work presented in the first two research chapters establishes that the ZA can be defined as a 
spatially confined zone of high Rho activity. Here, the Rho GEF ECT2 act in concert with 
centralspindlin to ensures proper activation of Rho (Priya et al., 2013; Ratheesh et al., 2012). Since 
Rho GTPases are implicated in myriad cellular functions, their activity should be tightly controlled 
in a precise spatio-temporal fashion. Indeed, it is increasingly becoming apparent that Rho-GTPase 
signaling is a multi-faceted event, which requires the co-ordination of various regulatory elements 
(apart from the classical GEF-GAP 
pathway) to produce a relevant biological 
response (Bement et al., 2006; Guilluy et 
al., 2011; McCormack et al., 2013). 
However, we still do not know what are 
these precise circuitry elements that 
generate an integrated picture of Rho 
signaling. Accordingly, in this study, I 
aimed to dissect the molecular components 
required to confine and strengthen Rho 
signaling at the epithelial zonula adherens 
(ZA). 
 
Fig 5.2 Myosin-ROCK feedback loop sustains 
junctional GTP-Rho. 
 
Once GTP loaded, Rho mediates its 
biological functions via various effector 
proteins (Bustelo et al., 2007). Previously, 
we identified non-muscle myosin IIA (NMIIA) as a downstream target of Rho at the epithelial 
zonula adherens (Shewan et al., 2005; Smutny et al., 2010).  NMIIA along with actin forms the 
contractile actomyosin network and is the prime modulator of cellular processes involving 
mechanical forces and tension (Gomez et al., 2011; Munjal and Lecuit, 2014; Vicente-Manzanares 
et al., 2009). Accordingly, in this chapter I have proposed that myosin itself can act to orchestrate a 
feedback loop that is required to maintain GTP-Rho levels at ZA.  This is achieved by two 
interlocking feedback loops intersecting at ROCK-1. In the first loop, ROCK-1 supports Rho by 
inhibiting the junctional association of the Rho-antagonist Rnd3, which thus prevents the GAP, 
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p190B, from localizing to junctions.  In the second loop, myosin localizes ROCK-1 to the ZA via 
its rod domain (Fig 5.2). Together, this whole cascade ensures that Rho-zone at the ZA remains 
spatially focused and stable over time. 
 
My studies reveal that myosin inhibition/depletion leads to a significant reduction in junctional Rho 
localization by enriching the GAP, p190B at the ZA. As Rho protein extensively distributes 
throughput the lateral junctions and the apical pole of the cells, to better characterize GTP-Rho 
distribution I used a GFP-AHPH location Rho-biosensor (obtained from the c-terminus of anillin) 
(Piekny and Glotzer, 2008; Tse et al., 2012).This showed a prominent concentration as a sharp band 
at the ZA and indeed, this was the most evident location of the biosensor in cells. Myosin inhibition 
led to an extensive redistribution of the GTP-Rho over the apical pole of the cells, and along with 
junctional Rho staining, this could also be restored by p190B GAP depletion. This implies that 
myosin is required to concentrate GTP-Rho zone at junctions by inhibiting the localization of 
p190B GAP. Further, I have found that Rnd3 is required to localize p190B GAP (and thus inhibit 
Rho) in a phosphorylation dependent manner. A phospho-deficient mutant of Rnd3 constitutively 
localizes to junctions and prevents Rho from signaling by constitutively recruiting p190B to 
junctions. This phosphorylation of Rnd3 is mediated by ROCK-1, as inhibition of ROCK-1 led to 
the loss of Rnd3 phosphorylation and induced its junctional association. This implies that in steady 
state, ROCK-1 prevents Rnd3 junctional localization by phosphorylating it, and thus supports GTP-
Rho levels. Lastly, I found that myosin contributes to junctional GTP-Rho by scaffolding ROCK-1 
at epithelial cadherin junctions, independent of its head-domain functions. In summary, the results 
presented here identify a novel feedback loop anchored via myosin IIA required to sustain and 
define GTP-Rho at cadherin junctions. 
 
Previously we reported that blocking microtubules (MT) dynamics led to increased junctional 
association of p190B GAP via the Rac GTPase(Ratheesh et al., 2012). At cadherin junctions, 
MgcRacGAP blocks Rac activity and thus prevents p190B GAP recruitment. Blocking MT 
dynamics by nocodazole perturbed MgcRacGAP localization, thus activating Rac and inducing 
p190B localization (Ratheesh et al., 2012). However, Rac GTPase does not seem to affect p190B 
junctional localization when myosin was displaced from junctions. In fact, myosin relies on the 
action of another GTPase: Rnd3 to modulate p190B GAP localization. Rnd3 has been shown to act 
as a Rho antagonist in various systems (Riento et al., 2003; Wennerberg et al., 2003) and stimulates 
the GAP activity of p190B in vitro (Wennerberg et al., 2003). Of note, Rac needs to be activated for 
localizing p190B (Bustos et al., 2008), and we have reported previously that blocking MT dynamics 
by nocodazole leads to enhanced Rac activity and thus enables Rac to localize p190B at the ZA 
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(Ratheesh et al., 2012). However, I didn’t observe any increase in Rac activity or localization when 
myosin was inhibited or depleted, thus further confirming the notion that Rac does not mediate the 
cross-talk between myosin II and p190B Rho GAP. Also, unlike nocodazole, blebbistatin didn’t 
affect MgcRacGAP localization and thus Rac activity was not changed. Overall, these current 
findings agree with our earlier observations that to sustain GTP-Rho levels, p190B junctional 
localization should be prevented. How might Rac and Rnd3 co-ordinate at cadherin junctions to 
regulate p190B localization? I don’t have any data to suggest that Rac and Rnd3 independently 
modulate p190B GAP localization. The fact that both Rac and Rnd3 bind to the middle domain of 
p190B makes it difficult to isolate the effect of the two GTPases (Bustos et al., 2008).Also, this 
might be a reflection of the differential upstream regulation of these GTPases; extended analysis of 
p190B Rho GAP binding with Rac1 and Rnd3 will be needed in the future to resolve this issue. 
However, these distinct regulatory effects of Rac and Rnd 3 suggest that p190B constitutes a key 
point of integration – i.e. it can respond to several important upstream signals to repress Rho 
signaling. 
 
I have illustrated that ROCK-1 supports Rho signaling at epithelial cadherin junctions by 
phosphorylating and thus inhibiting another small GTPase Rnd3. Cross-talk between small 
GTPases is a fundamental process behind regulation of various cellular functions and mostly 
happens on the level of activity, expression levels or downstream signaling (Boulter et al., 2012; 
Guilluy et al., 2011).Rnd proteins (basically Rnd1 and Rnd3) have been shown to affect cell 
morphology by antagonizing Rho, either via activating the GAP p190 or by inhibiting the ROCK-1 
(Riento et al., 2003; Wennerberg et al., 2003).I could not see any effect on p190B localization when 
Rnd1 was depleted, thus indicating the prevalent contribution of Rnd3 for p190B localization. Also, 
p190b recruitment seems to be the favored mode of Rho inhibition as Rnd3 depletion did not affect 
ROCK-1 localization.  
 
Interestingly, the results presented here identify that NMIIA (and not NMIIB) supports GTP-Rho 
zone at ZA. This is in accordance with our previous findings that the junctional accumulation of 
NMIIA responds to Rho signaling while Rap1 is the upstream regulator for NMIIB (Smutny et al., 
2010).Further, ROCK-1 junctional association was sensitive to the loss of NMIIA but not NMIIB 
and only NMIIA was found to be present in the immunoprecipitates of ROCK-1, suggesting that 
NMIIA selectively can scaffold ROCK-1 at cadherin junctions. Although I cannot ignore the fact 
that these two paralogues are differentially expressed inside MCF-7 cells (Smutny et al., 2010),still 
the findings reported here complement the growing idea that despite sharing significant sequence 
similarity, NMII paralogues exhibit unique functions and can be subjected to distinct upstream 
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regulatory pathways  (Betapudi, 2010; Sandquist and Means, 2008; Smutny et al., 2010; Wang et 
al., 2009).  
 
Indeed, its been shown in other systems that ROCK kinase can specifically regulate 
phosphorylation of NMIIA, rather than NMIIB and ROCK inhibition phenotype is exactly similar 
to NMIIA (but not NMIIB) depletion (Sandquist et al., 2006). How is this achieved, considering 
that both NMII isoforms share the same regulatory light chain (RLC)? Based on our current 
findings, one can envisage that once activated, ROCK-1 can induce similar levels of 
phosphorylation on NMIIA and NMIIB associated RLC, but NMIIA-RLC phosphorylation would 
be greatly enhanced as NMIIA specifically can bind and scaffold ROCK-1. Further to this, the rod 
domain of NMIIA has been implicated in these isoform specific functions, mostly because it 
exhibits greater dissimilarity in sequence between different paralogues (Conti and Adelstein, 2008; 
Heissler and Manstein, 2013; Vicente-Manzanares et al., 2009); can harbour unique regulatory 
modifications like phosphorylation (Rosenberg and Ravid, 2006) and has been shown to mediate 
interactions with exclusive binding partners (Li and Bresnick, 2006). Indeed, I also found out that 
the rod domain of NMIIA was capable of mediating junctional localization of ROCK-1, thus 
reinforcing the idea that the rod domain contributes to paralogue -specific functions.  
 
Also, it’s worth mentioning here that these findings argue for a novel regulatory feature of myosin. 
The conventional wisdom considers myosin as a motor-protein, which binds to filamentous actin 
and generates forces/contractile structures. However, there have been few studies recently 
speculating that it also contributes to signaling cascades (Conti and Adelstein, 2008; Kuo et al., 
2011; Lee et al., 2010; Shin et al., 2014), but the detailed mechanistic details have been missing. 
The results presented here illustrate an active role of myosin in sustaining junctional Rho signaling 
by localizing ROCK-1 at apical cadherin junctions and thus mediating a feedback loop leading to 
the inhibition of GAP.  
 
Intriguingly, while ROCK-1 localized specifically at apical cadherin junctions, myosin is also 
present elsewhere in the cells apart from at the ZA, including an extensive distribution throughout 
the lateral surface of the cells (Wu et al., 2014). How then can then myosin spatially recruit ROCK-
1 at the apical junctions, when it is present so extensively? Further study will be necessary to 
answer this question. One possibility might be that the stability of myosin differs in the apical vs. 
lateral junctions. Interestingly, apical cadherin junctions exhibit significantly higher contractile 
tension (Wu et al., 2014)and accumulate a stable, immobile pool of E-cadherin locally (Priya et al., 
2013)as compared to the lateral cadherin junctions. This fits well with the presumption that a 
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steady-stable pool of myosin at apical junctions will be more efficient in generating high tension 
locally and concentrating E-cadherin at these sites. I have not tested these ideas experimentally, but 
it does predict that at apical cadherin junctions, myosin might be stabilized and thus can bind and 
recruit ROCK-1 much more efficiently. This leads to a localized accumulation of ROCK-1 at the 
ZA, which by inhibiting p190B, leads to the formation of a sharp active zone of Rho. 
 
GTP-Rho zones have been implicated in various physiological processes like wound-healing and 
cytokinesis (Bement et al., 2006; Benink and Bement, 2005; Piekny et al., 2005; Simon et al., 
2013). The focusing and stabilization of these zones have been shown to depend on the anchoring 
functions of actin filaments, and a proper balance of GEF and GAP activity to maintain the GTPase 
flux and GTPase cross-talk (Benink and Bement, 2005; Miller and Bement, 2009; Miller et al., 
2008). Strikingly, using the GFP-AHPH location Rho biosensor, we could visualize a highly 
concentrated, stable zone of GTP-Rho at the apical junctions of interphase epithelial cells, which 
persisted for tens of minutes. Earlier, we identified that the Rho GEF ECT2 pool at the ZA is highly 
dynamic with a half time of ~3-4 seconds, indicating the transient nature of its junctional 
association (Ratheesh et al., 2012). Such a short-lived interaction won’t be able to generate a 
persistent zone of active Rho at ZA, thus warranting the need of other mechanisms. 
 
Indeed, this study reveals that myosin IIA; the downstream effector of Rho sustains and spatially 
restrains the Rho zone at epithelial cadherin junctions. NMIIA functions as a signaling module, 
which acts by antagonizing the localization of p190B GAP at the ZA.  This helps in sustaining the 
active Rho by increasing its lifetime. The intrinsic GTP-hydrolysis half-time of Rho is ~ 30 
minutes, which is reduced to ~ 0.4 seconds by the GAP activity of p190B (Zhang and Zheng, 1998). 
This implies that in the absence of p190B GAP activity, half-time of GTP-Rho will increase to 30 
minutes and thus produces a stable GTP-Rho zone. Though the possibility that other GAPs might 
be functional at the ZA cannot be excluded, the data presented here suggest that p190B GAP is the 
prominent GAP inhibiting Rho when NMIIA was depleted. This asserts the significance of 
inhibiting p190B GAP localization via myosin II to sustain GTP-Rho zone at the ZA. 
 
This pathway also identifies the contribution of Rho-Rnd3 cross talk in focusing the Rho-zone at 
the ZA. Further, myosin/ROCK depletion led to the loss of Rho activity, as assessed by FRET 
biosensor and localization studies. Of note, in a recent paper by Reyes et al, it was shown that 
depleting Anillin, a protein known to anchor/activate Rho and its regulators during cytokinesis, led 
to the broadening of the Rho-zone at intercellular junctions (Reyes et al., 2014). These observations 
imply that the activation state of Rho is essential to confine it spatially and ZA might act as a ‘sink’ 
 152 
that generates and thus sustains an active Rho zone by utilizing its components like myosin IIA. 
Here I envisage that myosin initiates a feedback loop, which creates a self-amplification machinery. 
Thus even an initial ‘weak’ accumulation of GTP-Rho signal (mediated by the GEF ECT2) can be 
rapidly and efficiently amplified. This confers robustness to junctional Rho signaling, making it less 
sensitive to the fluctuations inside the cells. Also, this adds to the growing notion that effectors of 
Rho signaling pathway can act both upstream and downstream of Rho, thus creating a feedback 
loop to strengthen the output signal (Ivetic and Ridley, 2004; Kitzing et al., 2007; Tang et al., 
2012).  
 
Further, the numerical simulations predicted that the signaling network I have unraveled has the 
tendency to exhibit bistability. Bistability is a phenomenon inherent to essential cellular pathways 
like the cell cycle or cell differentiation. A bistable system rests in two steady states and is capable 
of transforming an initial trigger to a sustained signal, which ultimately translates into a biological 
response (Bhalla and Iyengar, 2001; Ferrell, 2002). Indeed, we identified that in steady-state 
epithelial monolayer, junctional Rho can be categorized into two states; ON and OFF and the 
myosin to ROCK feedback loop skews the Rho activity towards ON state. This further asserts that 
the myosin to ROCK loop is necessary to maintain Rho in its GTP-loaded state. Also, the notion 
that Rho signaling exhibits bistability has great implications for Rho biology during morphogenetic 
processes. Physiological events like cytokinesis, extrusion and wound healing rely on the active 
remodeling of actomyosin based cellular structures, of which Rho is the master regulator. The 
bistability makes Rho signaling facile and amenable to morphogenetic cues. Also, by exploiting the 
myosin to ROCK feedback loop, cells can potentially tune the state of Rho activity quickly, thus 
enabling them to co-operate well with the changes in the cell-environment. 
 
In conclusion, my findings indicate the presence of a novel signaling cascade that assures the 
sustenance of a stable GTP-Rho zone at the ZA. Considering that an active Rho is required for such 
myriad cellular functions, whether some of the components and mechanism of this pathway is 
shared by other cellular processes remains an exciting question for the future. 
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Centralspindlin and ↵-catenin regulate Rho signalling
at the epithelial zonula adherens
Aparna Ratheesh1,4,6, Guillermo A. Gomez1,4, Rashmi Priya1, Suzie Verma1, Eva M. Kovacs1, Kai Jiang2,
Nicholas H. Brown3, Anna Akhmanova2, Samantha J. Stehbens1,5 and Alpha S. Yap1,6
The biological impact of Rho depends critically on the precise subcellular localization of its active, GTP-loaded form. This can
potentially be determined by the balance between molecules that promote nucleotide exchange or GTP hydrolysis. However, how
these activities may be coordinated is poorly understood. We now report a molecular pathway that achieves exactly this
coordination at the epithelial zonula adherens. We identify an extramitotic activity of the centralspindlin complex, better
understood as a cytokinetic regulator, which localizes to the interphase zonula adherens by interacting with the
cadherin-associated protein, ↵-catenin. Centralspindlin recruits the RhoGEF, ECT2, to activate Rho and support junctional
integrity through myosin IIA. Centralspindlin also inhibits the junctional localization of p190 B RhoGAP, which can inactivate Rho.
Thus, a conserved molecular ensemble that governs Rho activation during cytokinesis is used in interphase cells to control the
Rho GTPase cycle at the zonula adherens.
Rho family GTPases are fundamental regulators of cell behaviour
that are active in their GTP-loaded state1. This state is determined
by the action of guanosine nucleotide exchange factors (GEFs) that
catalyse GTP-loading, and GTPase-activating proteins (GAPs) that
stimulate Rho proteins to convert bound GTP to GDP (refs 2,3). The
biological impact of Rho also depends on the precise subcellular site
where Rho–GTP is expressed4–7. This is exemplified by cytokinesis,
where Rho accumulates at the contractile furrow and regulates
actomyosin-based processes necessary for cell division6,8,9. Importantly,
the precise spatio-temporal control of this Rho zone contributes to
orderly cell division3,8.
Interphase epithelial cells concentrate Rho at their cell–cell
junctions5,10. Rho signalling is necessary for cell–cell integrity11,12 and
this is probably mediated by the actomyosin cytoskeleton. Potential
Rho effectors at junctions include non-muscle myosin II (ref. 13)
and regulators of actin dynamics, such as formins14. However, the
molecular mechanism that controls Rho–GTP at junctions is poorly
understood. Formally, coordinate regulation of the GEF andGAP limbs
of its GTPase cycle can control the spatial expression of the Rho–GTP
signal3,12. However, for this to occur there must be mechanisms
that spatially coordinate the localization of relevant RhoGEFs and
RhoGAPs to cadherin junctions. We now report that this involves an
1Division of Molecular Cell Biology, Institute for Molecular Bioscience, The University of Queensland, St Lucia, Brisbane 4072, Queensland, Australia. 2Cell Biology,
Faculty of Science, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands. 3Gurdon Institute and Department of Physiology, Development and
Neuroscience, Cambridge University, Tennis Court Rd, Cambridge CB2 1QN, UK. 4These authors contributed equally to this work. 5Present address: Department of Cell
and Tissue Biology, University of California, San Francisco, San Francisco, California 94143, USA.
6Correspondence should be addressed to A.R. or A.S.Y. (e-mail: aparnaratheesh@gmail.com or a.yap@uq.edu.au)
Received 7 October 2011; accepted 25 May 2012; published online 1 July 2012; DOI: 10.1038/ncb2532
extramitotic action of the centralspindlin complex, a key regulator of
Rho signalling during cytokinesis9.
RESULTS
The zonula adherens is a microtubule-dependent Rho zone
We began by comparing the subcellular distribution of RhoA and
E-cadherin in interphase MCF-7 mammary epithelial monolayers.
E-cadherin distributed extensively throughout the lateral surfaces
of the cells, forming both a prominent apical ring denoting the
zonula adherens15 and puncta throughout the lateral surface below
the zonula adherens13,16 (Fig. 1a,b). Conspicuous RhoA staining5 was
also evident at the cell–cell contacts (Fig. 1a), concentrating at the
zonula adherens (Fig. 1a,b). This suggested that the zonula adherens
might represent a Rho zone in interphase epithelial cells, akin to that
of the cytokinetic furrow3,17.
C3-transferase (C3T) reduced the amount of junctional Rho
(Fig. 1c,d), implying that a significant proportion of it was likely to
be in the GTP-loaded state. We investigated this using a fluorescence
resonance energy transfer (FRET)-based Rho–GTP biosensor4 which,
like endogenous Rho, distributed in the cytoplasm and concentrated
at cell–cell junctions (Fig. 1e). However, greater energy transfer
(indicating Rho–GTP) was detected at the junctions (Fig. 1f) and
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Figure 1 The zonula adherens is a microtubule-dependent Rho zone.
(a,b) E-cadherin (E-cad, red) and RhoA (green) at apical junctions in
TCA-fixed MCF-7 monolayers. y –z views (taken at the vertical line) are
shown in (a) and the magnification (outlined in the square) shows E-cadherin
and RhoA at the zonula adherens in a maximum-intensity projection
(b). The arrowheads indicate the zonula adherens (a). (c,d) RhoA in
confluent MCF-7 cells treated with C3T (0.25 µgml 1, 1 h) or glycerol
(vehicle, Ctrl). Representative apical confocal images are shown (c) with
junctional RhoA fluorescence intensity (d). n=30; ⇤⇤⇤P <0.0001; Student’s
t -test. (e–g) Rho–GTP measured using a RhoA FRET biosensor in MCF-7
cells treated as in c,d. Representative images of CFP and the ratio of
FRET/CFP are shown (e). (f,g) Average emission ratios were determined
at the zonula adherens (ZA) and the cytoplasm (Cyt) of control cells (f)
and at the zonula adherens of control and C3T-treated (g) cells. n = 26;
⇤⇤⇤P <0.0001; Student’s t -test. (h) Fluorescence intensity of myosin (Myo)
IIA and IIB at cell junctions in MCF-7 cells treated with dimethylsulphoxide
(Ctrl) or nocodazole (Noc, 100nM, 3 h). n = 25; ⇤⇤⇤P < 0.001; NS, not
significant; Student’s t -test. (i,j) RhoA in control and nocodazole-treated
cells. A representative apical confocal image is shown (i) with junctional
RhoA fluorescence intensity (j). n =30; ⇤⇤⇤P <0.001; NS, not significant;
Student’s t -test. (k,l) Effect of nocodazole on Rho–GTP in confluent
MCF-7 cells. CFP and ratio of FRET/CFP representative images are shown
(k) with average emission ratios quantified at the apical junctions (l).
n =40; ⇤⇤⇤P <0.001; Student’s t -test. (m) Junctional Rho in MCF-7 cells
transfected with pECFP–C1 (Ctrl) or with pSUPER constructs containing
shRNAs against luciferase (Luc) or EB1 + EB3 (EB1/3 shRNA). n = 15;
⇤⇤⇤P < 0.001; one-way analysis of variance (ANOVA), Dunnett’s post hoc
test. Heat colour scales in e and k for FRET/CFP emission ratios are shown.
Data are control normalized means± s.e.m. pooled from three individual
experiments. Scale bars: 10 µm (a,c,i); 5 µm (b,e,k).
this was reduced by C3T (Fig. 1e,g). Thus, cadherin-based cell–cell
junctions are prominent sites of Rho signalling in interphase epithelial
cells. Mechanisms must then exist to ensure that Rho is activated, and
maintained in an active state, at those junctions.
Previously we demonstrated that cadherin junctions and their
associated cytoskeleton are influenced by dynamic microtubules18. In
particular, nocodazole, used at a concentration (100 nM) that blocks
microtubule plus-end dynamics without depolymerizing the lattice19,20,
prevented the junctional accumulation of myosin IIA, but not that of
myosin IIB (Fig. 1h and Supplementary Fig. S1a). As myosin IIA, but
not myosin IIB (ref. 13), requires Rho signalling to concentrate at the
zonula adherens13,21, this suggested that dynamic microtubule plus-
endsmight also regulate Rho. Indeed, nocodazole substantially reduced
both junctional Rho (Fig. 1i,j) andRho–GTP (Fig. 1k,l). Junctional Rho
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Figure 2 ECT2 is a junctional RhoA GEF. (a,b) E-cadherin (E-cad, green)
and ECT2 (red) in confluent MCF-7 cells. Representative confocal images at
the zonula adherens (a) and y –z views (taken at the vertical line) illustrating
the distribution of proteins along the z axis of cells. The arrows indicate
the apices of cell–cell contacts. (b) Magnification of the outlined area in a
shows E-cadherin and ECT2 at the zonula adherens in a maximum-intensity
projection. The arrowheads indicate the zonula adherens. (c,d) ECT2
in confluent MCF-7 cells treated with or without nocodazole (Noc and
Ctrl). Representative apical confocal images are shown (c) with junctional
ECT2 fluorescence intensity (d). n = 30; ⇤⇤⇤P < 0.001; Student’s t -test.
(e) Junctional ECT2 in MCF-7 cells transfected with pECFP–C1 (Ctrl) or
with pSUPER constructs containing shRNAs against luciferase (Luc) or
EB1 + EB3 (EB1/3 shRNA). n = 15; ⇤⇤⇤P < 0.001; NS, not significant;
one-way ANOVA, Dunnett’s post hoc test. (f) ECT2 and GAPDH (loading
control) immunoblots of lysates from MCF-7 cells infected with lentivirus
bearing an empty vector control (Ctrl) or an shRNA directed against
ECT2 (ECT2 shRNA). (g,h) Rho immunofluorescence in control (Ctrl),
ECT2 knockdown cells, and ECT2 knockdown cells transiently expressing
shRNA-resistant EGFP–ECT2 (ECT2 shRNA + FL). Representative apical
confocal images are shown (g) with junctional RhoA fluorescence intensity
(h). The asterisks mark cells transfected with EGFP–ECT2. n = 15;
⇤⇤⇤P <0.001; NS, not significant; one-way ANOVA, Dunnett’s post hoc test.
(i,j) Rho–GTP measured with a RhoA FRET biosensor in control (Ctrl), ECT2
knockdown and ECT2 knockdown cells expressing RNAi-resistant ECT2
(shRNA +FL). Representative images of CFP and ratio of FRET/CFP are
shown (i) with average emission ratios quantified at the apical junctions (j).
n =43; ⇤⇤⇤P <0.001; NS, not significant; Student’s t -test. Data represent
control-normalized means± s.e.m. pooled from three individual experiments.
Scale bars: 10 µm (a,b,c,g); 5 µm (i). Uncropped images of blots are shown
in Supplementary Fig. S8.
(Fig. 1m and Supplementary Fig. S1b) and myosin IIA (Supplementary
Fig. S1c) were also decreasedwhen dynamicmicrotubule plus endswere
independently perturbed by depletion of end-binding (EB) proteins 1
and 3 (Supplementary Fig. S1b)22,23. The zonula adherens thus seemed
to be a microtubule-dependent Rho zone.
ECT2 activates Rho signalling at the zonula adherens
We then examined the cellular localization of microtubule-sensitive
RhoGEFs. Strikingly, ECT2 (Fig. 2a,b), but not GEF-H1 (not shown),
was stained at junctions in interphase MCF-7 cells. ECT2 is a
RhoGEF best understood to operate during mitosis, where it localizes
to the contractile furrow (Supplementary Fig. S2a) and activates
Rho9,24,25. With some exceptions26, it is reported to be a nuclear
protein during interphase24, although these studies were generally
performed in isolated cells that did not make adhesive contacts
with one another. We found that although nuclear staining was
detectable in confluent MCF-7 cells, ECT2 also clearly localized at
cell–cell contacts (Fig. 2a), an observation that we confirmed in Caco-2
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and MDCK cells26 (Supplementary Fig. S2b). Furthermore, ECT2
selectively localized to the zonula adherens within contacts (Fig. 2a,b).
The specificity of this staining pattern was confirmed by ECT2
RNA-mediated interference (RNAi; Supplementary Fig. S2c,e) and
further corroborated by transiently expressed GFP–ECT2, which also
localized to cell–cell contacts (Supplementary Fig. S2d). Of note, the
amount of junctional ECT2 staining was reduced by both nocodazole
(Fig. 2c,d) and EB1/3 short hairpin RNA (shRNA; Fig. 2e). Thus, ECT2
was an attractive candidate to mediate microtubule-dependent Rho
signalling at the zonula adherens.
To investigate this, we depleted ECT2 in MCF-7 cells by lentiviral
shRNA (Fig. 2f). Both junctional Rho (Fig. 2g,h) and Rho–GTP
(Fig. 2i,j) were reduced by ECT2 knockdown. Furthermore, both
parameters were restored by expression of an RNAi-resistant transgene
(Fig. 2g–j), indicating that the changes in Rho signallingwere due to loss
of ECT2 itself. Junctional Rho was similarly reduced when ECT2 was
depleted by short interfering RNA (siRNA; Supplementary Fig. S2e,f).
Together, these findings identify ECT2 as a major activator of Rho
signalling at the zonula adherens.
ECT2 signalling regulates zonula adherens integrity and apical
junction tension
The zonula adherens is a specialized adhesive junction that supports
epithelial cohesion and apical contractility27. Its integrity requires Rho
signalling to the actomyosin cytoskeleton13,28.
We found that ECT2 supports the zonula adherens. When compared
with controls, ECT2-deficient cells failed to concentrate E-cadherin into
the apical ring of the zonula adherens (Fig. 3a,b and Supplementary
Fig. S2g), although cadherin clusters remained at the lateral contacts
(Fig. 3a). In contrast, tight junctions persisted in ECT2-knockdown
cells (Supplementary Fig. S3a,b), indicating a relatively selective effect
on the zonula adherens. As neither total nor surface levels of E-cadherin
were altered by ECT2 knockdown (Supplementary Fig. S3c), we postu-
lated that the defect arose from failure of surface cadherin to be concen-
trated in an apical junctional structure. To investigate this, we expressed
E-cadherin–EGFP in cadherin RNAi cells29 and measured fluorescence
recovery after photobleaching (FRAP) in the apical region. ECT2 knock-
down and C3T both decreased the immobile fraction and the half-time
of recovery (t1/2; Fig. 3c and Supplementary Table S1), indicating more
rapid turnover of apical E-cadherin. This implies that ECT2–Rho
signalling stabilizes E-cadherinmobility at the apical junctional zone.
To better understand how ECT2 stabilizes cadherin, we then
examined its effects on the junctional cytoskeleton. Surprisingly,
F-actin staining at the zonula adherens was not altered by ECT2
RNAi or by C3T (Supplementary Fig. S3d,e). However, ECT2 RNAi
depleted myosin IIA, but not myosin IIB, from apical junctions
(Fig. 3d,e). Myosin IIA depletion perturbs the zonula adherens in a
very similar manner to ECT2 RNAi (ref. 13) and, indeed, myosin
IIA shRNA also increased apical E-cadherin–EGFP mobility (Fig. 3c
and Supplementary Table S1). These findings thus suggested that
ECT2 supports zonula adherens integrity through myosin IIA. If so,
we predicted that junctional integrity might be restored in ECT2
shRNA cells if the amount of myosin IIA at the junctions could be
increased. Indeed, the intensity of the E-cadherin fluorescence signal
was increased in ECT2 knockdown cells by expression of GFP–myosin
IIA (Fig. 3f,g). As Rho is necessary for myosin IIA to concentrate at the
zonula adherens13 and acute treatment with C3T displaced myosin IIA,
but not ECT2, from junctions (Fig. 3h,i), ECT2 presumably recruits
myosin IIA indirectly by activating Rho.
The coordination of actomyosin contractility with cadherin adhesion
can also generate tension at the zonula adherens30, which influences
cell–cell movements and patterning within epithelia31,32. To determine
whether ECT2 signalling affects junctional tension, we used a femtosec-
ond laser to cut junctions and measured the instantaneous recoil of
their vertices as an index of tension32. Junctional tensionwas reduced by
ECT2 knockdown and also when its downstream targets were inhibited
byC3T andmyosin IIARNAi (Fig. 3j,k and Supplementary Fig. S3f).
Overall, these findings identify an extra-mitotic role for ECT2
to support cell–cell interactions between interphase epithelial cells.
We propose that selective localization of ECT2 to the zonula
adherens promotes local Rho signalling. This ultimately signals
to recruit and activate myosin IIA (refs 13,21), which stabilizes
apical cadherin to preserve the integrity of the zonula adherens and
support junctional tension.
The centralspindlin complex mediates microtubule-dependent
junctional localization of ECT2
To better understand how dynamic microtubules influence junctional
ECT2 we measured FRAP of junctional GFP–ECT2 expressed
in ECT2 RNAi cells (Fig. 4a). Nocodazole reduced the immobile
fraction, without significantly affecting t1/2, suggesting that dynamic
microtubules might influence cortical binding of ECT2 at junctions. In
parallel, we screened ECT2 immunoprecipitates by mass spectrometry
to identify potential junctional binding partners (not shown). Amongst
these we found the kinesin,MKLP1, a component of the centralspindlin
complex, which also contains MgcRacGAP, a direct binder of ECT2
(ref. 33). During cytokinesis centralspindlin localizes ECT2 to activate
Rho at the contractile furrow9,25 and we therefore wondered whether it
might play a similar role at the zonula adherens during interphase.
Indeed, both MgcRacGAP and MKLP1 localized to microtubule-
dense MCF-7 cell–cell junctions, as well as in nuclei, as has been
previously reported in isolated cells34 (Fig. 4b and Supplementary
Fig. S4a). Of note, like ECT2 (Fig. 2a), both centralspindlin compo-
nents selectively concentrated with E-cadherin in the zonula adherens
(shown for MgcRacGAP in Fig. 4b). RNAi of either protein abolished
its junctional staining (Supplementary Fig. S4b,c) and junctional
localization was further confirmed by GFP-tagged MgcRacGAP and
MKLP1 (Supplementary Fig. S4d). Centralspindlin is thus a junctional
constituent in interphase MCF-7 cells.
We then used RNAi (Supplementary Fig. S4b) to assess whether cen-
tralspindlin affected junctional ECT2 and Rho signalling. MgcRacGAP
or MKLP1 siRNA substantially reduced junctional ECT2 (Fig. 4c,d)
but not its total expression (Fig. 4e), whereas ECT2 RNAi did not affect
junctional centralspindlin (Supplementary Fig. S4e). This suggested
that centralspindlin influences the junctional localization of ECT2,
analogous to its action during cytokinesis9,25. Furthermore, the amount
of junctional Rho was reduced by either MKLP1 or MgcRacGAP
knockdown (Fig. 4f,g) and the amount of Rho–GTP was reduced
by MgcRacGAP depletion (Fig. 4h). Myosin IIA was also selectively
lost from junctions in centralspindlin-depleted cells (Fig. 4i and
Supplementary Fig. S4f). Supporting a central role for centralspindlin
in junctional signalling, the integrity of the zonula adherens was
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Figure 3 ECT2 is necessary for zonula adherens integrity and junctional
tension. (a,b) E-cadherin (E-cad) immunostaining in control (Ctrl) and
ECT2 knockdown (ECT2 shRNA) cells imaged by wide-field deconvolution
microscopy (in a, the arrowheads indicate apical junctional regions).
Peak junctional fluorescence intensity (b) was measured by line scan
analysis. n=25; ⇤⇤⇤P <0.001; Student’s t -test. (c) FRAP was performed
for E-cadherin–GFP (expressed in MCF-7 cells depleted of endogenous
E-cadherin by RNAi; Ctrl) or also treated with C3T or RNAi against ECT2
(ECT2 shRNA) or myosin IIA (IIA shRNA). The vertical lines represent
means ± s.e.m. and solid lines are best-fit single exponential curves
(n = 11). (d,e) Junctional myosin IIA or myosin IIB in control (8) and
ECT2 knockdown (shRNA) cells. Representative images are shown (d) with
junctional myosin fluorescence intensity (e). n = 20; ⇤⇤⇤P < 0.001; NS,
not significant; Student’s t -test. (f,g) Control (Ctrl) and ECT2 knockdown
cells transfected with either pEGFP–C1 (GFP) or EGFP–MyoIIA (GFP–Myo
IIA) were fixed and stained for E-cadherin (E-cad; magenta) and GFP
(green). Representative apical epi-illumination images in ECT2 knockdown
cells are shown (f) with junctional E-cadherin fluorescence intensity (g).
n=17;⇤⇤⇤P <0.001; NS, not significant; one-way ANOVA, Dunnett’s post
hoc test. (h,i) ECT2 and myosin IIA (Myo IIA) staining in MCF-7 cells
treated with glycerol (vehicle control, Ctrl) or C3T (0.25 µgml 1, 1 h).
Representative confocal images are shown (h) with junctional fluorescence
intensities (i). n = 20; ⇤⇤⇤P < 0.001; Student’s t -test. (j,k) Junctional
tension was measured by laser nanoscissors in control (Ctrl) MCF-7 cells
and cells treated with C3T or RNAi against ECT2 or myosin IIA. Vertex
displacement (j) and initial recoil (k) are shown. The error bars in j
represent means± s.e.m. and solid lines are best-fit single exponential
curves and in k means± s.e.m. of data. n=12; ⇤P <0.05; t -test. Unless
otherwise stated, data are control-normalized mean± s.e.m. pooled from
three individual experiments. Scale bars, 10 µm.
perturbed in both MKLP1 and MgcRacGAP knockdown cells (Fig. 4j
and Supplementary Fig. S4f). Interestingly, junctional localization of
centralspindlin was reduced by 100 nM nocodazole (Fig. 4k,l), making
it an attractive candidate to mediate the microtubule-dependent
localization of ECT2 to junctions. Indeed, the nocodazole sensitivity
of junctional ECT2 was abolished by MgcRacGAP RNAi (Fig. 4m).
Overall, these data implicate centralspindlin in localizing ECT2 to
the zonula adherens.
↵-catenin localizes ECT2 to the zonula adherens through
centralspindlin
Binding to centralspindlin alone did not readily explain the specific
localization of ECT2 to the zonula adherens. We were thus interested
to also identify ↵-catenin in our ECT2 interaction screen (not shown),
a finding confirmed by reciprocal co-immunoprecipitation analysis
(Fig. 5a). E-cadherin also co-precipitated with ECT2 and ↵-catenin
(Fig. 5a) suggesting that these proteins might exist in a complex.
Consistent with this, ECT2, ↵-catenin and E-cadherin co-localized,
principally at the zonula adherens (Fig. 5b and Supplementary Fig. S5a).
We then depleted ↵-catenin by siRNA (Supplementary Fig. S5b) and
examined cells after 24 h, when junctional ↵-catenin was significantly
diminished, but cell–cell contacts remained intact (Fig. 5b). The
amount of junctional ECT2 (Fig. 5b,c) and the biochemical association
of E-cadherin with ECT2 (Fig. 5d) were both significantly reduced in
↵-catenin knockdown cells. Thus, ↵-catenin also contributes to the
junctional localization of ECT2.
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Figure 4 Centralspindlin regulates junctional ECT2–Rho signalling.
(a) FRAP of GFP–ECT2 expressed in MCF-7 cells depleted of
endogenous ECT2 and treated with dimethylsulphoxide (vehicle control,
Ctrl) or nocodazole (Noc). The vertical lines represent means± s.e.m.
(n = 9) and the solid lines are best-fit double exponential curves.
(b) E-cadherin (E-cad, red) and either MgcRacGAP or MKLP1 (green)
in MCF-7 monolayers. The magnifications (taken from the outlined
area) show E-cadherin and MgcRacGAP at the zonula adherens in a
maximum-intensity projection (the direction of the arrow indicates
basal to apical). (c–e) ECT2 in MCF-7 cells transfected with siRNAs
against MgcRacGAP (Mgc siRNA), MKLP1 (MKLP1 siRNA) or with
scrambled siRNA (Ctrl). Representative confocal images are shown (c)
with junctional ECT2 fluorescence intensity (d). n=25; ⇤⇤⇤P <0.001;
one-way ANOVA, Dunnett’s post hoc test. (e) Lysates from control,
MgcRacGAP knockdown and MKLP1 knockdown cells immunoblotted
for ECT2 and  -tubulin ( -tub). (f–j) RhoA, myosin IIA, E-cadherin
and Rho–GTP in control (Ctrl), MgcRacGAP knockdown or MKLP1
knockdown cells. Representative images of RhoA staining at the
apical junctions are shown (f) with junctional RhoA (g), Rho–GTP
(h), Myo IIA (i) and E-cad (j). For RhoA (g), Myo IIA (i) and E-cad (j),
n=20; ⇤⇤⇤P <0.001; one-way ANOVA, Dunnett’s post hoc test and for
Rho–GTP (h), n=59; ⇤⇤⇤P <0.001; Student’s t -test. (k,l) MgcRacGAP
or MKLP1 in MCF-7 cells treated with nocodazole. Representative
confocal images are shown (k) with junctional MgcRacGAP and MKLP1
(CS) fluorescence intensity (l). n=30; ⇤⇤⇤P <0.001; Student’s t -test.
(m) MCF-7 cells were transfected with siRNA against MgcRacGAP
or scrambled (control) siRNA and were incubated with 100nM
nocodazole (3 h) or dimethylsulphoxide (Ctrl), after which nocodazole
was washed out and cells were allowed to recover (Noc w.o, 1 h). ECT2
staining was quantified by line scan analysis. n =15; ⇤⇤⇤P <0.001;
NS, not significant; one-way ANOVA, Bonferroni post hoc test, to
compare across all data sets. Unless otherwise stated, data are
control-normalized mean± s.e.m. pooled from three individual
experiments. Scale bars, 10 µm (c, and b,k for MgcRacGAP); 5 µm
(f, and b,k for MKLP1). Uncropped images of blots are shown in
Supplementary Fig. S8.
We then examined whether centralspindlin was involved in
the interaction between ↵-catenin and ECT2. MgcRacGAP im-
munoprecipitated with both E-cadherin and ↵-catenin (Fig. 6a)
and MgcRacGAP knockdown significantly reduced the amount of
ECT2 that co-immunoprecipitated with ↵-catenin (Fig. 6b), with-
out affecting the E-cadherin–↵-catenin interaction (Fig. 6c). This
implied that centralspindlin serves as an intermediate to localize
ECT2 to ↵-catenin at the zonula adherens. Consistent with this,
↵-catenin knockdown substantially reduced the amount of both
junctional MgcRacGAP and MKLP1 (Fig. 6d,e) but MgcRacGAP
knockdown had only a minor impact on the amount of junctional
↵-catenin (Fig. 6f,g) probably owing to loss of the mature zonula
adherens. Furthermore, nocodazole reduced the level of interac-
tion between MgcRacGAP and ↵-catenin (Fig. 6h), suggesting that
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Figure 5 ↵-catenin mediates the junctional retention of ECT2.
(a) Immunoprecipitates (IP) of ECT2, E-cadherin (E-cad) or ↵-catenin
(↵-cat) were immunoblotted for ECT2, E-cadherin and ↵-catenin. Rabbit
IgG was the negative immunoprecipitation control. (b,c) MCF-7 cells
transfected with SMARTpool siRNA against ↵-catenin (↵-cat siRNA) or
non-targeting siRNA pools (Ctrl) were fixed and stained for E-cadherin
(red), ↵ cat (magenta) and ECT2 (green). Representative apical confocal
images are shown (b) with junctional ECT2 fluorescence intensity (c).
n = 25; ⇤⇤⇤P < 0.001; Student’s t -test. (d) Immunoprecipitates of
E-cadherin (IP E-cad) from MCF-7 cells transfected with SMARTpool
siRNA against ↵-catenin or non-targeting siRNA pools (8) were
immunoblotted for ECT2 and E-cadherin. (e,f) Control and ↵-catenin
knockdown (↵ cat kd) cells were fixed and stained for RhoA.
Representative apical confocal images are shown (e) with junctional
RhoA fluorescence intensity (f). n =25;⇤⇤⇤P <0.001; Student’s t -test.
(g,h) MCF-7 cells transfected simultaneously with a Rho FRET biosensor
and a SMARTpool siRNA against ↵-catenin or non-targeting siRNA
pools (Ctrl) were imaged by live-cell confocal microscopy after 36 h.
Representative images of the ratio of FRET/CFP are shown (g) and average
emission ratios were quantified at the apical junctions (h). n = 46;
⇤⇤⇤P < 0.0001; Student’s t -test. Data represent control-normalized
mean± s.e.m. pooled from three individual experiments. Scale bars:
10 µm (b); 5 µm (e,g). Uncropped images of blots are shown in
Supplementary Fig. S8.
dynamic microtubules might regulate this interaction to support
junctional ECT2.
To better characterize the molecular basis of these interactions, we
expressed GFP-tagged ↵-catenin mutants in HEK293 cells (Fig. 6i and
Supplementary Fig S5d). Both endogenous ECT2 and MgcRacGAP
consistently co-precipitated with full-length ↵-catenin and with
amino-terminal fragments of ↵-catenin (1–290, 1–507), but not with
a carboxy-terminal fragment (507–906). Thus, the N terminus of
↵-catenin seems to mediate its association with centralspindlin and
ECT2. We therefore conclude that ↵-catenin serves as a cortical anchor
for centralspindlin at the zonula adherens, to thereby support the
ECT2–Rho signalling pathway.
This model further predicted that ↵-catenin would influence
junctional Rho signalling. Indeed, the amounts of junctional
Rho (Fig. 5e,f), Rho–GTP (Fig. 5g,h) and myosin IIA, but not
myosin IIB (Supplementary Fig. S5c), were reduced in ↵-catenin
knockdown cells.
Centralspindlin inhibits the junctional recruitment of p190B
RhoGAP
Finally, we investigated whether centralspindlin might also influence
junctional Rho by regulating its inactivation, as the spatial expression
of Rho–GTP is influenced by the localized action of RhoGAPs as
well as by RhoGEFs (refs 3,35). We focused on p190RhoGAP, which
has been implicated in cadherin junctions36,37 and in regulating
Rho signalling at the cytokinetic furrow35,38,39. Two members of
this protein family exist in mammals40,41 and both p190A RhoGAP
and p190B RhoGAP were detected in MCF-7 cells (Fig. 7f). In
control MCF-7 monolayers, staining for both these proteins was
predominantly cytoplasmic, with little apparent at junctions (Fig. 7a).
Strikingly, however, junctional p190B RhoGAP, but not p190A
RhoGAP, became evident after nocodazole treatment (Fig. 7b,c). This
suggested that dynamic microtubules might specifically inhibit the
junctional accumulation of p190B RhoGAP.
As dynamic microtubules support the junctional localization of the
centralspindlin complex, we then investigated whether centralspindlin
influenced junctional p190B RhoGAP. Indeed, junctional p190B
RhoGAP staining was significantly increased by either MgcRacGAP
or MLKP1 knockdown but not by ECT2 RNAi (Fig. 7d,e). Together,
these data suggested that the microtubule-dependent localization of
centralspindlin at the zonula adherens might also promote junctional
Rho–GTP by blocking recruitment of p190B RhoGAP, as well as
through local activation of Rho by ECT2.
We investigated this by examining whether the increased p190B
RhoGAP contributed to the reduced Rho found at junctions in
nocodazole-treated cells. This hypothesis predicted that reducing
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Figure 6 ↵-catenin mediates the junctional retention of centralspindlin.
(a) Whole-cell lysates from MCF-7 cells (WCL) and MgcRacGAP
immunoprecipitates immunoblotted for MgcRacGAP (Mgc), E-cadherin
(E-cad) and ↵-catenin (↵-cat). Rabbit IgG (IgG) was the negative
immunoprecipitation control. (b) ↵-catenin immunoprecipitates (IP
↵-cat) from control (8) and MgcRacGAP siRNA knockdown cells
(Mgc siRNA) were immunoblotted for ↵-catenin (↵ cat) and ECT2.
Whole cell lysates (WCL) from control and MgcRacGAP knockdown
cells were immunoblotted for MgcRacGAP, ECT2 and  -tubulin.
(c) E-cadherin immunoprecipitates (IP E-cad) from control (8) and
MgcRacGAP knockdown cells immunoblotted for E-cadherin and
↵-catenin. (d,e) MgcRacGAP or MKLP1 in MCF-7 cells transfected
with SMARTpool siRNA against ↵-catenin (↵-cat siRNA) or non-targeting
siRNA pools (Ctrl). Representative apical confocal images are shown (d)
with junctional MgcRacGAP and MKLP1 (CS) (e). n =25;⇤⇤⇤P <0.001;
Student’s t -test. (f,g) ↵-catenin (green) in MCF-7 cells transfected with
siRNAs against MgcRacGAP or scrambled (Ctrl) siRNA. Representative
apical confocal images are shown (f) with junctional ↵-catenin
fluorescence intensity (g). n = 25; ⇤⇤P < 0.005; Student’s t -test.
(h) MgcRacGAP immunoprecipitates from control (Ctrl) and nocodazole
(Noc)-treated MCF-7 cells immunoblotted for MgcRacGAP and ↵-catenin.
(i) GFP-tagged full-length (FL) ↵-catenin or truncation mutants were
transiently expressed in HEK293 cells, isolated by GFP-Trap and
then immunoblotted for GFP, MgcRacGAP or ECT2. The mutants are
illustrated in Supplementary Fig. S5d. Data represent control-normalized
mean± s.e.m. pooled from three individual experiments. Scale bars:
10 µm (f and d for MgcRacGAP); 6 µm (d for MKLP1). Uncropped images
of blots are shown in Supplementary Figs S8 and S9.
p190BRhoGAP should decrease the impact of nocodazole on junctional
Rho. Accordingly, we selectively depleted p190B RhoGAP by siRNA
(Fig. 7f). Nocodazole reduced junctional Rho and Rho–GTP in cells
transfected with control siRNAs (Fig. 7g–i), exactly as it did in
untransfected cells (Fig. 1i–l). Strikingly, however, nocodazole did
not reduce junctional Rho (Fig. 7g,h) or Rho–GTP (Fig. 7i) to the
same level in p190B RhoGAP knockdown cells as it did in control
cells. This implies that p190B RhoGAP contributed to the inhibition
of Rho by nocodazole.
p190B RhoGAP contains a GTP–Rac binding domain that regulates
its cortical recruitment40. As cell–cell contacts can be sites of Rac
signalling7, we therefore investigated whether p190B RhoGAP was
recruited to junctions in response to Rac. Indeed, the junctional
accumulation of p190B RhoGAP induced by nocodazole was reduced
by the expression of dominant-negative Rac (N17; Fig. 7j) or
treatment with the Rac inhibitor NSC 23766 (Supplementary Fig. S6b).
Furthermore, a p190B RhoGAP mutant lacking the Rac-interaction
domain40 did not localize to junctions in nocodazole-treated cells
(Supplementary Fig. S6a). Thus, the nocodazole-induced recruitment
of p190B RhoGAP seems to require Rac signalling. Potentially,
then, the microtubule–centralspindlin pathway may block p190B
RhoGAP recruitment by inhibiting junctional Rac. Indeed, using a
Raichu-Rac FRET biosensor we found that junctional GTP–Rac was
increased both by nocodazole and MgcRacGAP knockdown (Fig. 7k
and Supplementary Fig. S6c). Together, these results suggest that
centralspindlin may inhibit junctional p190B RhoGAP recruitment by
reducing the level of junctional Rac signalling.
DISCUSSION
In sum, our findings identify the epithelial zonula adherens as a Rho
zone that is an interphase equivalent of the Rho zone of the cytokinetic
furrow8,9. Like the cytokinetic furrow, the Rho zone of the zonula
adherens serves to concentrate actomyosin, acting through myosin
IIA to maintain the integrity of the junction itself. Remarkably, Rho
signalling at the zonula adherens is controlled by many of the same
molecules that regulate Rho at the cytokinetic furrow. The key role is
played by the centralspindlin complex, which supports the junctional
Rho zone by regulating both the activation and inactivation limbs of
the GTPase cycle: it activates Rho by recruiting the RhoGEF ECT2
and prevents Rho inhibition by blocking the junctional recruitment of
p190B RhoGAP (Supplementary Fig. S7). Recruitment of ECT2 may
reflect its known direct interaction withMgcRacGAP (refs 9,25) and we
postulate that centralspindlin blocks p190B RhoGAP recruitment by
directly or indirectly inhibiting junctional Rac (ref. 40). Of note, both
ECT2 and p190 RhoGAP have also been implicated in Rho regulation at
the cytokinetic furrow9,25,35,39, although other GAPs, includingMgcRac-
GAP itself3, may also contribute. Thus, the Rho zone of the zonula
adherens reflects the action during interphase of a conserved molecular
ensemble that can translate coordinated regulation of the Rho GTPase
cycle into spatial expression of an active Rho signal at the junction.
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Figure 7 Centralspindlin inhibits the junctional recruitment of p190B
RhoGAP. (a–c) E-cadherin (E-cad, magenta) and either p190A RhoGAP
(p190A) or p190B RhoGAP (p190B, green) in control (a) and nocodazole
(Noc; 100nM, 3 h)-treated MCF-7 cells (b). Representative apical
confocal images are shown (a,b) with junctional p190B in control and
nocodazole-treated cells (c). n = 60;⇤⇤⇤P < 0.001; Student’s t -test.
(d,e) p190B RhoGAP in MCF-7 cells transfected with siRNAs against
MgcRacGAP (Mgc siRNA), MKLP1 (MKLP siRNA) or scrambled (Ctrl) siRNA,
or infected with lentivirus bearing an shRNA directed against ECT2 (ECT2
shRNA). Representative apical junction images (d) and junctional p190B
RhoGAP fluorescence intensity (e) are shown. n = 25;⇤⇤⇤P < 0.001; NS,
not significant; one-way ANOVA, Dunnett’s post hoc test. (f) Whole-cell
lysates from MCF-7 cells transfected with non-targeting siRNA pools (Ctrl) or
SMARTpool siRNA against p190B RhoGAP (p190B siRNA) immunoblotted
for p190A RhoGAP, p190B RhoGAP or  -tubulin. (g–i) Junctional Rho
or Rho–GTP in control and p190B RhoGAP knockdown cells incubated
with or without nocodazole. Representative Rho images are shown (g)
with junctional fluorescence intensity (h). n =25; ⇤⇤⇤P <0.001; NS, not
significant; one-way ANOVA, Bonferroni post hoc test, to compare across
all data sets. Rho–GTP (i) was measured using a transiently expressed
Rho FRET biosensor. n =50; ⇤⇤⇤P <0.001; Student’s t -test. (j) Junctional
p190B RhoGAP in MCF-7 cells transfected with EGFP pcDNA3.1 (Ctrl) or
GFP–N17 Rac1 DN-pcDNA3.1 (N17), then treated with nocodazole. n=25;
⇤⇤⇤P < 0.001; NS, not significant; one-way ANOVA, Dunnett’s post hoc
test. (k) Junctional Rac–GTP was measured with a wild-type Raichu-Rac
biosensor in control (Ctrl) cells or cells treated with nocodazole (100nM,
3 h), MgcRacGAP siRNA or a constitutively active Raichu-Rac mutant
(V12). n = 30; ⇤P < 0.05; Student’s t -test. Data are control-normalized
mean± s.e.m. pooled from three individual experiments. Scale bars, 10 µm.
Uncropped images of blots are shown in Supplementary Fig. S9.
From this perspective, a key issue is what localizes centralspindlin
to the zonula adherens. Here we found that ↵-catenin supports the
cortical binding of centralspindlin, and thereby ECT2, at the zonula
adherens. This implies that ↵-catenin can influence cadherin biology by
regulating Rho signalling at the zonula adherens. Consistent with this,
↵-catenin knockdown reduced both Rho signalling and the cortical
recruitment of myosin IIA. Of note, too, these effects were observed
under conditions of incomplete ↵-catenin depletion; at later times after
siRNA transfection, cells detached from one another, a more extreme
phenotype that may reflect the other pathways by which ↵-catenin
can affect cadherin function42,43. Thus, Rho regulation may be a
relatively sensitive effect of↵-catenin on cadherin biology. Interestingly,
Drosophila ↵-catenin has been reported to associate with Rho itself10,
suggesting that multiple mechanisms may exist to allow ↵-catenin to
regulate Rho signalling at cadherin junctions.
It was striking that both centralspindlin and ECT2 selectively local-
ized to the zonula adherens. Moreover, ECT2 and the centralspindlin
complex seemed to selectively support zonula adherens integrity,
whereas tight junctions remained morphologically intact in ECT2 and
centralspindlin knockdown cells. In contrast, p114 RhoGEF, which
is recruited to tight junctions through an association with cingulin44,
supports tight junctions but not cadherin-based adhesive junctions.
Different GEFs may then control different pools of Rho to support
different junctions within the apical junctional complex and elsewhere
in the contact zone between cells. Such a conclusion is consistent with
the general paradigm that the action of specific GEFs may allow the
common Rho signal to be used for different functional outcomes1,40.
Furthermore, although ↵-catenin was necessary to localize central-
spindlin and ECT2 to the zonula adherens, it is noteworthy that
↵-catenin also distributes with E-cadherin more extensively outside
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the zonula adherens itself. Thus, centralspindlin is unlikely to associate
constitutively with ↵-catenin. Instead, other as yet unknown factors
must collaborate to confer specificity for this interaction on the pool of
↵-catenin associated with the zonula adherens itself.
Finally, our experiments also identify a role for dynamic
microtubules to affect Rho signalling at the zonula adherens, apparently
by influencing the capacity of the junctional cortex to bind ECT2.
Dynamic microtubules seemed to regulate the association between
centralspindlin and↵-catenin, but not the catenin–cadherin interaction
(not shown). The detailed mechanism responsible for this effect
remains to be clarified. During cytokinesis it has been proposed that
centralspindlin mediates the microtubule-dependent delivery of ECT2
to cytokinetic furrows45. Cell–cell junctions are regions that interact
with and regulate microtubules15,46,47, including a subpopulation that
extend with their dynamic plus-ends directed towards the junctional
cortex18. Such dynamic microtubules could facilitate the delivery of
centralspindlin by microtubule-dependent transport48 or by serving as
diffusional traps47 at the cortex. However, so far we have been unable
to demonstrate microtubule-dependent transport of centralspindlin or
ECT2 (not shown). Alternatively, dynamic microtubules might affect
the binding of centralspindlin to ↵-catenin indirectly, through cortical
signalling49. These signalsmay include post-translationalmodifications,
such protein phosphorylation, which influences ECT2 activation and
its interaction with centralspindlin during cytokinesis50. Whether some
of these pathways are also reused at the zonula adherens will be an
important issue for future research. ⇤
METHODS
Methods and any associated references are available in the online
version of the paper.
Note: Supplementary Information is available in the online version of the paper
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METHODS
Cell culture and transfection. MCF-7, MDCK and HEK293T cells were cultured
in DMEM; Caco2 cells were cultured in RPMI media. Cells were transfected using
Lipofectamine 2000 (Invitrogen) for expression constructs or with Lipofectamine
RNAiMAX (Invitrogen) for RNAi oligonucleotides according to the manufacturer’s
instructions and analysed 24–48 h after transfection.
Plasmids. The following were gifts: EGFP–ECT2 (R. Saint, Australian National
University, Australia); CYK4–EGFP and MKLP1–EGFP (M. Glotzer, University
of Chicago, USA); GFP–N17 Rac1-DN (ref. 51; A. Hall, UCL, UK); Raichu-
Rac FRET biosensors52 (M. Matsuda, Kyoto University, Japan); and Flag–p190B
RhoGAP (WT) and Flag–p190B1RBS (1RBS; ref. 40; S. Hansen, Harvard Medical
School, USA). pTriEx–RhoA biosensor WT (ref. 4) was obtained from Addgene;
pSuper-based simultaneous EB1 and EB3 shRNA vectors, the control vector
(expressing luciferase-specific shRNA; ref. 23); and EGFP–Myosin IIA (GFP-Myo
IIA) and Ecad–GFP (refs 13,29) have been described previously. Full-length mouse
↵-catenin was initially cloned into pEGFP–C2 vector and mouse ↵-catenin deletion
mutants were cloned into pEGFP–C1 vector using EcoRI and SalI sites. Truncation
mutants were created by PCR mutagenesis based on the secondary structure of
↵-catenin.
Mass Spectrometry. Mass spectrometry was performed as previously described53.
siRNA and shRNA knockdowns. A lentivirus-based shRNA system54,55 was used
to deplete ECT2 in MCF-7 cells. The lentivirus expression vector LentiLox pLL5.0
(backbone pLL3.7) and the third-generation packaging constructs pMDLg/pRRE,
RSV–Rev and pMD.G were gifts from J. Bear55 (UNC Chapel Hill, USA).
Algorithms from Dharmacon were used to predict sequences that would
lead to silencing of human ECT2 (NM_018098). Predicted sequences were
used to design shRNAs containing a stem loop sequence based on previous
studies56, and these were cloned into pLL5.0 yielding pLL5.0 Cherry–shECT2.
In brief, shRNA was cloned downstream of the U6 promoter (HpaI and
XhoI) into a modified version of pLL5.0 carrying a soluble cherry as a
reporter gene (pLL5.0 Cherry–shECT2). To reconstitute full-length ECT2 in
the same vector, the ECT2 coding sequence was amplified and cloned into
the BsrGI site of pLL5.0 Cherry–shECT2 (pLL5.0 mCherry–shRNA resistant
ECT2). Alternatively, to reconstitute GFP-tagged shRNA-resistant ECT2 in an
ECT2 knockdown background, the mCherry reporter was replaced by a sequence
encoding GFP from pEGFP–C1 and then the ECT2 coding sequence was cloned
into the vector using EcoR1 and BamH1 sites (pLL5.0 GFP–shRNA resistant
ECT2).
The generation and titre of lentivirus stocks has been described previously13.
MCF-7 cells were infected with lentiviral particles at a multiplicity of infection of
10 per cell as described previously13 and used within the first week after infection.
siRNA and shRNA sequences are shown in Supplementary Table S2.
Antibodies, immunoprecipitations and inhibitors. Primary antibodies used
in this study are shown in Supplementary Table S3. Secondary antibodies were
species-specific antibodies conjugated with AlexaFluor 488, 594 or 647 (Invitrogen;
1:500) and F-actin was stained with AlexaFluor 488–phalloidin or 594–phalloidin
(1:1,000 dilution; Invitrogen).
For each immunoprecipitation assay,⇠2mg of total protein was used, and 2 µg of
antibody and 20ml packed slurry of Protein A or 15ml packed slurry of GFP-Trap
coupled to agarose beads (Chromotek) were added. Surface trypsin sensitivity assays
were carried out as described previously57.
Nocodazole (Sigma Aldrich) was used at 100 nM and the Rho inhibitor CT04
(Cytoskeleton) was used at 0.250 µgml 1. The Rac inhibitor NSC 23766 (Sigma
Aldrich) was used at 50 µM.
Immunofluorescence microscopy. Cells were fixed with 10% TCA on ice for
15min for RhoA staining or with 4% paraformaldehyde in PBS at 22  C for 20min
for F-actin staining, and were then permeabilized with 0.25% Triton-X100 in PBS
for 5min at room temperature. Otherwise, cells were fixed with ice-cold methanol
for 5min on ice.
Wide-field images were acquired with either an IX81 Olympus epi-illumination
microscope (⇥60 and ⇥100, 1.4 numerical aperture (NA) objectives) and a
Hamamatsu Orca-1 ER camera driven by Metamorph imaging software (version
7; Universal Imaging) or a Personal Deltavision deconvolutionmicroscope (Applied
Precision,⇥60, 1.4NAobjectives) and aRoperCoolsnapHQ2monochrome camera.
Confocal images were captured with a Zeiss 510 or a Zeiss 710 Meta laser-scanning
confocal microscope, and z-stacks were processed with ImageJ (National Institutes
of Health) software. Background correction, contrast adjustment and z-projections
of raw data images were performed with ImageJ, Imaris (Bitplane) or Photoshop
(Adobe).
Quantification of fluorescence intensity at contacts. The fluorescence intensity
at contacts was quantified using the line scan function in ImageJ as described
earlier13. Up to 50 contacts weremeasured, derived from three different experiments.
To quantify MgcRacGAP or MKLP1 at contacts (Supplementary Fig. S4e), the num-
ber of contacts that were positive for the protein was normalized to the total number
of contacts. Up to 180 contacts were counted in each experiment and the data from
three different experiments were pooled. Data were normalized to control values.
FRET microscopy. MCF-7 cells were transiently transfected with the following
constructs; RhoA biosensor4; RhoA biosensor with either pLL5.0 Cherry–shECT2
or pLL5.0 mCherry–shRNA-resistant ECT2; Raichu-Rac biosensors52. For siRNA
experiments, the biosensor was co-transfected with the indicated siRNA and
FRET measurements were performed 48 h after transfection. Cells were imaged
live at 37  C by confocal microscopy and images were acquired on an LSM 710
Zeiss confocal microscope equipped with a ⇥63 oil immersion objective (Plan
Apochromat ⇥63 1.4 NA, Zeiss). Donor and FRET channels were recorded by
scanning using a 458 nm laser line and collecting the emission in the donor
emission region (BP 470–490 nm) and acceptor emission region (BP 530–590 nm),
respectively. In addition, crosstalk and acceptor channels were collected using the
514 nm laser line for excitation and collecting the emission in the donor and acceptor
emission regions.Where necessary, a third scanwas included to acquire themCherry
fluorescence signal (mCherry channel) using a 561 nm laser line and fluorescence
signal was collected in the region 590–620 nm.
A modified version of the FRET emission ratio method4 was used to calculate
this parameter on a pixel-by-pixel basis. The FRET index was calculated for every
image as the average (FRET/donor) emission ratio for pixels located in the selected
regions of interest (ROIs). FRET valueswere calculated for the cell–cell junctions and
cytosolic regions independently and were normalized to the value corresponding to
the average FRET emission ratio value observed at the cell–cell contacts in control
conditions. Data presented are mean FRET emission ratios calculated across the
different images and their standard errors.
FRAP. FRAP experiments were performed either on an LSM 510 or LSM 710 meta
Zeiss confocal microscope with a heated stage maintained at 37  C. Images were
acquired using a ⇥63 objective, 1.4 NA oil Plan Apochromat immersion lens at ⇥4
digital magnification.
To assess E-cadherin dynamics, a vector that allows simultaneous expression of
a shRNA specific for human E-cadherin and full-length mouse E-cadherin–EGFP
(E-cad–GFP; ref. 29) and pLL5.0 Cherry–shECT2 were introduced into MCF-7 cells
by lentivirus and cells analysed after 24 h. A constant ROI in the centre of the cell–cell
contact was bleached to ⇠70% with a 488 nm laser at 100%. Time-lapse images
were acquired before and after photobleaching with an interval of ⇠5 s per frame
for a total of 280 s. Image analysis was performed using ImageJ. To calculate FRAP
profiles, a ROI at the bleached GFP–E-cadherin area was marked and the plug-in
FRAP profiler (McMaster University) was applied to obtain fluorescence intensity
profiles, F(t ). Fluorescence intensities were normalized to prebleach values F( t )
and fitted to the equation:
Fluorescence recovery= F(t ) F(0)
F( t ) =Mf ·
⇣
1 e ln2·tt1/2
⌘
where F(t) is the average fluorescence of the ROI, Mf is the mobile fraction, t1/2 is
the half-time of recovery and t is time in seconds.
ECT2 dynamics were assessed using EGFP–ECT2 expressed with ECT2 shRNA
by lentiviral infection. A constant circular ROI in the centre of the cell–cell
contact was bleached to ⇠70% with 488 and 405 nm lasers at 100%. Time-lapse
images of the same were acquired before (20 frames, 5 s) and after (210 frames,
50 s) photobleaching with an interval of ⇠250ms per frame. Image analysis was
performed using ImageJ. To calculate FRAP profiles, a ROI at the bleached
GFP–ECT2 area was marked and its average fluorescence intensity was determined
at every time point. Fluorescence intensities were normalized to average prebleach
values F( t ) and fitted to the double exponential equation:
Fluorescence recovery = F(t ) F(0)
F( t ) =Mf ·

ffast ·
✓
1 e
ln2·t
t fast1/2
◆ 
+Mf ·

fslow ·
✓
1 e
ln2·t
t slow1/2
◆ 
where F(t ) is the average fluorescence of the ROI,Mf is the mobile fraction, ffast and
fslow are weighting factors for fast and slow mobile components, t fast1/2 and t slow1/2 their
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respective half-times and t is time in seconds. A numerical solution of the above
equation for Fluorescence recovery= 0.5 was applied to obtain the global half-time
for ECT2 recovery.
Laser nanoscissors. Ablation experiments were performed on an LSM 510 meta
Zeiss confocal microscope at 37  C. Images were acquired using a ⇥63 objective,
1.4 NA oil Plan Apochromat immersion lens at ⇥1.5 digital magnification,
with the pinhole adjusted to 3 Airy units to obtain optical sections 2 µm
thick. Time-lapse images were acquired before (3 frames) and after (4 frames)
ablation with an interval of 15 s per frame. For ablation, a Ti:sapphire laser
(Chameleon Ultra, Coherent Scientific) tuned to 790 nm was used to ablate cell
contacts identified with E-cadherin–GFP fluorescence emission. A constant ROI
was marked for each experiment and ablated with 30 iterations of a 790 nm laser
with 50% transmission. GFP fluorescence intensity was determined before and
after the induced ablation using a 488 nm laser for excitation and a 500–550 nm
emission filter.
51. Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D. & Hall, A. The small
GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell
70, 401–410 (1992).
52. Itoh, R. E. et al. Activation of rac and cdc42 video imaged by fluorescent resonance
energy transfer-based single-molecule probes in the membrane of living cells. Mol.
Cell. Biol. 22, 6582–6591 (2002).
53. Grigoriev, I. et al. STIM1 is a MT-plus-end-tracking protein involved in remodelling
of the ER. Curr. Biol. 18, 177–182 (2008).
54. Rubinson, D. A. et al. A lentivirus-based system to functionally silence genes in
primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat.
Genet. 33, 401–406 (2003).
55. Vitriol, E. A., Uetrecht, A. C., Shen, F., Jacobson, K. & Bear, J. E. Enhanced EGFP-
chromophore-assisted laser inactivation using deficient cells rescued with functional
EGFP-fusion proteins. Proc. Natl Acad. Sci. USA 104, 6702–6707 (2007).
56. Reynolds, A. et al. Rational siRNA design for RNA interference. Nat. Biotechnol. 22,
326–330 (2004).
57. Verma, S. et al. Arp2/3 activity is necessary for efficient formation of E-cadherin
adhesive contacts. J. Biol. Chem. 279, 34062–34070 (2004).
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Figure S1 Dynamic microtubules selectively support junctional localization 
of myosin IIA but not myosin IIB. (a) Confluent MCF-7 cells were treated 
with DMSO (Ctrl) or nocodazole (Noc, 100nM, 3h), fixed and stained for 
myosin IIA (Myo IIA) or myosin IIB (Myo IIB). Representative apical confocal 
images are shown. (b) MCF-7 cells were transfected with pECFP-C1 (Ctrl) 
or with pSUPER constructs containing shRNAs encoding RNAi against 
Luciferase (Luc) or EB1 + EB3 (EB1/3) and whole cell lysates were prepared 
after 48 hours. Lysates were immunoblotted for EB1, EB3 and b-tubulin 
(b-tub).  (c) MCF-7 cells were transfected with pECFP-C1 or with pSUPER 
constructs containing shRNAs encoding RNAi against Luciferase (Luc) 
or EB1 + EB3. Junctional myosin IIA (Myo IIA) in CFP-positive cells was 
quantified by linescan analysis; data represent mean ± S.E.M. pooled 
from three individual experiments (n=15), ***P<0.001; One way Anova, 
Dunnett’s post hoc test. Scale bar: 10 µm.
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Figure S2 Ect2 localization and knockdown. (a) MCF-7 cells stained for Ect2 
(green), `-tubulin (`-tub, red) and DAPI to detect Ect2 at the cytokinetic 
furrow. Representative images of cells undergoing cytokinesis are shown. (b) 
Caco-2 and MDCK cells were fixed and stained for Ect2 (green). Representative 
apical confocal images are shown. (c) Ect 2 staining in MCF-7 cells infected 
with lentivirus bearing an empty vector control (Ctrl) or an shRNA-directed 
against Ect2 (Ect2 kd). Representative apical confocal images are shown. (d) 
MCF-7 cells were transiently transfected with an expression construct encoding 
EGFP-Ect2. Cells were fixed and stained for GFP 36-48h-post transfection.  
Arrowheads indicate accumulation of the transgene at junctions. (e) Lysates 
from MCF-7 cells transfected with SMARTpool siRNA against Ect2 (Ect2 
siRNA) or non-targeting siRNA pools (Ctrl siRNA) were immunoblotted for 
Ect2 and `-tubulin (`-tub). (f) MCF-7 cells transfected with SMARTpool siRNA 
against Ect2 (Ect2 siRNA) or non-targeting siRNA pools (Ctrl siRNA) were fixed 
and stained for RhoA and fluorescence intensity of RhoA at cell junctions was 
quantitated by linescan analysis. Data represent mean ± S.E.M. pooled from 
three individual experiments (n=25), ***P<0.001; One way Anova, Dunnett’s 
post hoc test. (g) E-cadherin (E-Cad,red) and Ect2 (green) immunostaining 
in Control (Ctrl) and Ect2 knockdown (Ect2 KD) cells imaged by wide-field 
deconvolution microscopy. Scale bars: a,b,d 5 µm; c,g 10 µm.
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Figure S3 Ect2 knockdown does not affect tight junctions or total and 
surface expression levels of E-Cadherin. (a-b) Immunostaining for Zona 
occludens protein 1 (ZO-1) in control (Ctrl) and Ect2 knockdown (Ect2kd) 
cells. Representative apical confocal images were taken (a) and junctional 
ZO-1 was quantitated by linescan analysis (b). Data represent mean ± S.E.M. 
pooled from three individual experiments (n= 25, n.s. Student’s t-test). 
(c) Surface expression of E-cadherin was measured using surface trypsin 
protection assays in control (Ctrl) and Ect2 knockdown (Ect2kd) cells. 
Cells were lysed immediately (WCL) or after trypsinisation in the presence 
(+Ca) or absence (–Ca) of extracellular Ca2+ . Lysates were immunoblotted 
for E-Cadherin (E-Cad) and `-tubulin (`-tub). (d,e) Control (Ctrl) and Ect2 
knockdown (kd) cells and cells treated with glycerol (vehicle control, \) or 
C3T (0.25µg/ml) for an hour were fixed and stained for F-actin (phalloidin). 
Representative confocal images were taken (d) and junctional F-actin was 
quantified by linescan analysis (e). Data represent mean ± S.E.M. pooled 
from three individual experiments (n=17); n.s. no statistically significant 
difference was identified by Student’s t-test). (f) Junctional tension was 
measured by laser nanoscissors in control (Ctrl) MCF7 cells and cells 
treated with C3-T (C3T) or RNAi to Ect2 (Ect2 kd) or Myosin IIA (IIA kd). 
Representative confocal images were taken at various time points before and 
after ablation. The region of ablation is indicated in each case. Scale bars: 
10 µm.
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Figure S4 Centralspindlin and the zonula adherens. (a) MCF-7 cells were 
fixed and stained for MgcRacGAP (MgcRacGAP, red) and b-tubulin (b-tub, 
green) Representative apical confocal images were taken. (b) Lysates from 
MCF-7 cells transfected with two different siRNAs (siRNA1 and siRNA2) 
each against MgcRacGAP (MgcRacGAP) or MKLP1 (MKLP1) or with 
scrambled siRNA (Ctrl) were immunoblotted for MgcRacGAP or MKLP1 
and `-tubulin (`-tub). (c) MCF-7 cells were transfected with siRNAs against 
MgcRacGAP (Mgc kd), MKLP1 (MKLP1 kd) or with scrambled siRNA (Ctrl). 
Cells were fixed after 48 hours and stained for MgcRacGAP (MgcRacGAP) or 
MKLP1 and ZO-1. Representative apical confocal images were taken. Arrows 
indicate lack of junctional staining for MgcRacGAP or MKLP1 in knockdown 
cells. (d) MCF-7 cells were transiently transfected with expression constructs 
encoding MgcRacGAP-EGFP (MgcRacGAP GFP) or MKLP1-EGFP (MKLP1 
GFP). Cells were fixed and stained for GFP 36-48h-post transfection.  
Arrows indicate accumulation of the transgene at junctions. (e) Junctional 
MgcRacGAP and MKLP1 were immunostained in control (Ctrl) and Ect2 
knockdown (Ect2 kd) cells. Data represent the percentage of contacts that 
stained for MgcRacGAP (Mgc) or MKLP1 normalised to the total number 
of contacts. Data represent mean ± S.E.M. pooled from three individual 
experiments (n=60; n.s. no statistically significant difference was identified 
by Student’s t-test). (f) MCF-7 cells were transfected with siRNA against 
MgcRacGAP (Mgc kd). Cells were fixed after 48 hours and stained for myosin 
IIA (Myo IIA) and E-Cadherin (E-Cad). Representative apical confocal images 
were taken. Scale bars: a,d 5µm; d 10 µm ; f Myo IIA 10 µm, E-Cad 5 µm.
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Figure S5 Impact of _-catenin on Ect2 at the zonula adherens. (a) 
Magnified image of MCF-7 cells fixed and stained for E-Cadherin (E-
Cad, red), _- catenin (_ cat , blue) and Ect2 (green). Representative 
confocal images were taken at the ZA and the distribution of proteins 
along the z-axis of cells is represented in x–z views. (b) Lysates from 
MCF-7 cells transfected with SMARTpool siRNA against _- catenin (_ 
cat kd) or non-targeting siRNA pools (\) were immunoblotted for  
_- catenin (_ cat) and `-tubulin (`-tub). (c) MCF-7 cells transfected 
with SMARTpool siRNA against _- catenin (_ cat kd) or non-targeting 
siRNA pools (Ctrl) were fixed and stained for Myosin IIA (Myo IIA) 
or Myosin IIB(Myo IIB). Representative confocal images were taken. 
(d) Schematic representation of full length a-catenin (FL) and the 
constructs used. The positions of the VH1, VH2, VH3 domains are 
indicated. Scale bars: a 5 µm; c 10 µm.
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Figure S6 Nocodazole-induced recruitment of p190 B RhoGAP requires Rac 
signaling. (a) MCF-7 cells were transfected with either Flag-p190B RhoGAP 
(WT) or Flag-p190B6RBS (DRBS) and then treated with DMSO (vehicle 
control, Ctrl) or Nocodazole (Noc). Cells were fixed and stained for FLAG. 
Representative apical confocal images were taken. Arrow indicates increase 
in junctional p190B in Nocodazole treated cells. (b) MCF-7 cells were 
treated with DMSO (Ctrl), Nocodazole alone (100nM,3h, Noc), NSC 23766 
alone ( 50µM, 12h, NSC) or NSC 23766 and Nocodazole ( Nocodazole was 
added in the last three hours of NSC incubation, Noc + NSC). Junctional 
p190 B RhoGAP was quantitated by linescan analysis. Data represent mean 
± S.E.M. pooled from three individual experiments (n=25; ***P<0.001; One 
way Anova, Dunnett’s post hoc test). (c) Junctional Rac-GTP was measured 
by using a Raichu-Rac biosensor expressed in control (Ctrl) cells or cells 
treated with nocodazole (Noc), MgcRacGAP RNAi (Mgc kd) or a transiently 
expressed constitutively-active Rac mutant (V12). Representative images of 
CFP and ratio of FRET/CFP are shown. Scale bars: a, c 10µm,
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Table S1 FRAP analysis of E-cadherin-GFP in control, Ect2 KD, Myosin IIA KD, and C3 transferase-treated cells. Fluoresence recovery after photobleaching 
E-cadherin-GFP expressed in E-cadherin knock-down cells treated with or without Ect2 RNAi, Myosin IIA RNAi or C3-transferase. Fluoresence recovery 
parameters are shown.
Table S2 List of siRNA and shRNA sequences. DNA sequences used for RNAi experiments. siRNAs were commercially-available oligonucleotide pools.
Table S3 Primary antibodies for immunofluorescence and western blotting. Details of primary antibodies used in these experiments: species, sources and 
dilutions used.
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Abstract
In this chapter, we discuss the cell biology of contractility at cell–cell junctions. As dis-
cussed elsewhere in this volume, contractile forces play key roles in development and
tissue homeostasis. Here, we review our understanding of the cellular mechanisms that
functionally and physically link cadherin adhesion to the actomyosin contractile appa-
ratus of the cell. Focusing on epithelia, we argue that E-cadherin junctions can be
Current Topics in Developmental Biology, Volume 112 # 2015 Elsevier Inc.
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considered as active mechanical agents, which contribute to the assembly of actomy-
osin at the junctional cortex itself. This reflects cortical signaling, notably that regulated
by the Rho GTPase, coordinated with actin regulation at junctions. The product, con-
tractile tension at junctions, can then be regarded as an emergent property of a com-
plex dynamical system that integrates adhesion with the cytoskeleton.
1. INTRODUCTION
Cell–cell interactions have long been recognized to participate in the
genesis and homeostasis of tissue organization. Adhesive interactions
between cells influence patterning in the early embryo and counteract forces
that tend to disrupt tissue integrity (Levine, Lee, Kintner, & Gumbiner,
1994; Takeichi, 2014). These adhesive interactions have commonly been
envisaged as passive resistance elements that respond to large-scale forces act-
ing on organisms and tissues. Increasingly, we have come to realize that
many of the forces that act upon cell–cell adhesions are generated by the
neighboring cells themselves (Gomez, McLachlan, & Yap, 2011; Luo
et al., 2013). Effectively, cells pull upon each other and cell–cell adhesion
systems serve to mechanically couple the contractile apparatuses of neigh-
boring cells together (Maitre et al., 2012). This is best understood for epi-
thelia where a dominant adhesion system is mediated by E-cadherin.
Mechanical coupling of contractility to E-cadherin adhesion is reflected
in contractile tension within junctions that scales-up to tissue level patterns
of tension (Fernandez-Gonzalez, Simoes Sde, Roper, Eaton, & Zallen,
2009; Martin, Gelbart, Fernandez-Gonzalez, Kaschube, & Wieschaus,
2010; Rauzi, Verant, Lecuit, & Lenne, 2008). Adhesion can effectively con-
vert the isolated contractile apparatus of a single cell into a supracellular con-
tractile network. This is implicated in both local cellular rearrangements and
tissue-level morphogenesis (Martin, 2010).
At the cellular level, contractility is predominantly generated by the acto-
myosin system, involving the interaction of F-actin microfilaments with
myosin II motors (Vicente-Manzanares, Ma, Adelstein, & Horwitz,
2009). Mechanistically, a key question is how cadherin molecular systems
physically interact with actomyosin to couple adhesion and contractility.
However, cadherin adhesion also contributes to the biogenesis of actomy-
osin at cell–cell junctions (Ladoux et al., 2010; Shewan et al., 2005). This
entails the recruitment of cytoskeletal regulators to the junctional cortex,
responding to cortical signals that are often influenced by cadherin adhesion
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itself (Ratheesh & Yap, 2012). Thus, the integration of adhesion and con-
tractility not only reflects the passive association of cadherins with the cyto-
skeleton but also involves an active role of adhesion in establishing the
junctional cytoskeleton (Kovacs, Goodwin, Ali, Paterson, & Yap, 2002;
Kovacs et al., 2011; Priya, Yap, & Gomez, 2013; Shewan et al., 2005;
Smutny et al., 2011). In this chapter, we review our growing understanding
of how this comes about. A recurring theme in this discussion is the emerg-
ing role that contractile tension itself can play in regulating actomyosin at
cell–cell junctions.
2. THE CONTRACTILE APPARATUS: ACTOMYOSIN
Actomyosin constitutes the principal contractile apparatus in non-
muscle cells, as well as in muscle (Fernandez-Gonzalez & Zallen, 2009;
Kasza & Zallen, 2011; Fig. 1). Contractility is generated by the physical
interaction of the myosin II head domains with actin filaments. In the
best-understood model, force is generated by the ability of myosin II to slide
actin filaments once the motor is activated by phosphorylation of its regu-
latory light chain (RLC) (Craig, Smith, & Kendrick-Jones, 1983;
Matsumura, 2005). myosin II activation also entails the assembly of Myosin
motors into antiparallel minifilaments that can each consist of 10–30 individ-
ual myosins (Heissler & Manstein, 2013; Niederman & Pollard, 1975). This
antiparallel orientation allows minifilaments to slide F-actin inward, thereby
generating contractility (Fig. 1B). Importantly, the organization of the actin
filaments with which myosin interacts can influence contractile output
(Reymann et al., 2012). This is exemplified by the alignment of myosin
minifilaments with parallel actin filaments that is found in the sarcomeres
of muscle cells. Something similar has also been observed at epithelial
cell–cell junctions (Ebrahim et al., 2013). However, Myosin minifilaments
can also act upon actin filaments that are organized into less well organized,
nonparallel networks; under these latter circumstances, contractility can
aggregate F-actin and even induce filament turnover (as will be discussed
further below) (Haviv, Gillo, Backouche, & Bernheim-Groswasser, 2008;
Reymann et al., 2012).
The functional impact of actomyosin is demonstrated by the observation
that morphogenetic events, such as germ-band extension during Drosophila
development, are perturbed when components of myosin II are depleted
from embryos (Bertet, Sulak, & Lecuit, 2004) This is thought to reflect local
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cellular rearrangements that are driven by contractile coupling to cadherin
cell junctions. Consistent with this, a number of patterns of myosin II
networks are found to mechanically associate with junctions in tissues and
cultured epithelial cells. One pattern involves myosin II networks located
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Figure 1 The contractile apparatus at junctions and its biogenesis. (A) Spatial relation of
actomyosin network with cadherin junctions. F-actin and myosin form a mesh at the
apical pole of the cells (medial–apical network) and also orient themselves parallel to
the junctions (junctional actomyosin). (A0) The contractile cortices of neighboring cells
are mechanically coupled through association with the cadherin–catenin complex (A00).
(For clarity, this coupling is illustrated only for junctional actomyosin.) (B) Kinases (ROCK
andMLCK) activate myosin by phosphorylating its RLC. This leads to association of myo-
sin with F-actin and minifilament assembly (which is also controlled by heavy chain
phosphorylation). (C) Cadherin ligation recruits actin regulators directly or indirectly
via adaptor proteins to modulate local actin assembly and remodeling. Cadherin can
also scaffold upstream Rho activators and thus support Rho signaling, which further
mediates actomyosin assembly via its effectors.
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at the apical poles of epithelial cells (often described as medial–apical net-
works; Martin, Kaschube, & Wieschaus, 2009); these commonly display
pulsatile contractions which are transmitted to junctions. As well, myosin II
accumulates at cell–cell junctions themselves, typically decorating F-actin
bundles that circumscribe the apical junctions (Shewan et al., 2005;
Smutny et al., 2010;Wu et al., 2014; Fig. 1A). These also contribute to con-
tractile tension in junctions. But the latter appear to manifest as a line tension
in the apical junctions rather than the pulsatile fluctuations seen with
medial–apical networks. In both these systems, active myosin must physi-
cally interact with the cadherin adhesion system to allow force to be trans-
mitted to, and through, junctions. This involves both cell-signaling
pathways that regulate the activity and localization of myosin II and associ-
ation of myosin-bound actin filaments with the cadherin complex (Fig. 1C).
2.1. The role of cadherin signaling in myosin II regulation
As noted in the preceding text, myosin II is regulated by a variety of cellular
signals. In the best-characterized model, phosphorylation of the RLC (at
Thr18 and Ser19) promotes F-actin binding and actin-induced ATPase
activity (Heissler & Manstein, 2013); it also allows myosins to assemble into
minifilaments (Sellers, 1991). Monophosphorylation of Ser19 is sufficient to
stimulate myosin ATPase activity, motor activity, and minifilament assem-
bly, although these can be further enhanced by additional phosphorylation
of Thr18 ( Julian & Olson, 2014). These combined effects promote actin fil-
ament sliding and therefore contractility. RLC phosphorylation is, in turn,
determined by the balance between the action of kinases and myosin light-
chain phosphatase (MLCP; Julian & Olson, 2014; Schofield & Bernard,
2013). A number of kinases can directly phosphorylate RLC, including
myosin light-chain kinase (MLCK), which commonly responds to changes
in intracellular Ca2+ levels that can activate contractility (Heissler &
Manstein, 2013). Rho kinase (ROCK) is another Ser/Thr kinase that medi-
ates signaling downstream of the small GTPase, Rho, a major regulator of
cellular contractility (Riento & Ridley, 2003). Although ROCK can
directly phosphorylate myosin in vitro, within cells its major impact may
occur indirectly. In contrast to MLCK, ROCK can also inhibit the action
ofMLCP, thereby preventing RLC dephosphorylation (Amano et al., 1996;
Kimura et al., 1996; Totsukawa et al., 2000).
Both MLCK and ROCK participate in building the contractile cyto-
skeleton at cadherin junctions (Smutny et al., 2010). In the case of ROCK,
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this appears to reflect an E-cadherin-based Rho signaling pathway (which
will be discussed in greater detail below). Thus, myosin II can be recruited
to sites of adhesion when E-cadherin alone is ligated, which is isolated from
other juxtacrine pathways that may come into effect when cell surfaces
come into contact with one another (Shewan et al., 2005). This implies
that cadherin adhesion itself can provide an instructive cue to recruit
myosin II. Myosin recruitment to cadherin adhesions is disrupted when
ROCK is inhibited, implying that ROCK serves in a cadherin-dependent
signaling pathway to activate myosin II (Shewan et al., 2005). Similarly,
junctional myosin II levels are reduced when ROCK is inhibited
(Smutny et al., 2010). Consistent with the role of ROCK as a major medi-
ator of Rho signaling (Riento & Ridley, 2003), junctional myosin II and
contractile tension are also reduced when Rho signaling itself is blocked or
the molecular mechanisms that activate Rho at junctions are disrupted
(Ratheesh et al., 2012). The ability of myosin activation to promote junc-
tional localization of the motor likely reflects the increased F-actin binding
that accompanies RLC phosphorylation, as junctional myosin II is lost
when junctional F-actin is reduced (Leerberg et al., 2014; Verma et al.,
2012). MLCK is also necessary for E-cadherin adhesion to recruit myosin
II (Shewan et al., 2005; Smutny et al., 2010), and intracellular calcium
signaling is increased at junctions when cells make contacts with one
another (Nigam, Rodriguez-Boulan, & Silver, 1992). However, what rela-
tionship this has to cadherin signaling has yet to be determined. As well,
it is likely that many other signaling pathways impinge to influence the
biogenesis and contractile activity of actomyosin at junctions.
Interestingly, mammalian cells have three myosin II paralogs (A–C)
(Vicente-Manzanares et al., 2009), in contrast to the single myosin II pos-
sessed by invertebrates, and different sets of signaling pathways may influ-
ence individual myosin II paralogs at cadherin junctions in mammalian
cells. For example, although both myosin IIA and myosin IIB were found
at the zonulae adherente (ZA) in culturedMCF7 cells, a breast epithelial cell
line, inhibition of Rho-ROCK signaling reduced the junctional accumula-
tion of myosin IIA to a significantly greater extent than it did myosin IIB
accumulation (Smutny et al., 2010). In contrast, myosin IIB localization
was preferentially sensitive to Src and Rap1 activity (Smutny et al.,
2010). Thus, multiple signaling pathways may determine the ability of dif-
ferent myosin paralogs to recruit to, and exert contractile force upon,
cadherin-based cell–cell junctions.
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2.2. F-actin mediates the association of myosin motors with
cadherin adhesion
For activatedmyosin to generate contractile force upon junctions, molecular
mechanisms are necessary to physically link myosin II to the cadherin adhe-
sion complex. To date, there is no convincing evidence that myosin II inter-
acts directly with cadherins or their associated proteins. Instead, it is probable
that the mechanical coupling is achieved through the actin filaments with
which the myosins interact. Junctional myosin is reduced, and contractile
tension compromised, when the assembly of actin filaments is decreased
at the junctions, either by drugs that disrupt F-actin or when regulators
of F-actin dynamics are perturbed (Leerberg et al., 2014; Verma et al.,
2012; Wu et al., 2014). This implies that cortical F-actin also contributes
to localizing myosin II to the junctions.
How cadherin complexes associate with F-actin is an active and contro-
versial area which has been reviewed in detail elsewhere (Ratheesh & Yap,
2012). For the purposes of the present discussion, it is sufficient to emphasize
the following points. A number of actin-binding proteins can associate with
E-cadherin and potentially serve to couple adhesion complexes to cortical
F-actin (Fig. 2A). These include α-catenin, undoubtedly the most extensively
discussed candidate, and also proteins such as vinculin, cortactin, and myosin
VI. The reason(s) for this variety have yet to be resolved. Importantly, there is
increasing evidence that contractile tensionmay influence the activity of some
of these proteins. For example, α-catenin can directly associate with F-actin.
Despite this, early efforts failed to reconstitute a minimal quaternary complex
consisting of the cadherin cytoplasmic tail, β- and α-catenin bound to purified
actin filaments (Drees, Pokutta, Yamada, Nelson, & Weis, 2005; Yamada,
Pokutta, Drees, Weis, & Nelson, 2005). Those studies were performed in
solution using purified proteins. However, it has recently been reported that
theminimal cadherin–catenin complexwill bind stably to actin filament when
force is applied. Kinetic analysis of bond dissociation indicated that the inter-
action could be explained by a catch-bond model, where force strengthened
the bond between cadherin/catenin and F-actin (Buckley et al., 2014).
α-Catenin can also interact indirectly with F-actin, through the recruit-
ment of proteins such as vinculin (Choi et al., 2012; Rangarajan & Izard,
2012; Watabe-Uchida et al., 1998). Although other proteins may contribute
(Peng, Cuff, Lawton, &DeMali, 2010), the junctional recruitment of vinculin
is dominantly mediated by α-catenin (Huveneers et al., 2012; Leerberg et al.,
2014). This effect is also force dependent, being decreased when myosin is
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Figure 2 Cadherin and actin cooperativity. (A) The core cadherin–catenin complex is
composed of cadherin, β-catenin, α-catenin, and p120-catenin. This core complex asso-
ciateswith actin in variousways: direct binding of α-catenin to F-actin; α-catenin binds to
proteins such as vinculin which can interact with F-actin; myosin VI can directly associate
with the cytoplasmic domain of cadherin and thus mediates the interaction of cadherin
and F-actin. (For clarity, one of the cadherin dimers is drawn without its associated core
catenins.) (B) Actin assembly and remodeling at junctions is an outcome of multiple
overlapping pathways. WAVE-Arp2/3 responds to Rac signaling and nucleates actin
assembly at junctions. Cortactin can directly bind WAVE and Arp2/3 and thus promote
actin nucleation by scaffolding these regulators at cadherin junctions. Cortactin can also
be phosphorylated by Src kinases. Further, Mena-VASP is recruited to cadherin junctions
via vinculin to promote postnucleation elongation of actin filaments. N-WASP acts
downstream of Cdc42 and binds to F-actin via the WIP family protein, WIRE. This pro-
motes actin stability and organization. Rho-mediated activation of formins promotes
elongation of preexisting filaments and also contributes to actin assembly by nucleation.
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inhibited (Leerberg et al., 2014; Yonemura, Wada, Watanabe, Nagafuchi, &
Shibata, 2010). An attractive notion is that contractile tension alters themolec-
ular conformation of α-catenin to reveal or promote its vinculin-binding
capacity. This concept was first suggested by evidence that an epitope near
the vinculin-binding domain of α-catenin is revealed in a force-dependent
fashion within cells (Yonemura et al., 2010). Recently, it was demonstrated
that the vinculin-binding domain of α-catenin became unfolded when iso-
latedmolecules were stretched usingmagnetic tweezers. This promoted bind-
ing of vinculin, which then stabilized α-catenin in its open conformation (Yao
et al., 2014). Thus, it is possible that the number of sites for cadherin com-
plexes to interact with F-actin may be modulated in response to the force act-
ing upon those adhesion complexes. Similar, myosin VI, which can bind
directly to the E-cadherin cytoplasmic tail and contribute to the organization
of F-actin at junctions (Mangold, Norwood, Yap, & Collins, 2012; Mangold
et al., 2011), can function as a tension-sensitive actin-based anchor (Altman,
Sweeney, & Spudich, 2004; Chuan, Spudich, & Dunn, 2011). Overall, this
implies that cadherin–actin binding may not be a static process, but one that
can be tuned in response to the forces that act upon junctions.
The association of actin with myosin II not only influences the junctional
recruitment of myosin but also affects cortical F-actin itself. Myosin can con-
trol F-actin organization both by crosslinking filaments and by aggregating
filaments as they slide. Furthermore, contractile stresses can induce F-actin
severing, which leads to actin disassembly and turnover (Reymann et al.,
2012). Effectively, stress-induced turnover would constitute a mechanism
that inherently limits the force that can be generated by actomyosin, as it
would turn over the F-actin scaffolds that myosin II requires to generate
force. This has been demonstrated to occur in polarized cultured epithelial
cells where stress-induced F-actin turnover limits the tension that is gener-
ated in the lateral cell–cell junctions found below the apical ZA (Wu et al.,
2014).What functionmight be served by limiting the contractile stresses that
junctional actomyosin can generate? One possibility is that it limits the forces
that lateral membranes can exert on the cytoplasm, thereby allowing hydro-
dynamic behavior to be coupled across cell boundaries to drive cellular flows
during morphogenesis (He, Doubrovinski, Polyakov, & Wieschaus, 2014).
Additionally, control of contractility at lateral junctions contributes to
integrating cells within epithelia (Wu et al., 2014). This further implies that
the morphogenetic impact of actomyosin may depend not only on the
myosin II and its regulation but also on the F-actin networks with which
it interacts.
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3. CADHERINS AND BIOGENESIS OF THE JUNCTIONAL
ACTIN CYTOSKELETON
As well as influencing signaling pathways that impinge on myosin,
cadherin adhesion can influence the biogenesis of junctional actomyosin
by regulating multiple aspects of the actin cytoskeleton itself. These include
actin filament dynamics and also potentially actin filament organization. At
the mechanistic level, they are likely to reflect both intermolecular interac-
tions that recruit actin regulators to the junctional cortex and cell signaling at
cadherin junctions.
3.1. The dynamic junctional actin cytoskeleton
F-actin at the cortex of cell–cell junctions is dynamic. FRAP studies suggest
that actin filaments undergo turnover on time scales of tens of seconds
(Kovacs et al., 2011; Smutny et al., 2010; Yamada et al., 2005). It is also
likely that multiple pools of F-actin exist at junctions that have different
degrees of stability (Cavey, Rauzi, Lenne, & Lecuit, 2008; Zhang et al.,
2005). Nonetheless, the fact that filaments are highly dynamic implies that
the maintenance of the overall F-actin content at cell–cell junctions involves
ongoing assembly of filaments to replenish those that are being lost. More-
over, the disruption of actin homeostasis affects junctional integrity and con-
tractile tension (Verma et al., 2012), as will be discussed further. This
indicates that, although filament pools may differ in their stability, the reg-
ulation of filament dynamics is functionally important.
3.2. Actin assembly
The process of assembling actin filaments can be thought of as consisting
of two stages. The first is actin filament nucleation, the energetically rate-
limiting step of building filaments from monomers to trimers (Pollard,
Blanchoin, & Mullins, 2000). The subsequent growth of filaments from
trimers can occur by actin self-assembly, but this is relatively slow. There-
fore, within cells, the postnucleation assembly (growth) of filaments is
commonly accelerated by proteins such as Ena/VASP proteins and
formins (Chesarone & Goode, 2009; Krause, Dent, Bear, Loureiro, &
Gertler, 2003).
Consistent with the notion that actin assembly may contribute to the
homeostasis of dynamic filaments, actin assembly, including nucleation
itself, can be identified at E-cadherin-based cell–cell junctions themselves
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(Kovacs et al., 2011; Tang & Brieher, 2012; Vasioukhin, Bauer, Yin, &
Fuchs, 2000; Yamada et al., 2005). A number of proteins can mediate actin
filament nucleation, and several of these have been identified at E-cadherin
junctions (Fig. 2B). These include the Arp2/3 complex, which mediates the
assembly of branched networks of actin filaments (Pollard et al., 2000;
Ydenberg, Smith, Breitsprecher, Gelles, & Goode, 2011). Arp2/3 concen-
trates at E-cadherin junctions (Tang & Brieher, 2012; Verma et al., 2012),
through an interaction with the scaffolding protein, cortactin, which can
directly associate with Arp2/3 (Han et al., 2014; Weed & Parsons, 2001).
In cultured epithelial cells, depletion of Arp2/3 or cortactin reduces actin
assembly at junctions, decreases steady-state levels of F-actin, and leads to
fragmentation of the apical ZA (Han et al., 2014; Verma et al., 2012). Of
note, Arp2/3 depletion reduces contractile tension at junctions, as well as
the junctional accumulation of myosin II (Verma et al., 2012). Therefore,
the local generation of F-actin by Arp2/3 appears to contribute to junctional
contractility, by generating actin filaments that promote junctional accumu-
lation of myosin and which are themselves necessary for active myosin to
generate force. Arp2/3 has little intrinsic activity and instead is stimulated
by cell-signaling pathways that are mediated by proteins, particularly those
of the WASP/WAVE family, which transduce signals from Cdc42 and
Rac1, respectively (Insall & Machesky, 2009). Indeed, both N-WASP
and WAVE2 are found at cell–cell junctions, and WAVE2 is necessary
for actin assembly to occur there (Kovacs et al., 2011; Verma et al.,
2012). Consistent with this, Rac1 can promote actin assembly at
E-cadherin adhesions (Kraemer, Goodwin, Verma, Yap, & Ali, 2007).
Therefore, Arp2/3 may serve to mediate Rac-dependent actin assembly
at cadherin-based junctions.
In contrast to Arp2/3, members of the formin family promote nucleation
of parallel actin filaments (Chesarone & Goode, 2009), which would be
predicted to be favored for the generation of F-actin bundles. Two formin
family members have been identified at cell–cell junctions, formin-1 in
keratinocytes and mDia1 in human mammary epithelial cells. Formin-1
was reported to interact with α-catenin, which may be responsible for its
junctional recruitment (Kobielak, Pasolli, & Fuchs, 2004), whereas how
mDia1 localizes to junctions remains poorly understood, although it is likely
to respond to Rho (Carramusa, Ballestrem, Zilberman, & Bershadsky,
2007). Formin activity is also tightly regulated in response to cellular context
(Chesarone & Goode, 2009). Interestingly, formins can also respond to
changes in cellular tension, potentially independent of other known signals
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(Higashida et al., 2013), although whether this is relevant at junctions
remains to be determined.
A growing list of other proteins also cooperates to promote actin nucle-
ation at junctions. α-Actinin-4 appears to facilitate Arp2/3-based actin
nucleation at E-cadherin adhesion in cultured mammalian epithelial cells
(Tang & Brieher, 2012), and cortactin also has a weak capacity to nucleate
filaments in vitro (Weed & Parsons, 2001). The major contribution of cor-
tactin to junctional nucleation in cells may, however, be to recruit Arp2/3
and WAVE2 to the junctions (Han et al., 2014). The plethora of molecules
that can support actin nucleation attests to the functional importance of actin
filament homeostasis at junctions, although it is possible that these diverse
nucleators serve different functions depending on cellular context.
Postnucleation actin assembly also plays an important part in F-actin
homeostasis at cadherin junctions. This is exemplified by members of the
Ena/VASP protein family, which vary in their number from Drosophila
(where Enabled [Ena] is the only member) to mammalian cells (which have
three: Mena, VASP, and EVL; Krause et al., 2003). In vitro, Ena/VASP pro-
teins have been reported to have weak nucleating capacity, but in cells their
primary function appears to be to promote postnucleation elongation at
F-actin barbed ends (Barzik et al., 2005). They may achieve this by antag-
onizing capping protein (Bear et al., 2002), which inhibits F-actin elonga-
tion at the barbed ends, and/or by acting as processive actin polymerases
(Hansen & Mullins, 2010). In mammalian epithelia, Mena/VASP proteins
localize to E-cadherin junctions where they contribute to actin assembly
(Scott et al., 2006; Vasioukhin et al., 2000). Interestingly, their recruitment
to junctions appears to constitute a mechanism for tension-dependent reg-
ulation of actin assembly (Leerberg et al., 2014). Thus, actin assembly at
adherens junctions was sensitive to tension, increasing when contractility
was stimulated and decreasing when myosin II was inhibited. This entailed
the tension-sensitive recruitment of Mena/VASP downstream of vinculin
(Leerberg et al., 2014; Peng et al., 2010). Of note, this tension-sensitive actin
assembly apparatus was necessary for sustained contractile stress to be gen-
erated at the apical ZA (Leerberg et al., 2014).
Together, these findings argue that both nucleation and postnucleation
mechanisms may play important roles in actin assembly at cell–cell junctions.
This is further attested by the diverse impacts of Arp2/3 and Mena/VASP
proteins during development. Arp2/3 and its activator, WASP, were
reported to promote E-cadherin endocytosis for junctional remodeling dur-
ingDrosophilamorphogenesis (Georgiou, Marinari, Burden, & Baum, 2008;
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Leibfried, Fricke, Morgan, Bogdan, & Bellaiche, 2008). Arp2/3 also con-
tributes to junctional maturation and maintenance in the Caenorhabditis
elegans gastrointestinal epithelium, although in that system other adhesion
molecules may play a greater role in their recruitment than cadherin
(Bernadskaya, Patel, Hsu, & Soto, 2011). Although Mena/VASP proteins
do not appear to be essential during development, their impact becomes
more apparent in tissues that are under mechanical stress. For example,
mouse embryos lacking all Mena/VASP proteins have a defective endothe-
lial barrier, a tissue that experiences shear forces (Furman et al., 2007), while
duringDrosophila development the contribution of Ena is most evident dur-
ing dynamic morphogenetic events where cell–cell junctions experience
strong forces (Gates et al., 2007, 2009). Together, these observations imply
that Ena/VASP proteins may especially contribute to strengthening junc-
tions against stress, potentially by mediating tension-sensitive actin assembly
(Leerberg et al., 2014).
3.3. Actin filament stability and junctional contractility
Conversely, what are the mechanisms that challenge junctional actin
homeostasis by inducing actin filament turnover? Isolated actin filaments
have an intrinsic tendency toward disassembly, which is favored at the
pointed (minus) end compared with the barbed end. However, this intrinsic
process is often quite slow compared with the turnover rates of actin fila-
ments within cells. Thus, other molecular mechanisms must exist within
cells to accelerate actin filament turnover and promote the remodeling of
actin networks (Brieher & Yap, 2013). One of these is contractile stress
driven by myosin II (Haviv et al., 2008; Medeiros, Burnette, & Forscher,
2006; Reymann et al., 2012). As noted earlier, in epithelial cells, stress-
induced filament turnover can limit the contractile tension that is generated
at the lateral junctions located below the ZA (Wu et al., 2014). This carries
the important implication that mechanisms that allow filaments to resist, or
compensate for, stress-induced turnover can influence the active stresses that
cells generate at junctions.
Indeed, several such compensatorymechanisms have recently been iden-
tified. One is tension-sensitive actin assembly itself; of note, targeting of
Mena/VASP to junctions could restore contractile tension at the ZA when
vinculin was depleted (Leerberg et al., 2014). A second is N-WASP, a mem-
ber of the WASP/WAVE protein family that is selectively localized at the
ZA in mammalian epithelial cells (Kovacs et al., 2011; Wu et al., 2014).
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Although best understood as a regulator of Arp2/3-mediated actin nucle-
ation (Padrick & Rosen, 2010), N-WASP at the ZA appears to function
to stabilize actin filaments (Kovacs et al., 2011). This contributes to sustain-
ing contractile tension at this apical junction (Wu et al., 2014). The precise
molecular mechanism that allows N-WASP to stabilize F-actin is less clear.
It involves the WIP family protein, WIRE, which associates directly with
the N-terminal of N-WASP (Kovacs et al., 2011). WIRE can bundle actin
filaments (Kato & Takenawa, 2005), an observation that is consistent with
increasing evidence that network organization critically influences the sen-
sitivity of F-actin to stress-induced turnover (Reymann et al., 2012).
Branched networks appear to be especially sensitive to myosin-induced
turnover (Medeiros et al., 2006), perhaps because contractility is more prone
to generate compressive forces that buckle F-actin and increase its sensitivity
to severing by cofilin. Conversely, actin filaments that are tense, as occur in
bundles such as stress fibers, are actually resistant to cofilin (Hayakawa,
Tatsumi, & Sokabe, 2011). Whether N-WASP and WIRE stabilize fila-
ments by promoting bundling has yet to be determined. However, it is note-
worthy that other bundling proteins, such as α-actinin (Knudsen, Soler,
Johnson, & Wheelock, 1995) are recruited to junctions and associate with
E-cadherin complexes.
4. REGULATION OF CORTICAL SIGNALING BY CADHERIN
ADHESION
In this section, we will consider how cortical signals are regulated at
cadherin junctions to influence junctional contractility. We focus on the
Rho family of small GTPases, which have diverse and profound contribu-
tions to cytoskeletal regulation (Etienne-Manneville & Hall, 2002). Indeed,
the best-known members of this family—Rho, Rac, and Cdc42—have all
been identified as active at cadherin junctions (Kim, Li, & Sacks, 2000;
Ratheesh et al., 2012). For the purposes of the present discussion, we will
concentrate on Rho, given its central role in regulating contractility,
cadherin biology and in development.
4.1. Rho signaling and morphogenesis
Morphogenesis involves the coordinated self-assembly of cells into multilay-
ered tissues that undergo deformations such as bending, folding, and tube
formation to generate specialized three-dimensional structures (Guillot &
Lecuit, 2013; Mammoto, Mammoto, & Ingber, 2013).
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Rho contributes tomanymorphogenetic processes during development.
Its role has often been identified by experiments that targeted its upstream
regulators, thereby identifying Rho as a common effector in many develop-
mental signaling pathways. For example, DRhoGEF2 (an activator of Rho)
is important for cell-shape changes required for gastrulation: deletion of
DRhoGEF2 or expression of dominant-negative Rho caused gastrulation
to fail inDrosophila embryos (Barrett, Leptin, & Settleman, 1997). The junc-
tional localization of DRhoGEF2 protein also appears to be important for its
developmental impact inDrosophila, as the transcription factor Twist induces
the expression of a transmembrane protein, T48, that serves to concentrate
RhoGEF2 at cell junctions. The subsequent stimulation of Rho signaling
was necessary to initiate mesoderm invagination (Kolsch, Seher,
Fernandez-Ballester, Serrano, & Leptin, 2007). This emphasizes the impor-
tant role that spatial coordination of signaling plays in the developmental
impact of Rho. Similarly, the transcription factor Snail acts through its target
gene folded gastrulation (Fog) to promote Rho-ROCK activity for apical
constriction during fly gastrulation (Mammoto et al., 2013).
Rho is also implicated in developmental processes where junction rem-
odeling is coupled to morphogenesis. For example, during the process of
germ-band extension in Drosophila, cells intercalate to extend the body axis
(Guillot & Lecuit, 2013; Mammoto et al., 2013). Here, Rho-mediated acti-
vation of ROCK leads to polarized localization of myosin filaments at the
junctional interface undergoing shrinkage and at the same time regulates
the preferential localization and stability of adherens junction components
at the growing interface (Bertet et al., 2004).
The close link among Rho signaling, contractility, and cell–cell junc-
tions is also evident in vertebrates. In chick embryos, Rho, along with its
downstream effector myosin, becomes concentrated at the apical surface
of neural plate cells, and drugs that inhibited this cascade caused gross dis-
ruptions in neural plate morphogenesis (Kinoshita, Sasai, Misaki, &
Yonemura, 2008). ROCK has been implicated in neural tube closure, as
the neural folds failed to bend and close normally when ROCK-1 signaling
was diminished at the apical surfaces of the neural plates (Nishimura &
Takeichi, 2008; Wei et al., 2001). Although RhoA null-knockout mice
are embryonic lethal (Thumkeo, Watanabe, & Narumiya, 2013), condi-
tional gene targeting has revealed its role in a variety of developing tissues.
For example, ROCK-mediated phosphorylation of myosinRLC is required
for eyelid closure as gross defects in actin-filament organization, and loss of
pRLC was observed in the eyelid epithelium of ROCK-1-knockout mice
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(Shimizu et al., 2005). Similarly, using conditional knockout in the lens epi-
thelium, Chauhan, Lou, Zheng, and Lang (2011) reported that mutual
antagonism of Rho and Rac modulates apical constriction and the changes
in cell width required for epithelial invagination. RhoA, via ROCK, gen-
erates active myosin and contractility, which is needed for apical constric-
tion. Thus, when RhoA was deleted, lens pits were open in shape
(Chauhan et al., 2011). In the neuroepithelium of mice, ablation of RhoA
disrupts adherens junctions and apical–basal cell polarity, causing aberrant
proliferation of neuronal progenitors and defects in organization of ventric-
ular region (Herzog et al., 2011; Katayama et al., 2011). Similar defects were
seen when the Rho effector, mDia, was disrupted (Thumkeo et al., 2011).
4.2. Rho and cadherin biology
Rho is also essential for the stability and integrity of cadherin-based junc-
tions. Although three Rho family genes are found in mammals, much work
has focused on RhoA, as disruption of RhoA signaling perturbs the integrity
of cadherin-based adhesions (Braga, 2000; Braga, Machesky, Hall, &
Hotchin, 1997; Priya et al., 2013; Ratheesh et al., 2012; Ratheesh &
Yap, 2012; Shewan et al., 2005; Smith, Dohn, Brown, & Reynolds,
2012; Takaishi, Sasaki, Kotani, Nishioka, & Takai, 1997). Rho signaling
can contribute to adherens junction integrity by stabilizing cadherin recep-
tors, cytoskeleton organization, generation of tension, and possibly facilitat-
ing E-cadherin clustering (Braga, Betson, Li, & Lamarche-Vane, 2000; Priya
et al., 2013; Ratheesh et al., 2012; Ratheesh, Priya, & Yap, 2013; Shewan
et al., 2005; Smutny et al., 2010, 2011).
In the context of our present discussion, myosin II is a major downstream
target for Rho to promote cadherin biology. The recruitment and activity of
myosin II at junctions responded to the Rho pathway. Inhibition of Rho
kinase signaling not only led to the loss of myosin II from junctions but also
abolished its activity as suggested by the loss of MLC phosphorylation and
decreased junctional staining of ppRLC (Shewan et al., 2005). Moreover,
the phenotype observed after ROCK inhibition was very similar to that
of myosin inhibition, namely, an inability to concentrate E-cadherin in
junctions and reduced adhesion to cadherin-coated substrata (Shewan
et al., 2005). These observations placed myosin II as a potent downstream
effector that allows Rho to modulate cadherin adhesion (Shewan et al.,
2005). Interestingly, as noted earlier, although both myosin IIA and myosin
IIB can be found at apical ZA, the junctional concentration of myosin IIA
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was more dependent on the Rho/ROCK pathway than that of myosin IIB
and served to promote cadherin clustering and the concentration of
E-cadherin at the apical ZA (Smutny et al., 2010). Thus, a Rho-ROCK-
Myosin II pathway can play an integral role in supporting the integrity of
the ZA.
However, to perform its biological functions, Rho must undergo a reg-
ulated activation/inactivation cycle facilitated by ancillary stimulatory and
inhibitory proteins ( Jaffe & Hall, 2005). The spatiotemporal activity of these
regulatory molecules decides the site and timing of Rho signaling (Bement,
Miller, & von Dassow, 2006). An important emerging theme here is the
ability of cells to localize contiguous elements of signaling pathways to
cadherin junctions. This is well illustrated by the Rho-ROCK pathway.
Both active, GTP-loaded Rho and its immediate downstream mediator,
Rho-activated kinase (ROCK), are found at cadherin junctions (Priya
et al., 2013; Ratheesh et al., 2012; Smith et al., 2012; Figs. 3B and 4A). Inhi-
bition of either Rho or ROCK decreases junctional contractility. More-
over, disruption of mechanisms that activate or recruit Rho or ROCK to
junctions also compromises junctional contractility (Ratheesh et al.,
2012). This implies that the local regulation of this signaling module plays
an important role in regulating junctional actomyosin. Indeed, this notion
is teleologically attractive, as it would provide a mechanism to focus contrac-
tility at junctions. The important mechanistic issue is how such junctional
localization of Rho-ROCK signaling might be achieved.
4.3. Focusing Rho signaling at cell–cell junctions
One major paradigm for the spatial control of Rho signaling lies in the pro-
teins that control its activation and inactivation at the plasma membrane
(Etienne-Manneville & Hall, 2002). This reflects two broad processes: the
control of Rho nucleotide status and the localization of active Rho at the
plasma membrane.
Like other GTPases, the ability of Rho to mediate cellular regulation
depends on its nucleotide-loaded status. Binding of GTP induces conforma-
tional changes that allow Rho to interact with, and regulate the activity of,
downstream effectors (Bustelo, Sauzeau, & Berenjeno, 2007). In contrast,
conversion of bound GTP to GDP, mediated by the intrinsic GTPase activ-
ity of Rho, disables its ability to interact with its effectors, thereby terminat-
ing its signaling. However, the intrinsic nucleotide turnover rate for Rho is
slow (half-life of !30 min), relative to many of the cellular processes that it
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controls (Zhang & Zheng, 1998). Instead, the nucleotide status of Rho is
further regulated by two sets of proteins. Guanine nucleotide-exchange fac-
tors (GEFs) catalyze the exchange of GDP for GTP, thereby activating Rho,
and GTPase-activating proteins (GAPs) stimulate nucleotide hydrolysis to
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Figure 3 Junctional Rho regulation. (A) Domain structure of ECT2: N, amino-terminal;
BRCT, BRAC1 C-terminal domain; XRCC1, X-ray repair complementing defective repair
inChinesehamster cells 1domain; PH, pleckstrin-homologydomain; C, carboxyl-terminal
region; S, small central region. Domain structure of p190B Rho GAP: The N-terminus con-
sists of a GTPase-like domain, followed by a relatively less well-characterized middle
domain and a GAP domain at the C-terminus; FF, phosphorylation-regulated protein–
protein interacting domain; Y, SH2 domain. (B) Rho signaling at the epithelial cadherin
junctions. RhoA localizes to E-cadherin-based junctions as illustrated by immunofluores-
cence in MCF-7 cells. ECT2 acts as a GEF, which can activate Rho at epithelial cadherin
junctions, while p190B Rho GAP is the GAP that can inhibit Rho activity. Junctional local-
ization of ECT2 relies on the centralspindlin complex, which can also inhibit Rac and thus
prevents p190B GAP localization. The GTP-Rho further supports cadherin stabilization
and junctional tension via myosin-ROCK pathway. Scale bar¼10 μm.
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GDP to inactivate Rho (Bos, Rehmann, & Wittinghofer, 2007; Etienne-
Manneville & Hall, 2002).
In addition, Rho signaling typically occurs at cellular membranes. In the
context of contractility, this allows GTP-Rho to ultimately activate the
contractile apparatus at the cell cortex where it can interact with membrane
proteins to control cell shape and motility. Accordingly, Rho bears a
C-terminal CAAX box that serves as a lipid-binding membrane anchor.
Conversely, inactivation of Rho signaling also involves its removal from the
membrane. This is mediated by Guanine nucleotide dissociation inhibitors
(GDIs) that extract Rho frommembranes and sequester it in its GDP-bound
state within the cytosol (Ridley, 2012).
Ultimately, the localized expression of Rho signaling at specific sites
within cells is influenced by the action of these three sets of proteins. While
it is likely that GDI function will also contribute, coordination of GEF and
GAP activity is currently the best-understood way in which localized zones
of Rho signaling can be established. Formally, one might envisage that a
localized zone of GTP-Rho might be achieved at sites where GEF activity
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predominates over GAP activity. Evidence for such a model has been
identified during cell division, where Rho signaling is focused to support
contractility at the cytokinetic furrow (Glotzer, 2005; Piekny, Werner, &
Glotzer, 2005). To date, the GEFs and GAPs that regulate Rho signaling
at cell–cell junctions are poorly understood. Surprisingly, however, one
set involves proteins that are already implicated in cytokinesis, the GEF
ECT2 and the GAP p190B RhoGAP (Fig. 3A).
4.4. ECT2
ECT2 belongs to the Dbl family of Rho GEFs and was first identified as a
proto-oncogene (Chan et al., 1993). ECT2 is highly conserved across evolu-
tion, human ECT2 sharing a significant degree of similarity in its coding
region with murine ECT2, Let-21 (the ECT2 ortholog in C. elegans), and
XECT2 (Xenopus ECT2) (Fields & Justilien, 2010). ECT2 is composed of
various structural domains, each with a distinct role (Fig. 3A). The
N-terminal half contains many domains which are common to cell-cycle reg-
ulators while the C-terminal half is mainly responsible for the Rho-GEF cat-
alytic activity (Tatsumoto,Xie, Blumenthal,Okamoto,&Miki, 1999). At the
extreme N-terminus lies a XRCC1 domain, which shows sequence homol-
ogy to human XRCC1, a protein involved in DNA repair. The major struc-
tural motif in the N-terminal half is a tandem array of BRCT repeats, which
are highly conserved in proteins involved in DNA repair and cell-cycle
checkpoint responses (Fields & Justilien, 2010). This BRCT motif can bind
phosphorylated peptides (Manke, Lowery,Nguyen,&Yaffe, 2003), and it has
been suggested that it can also bind to theC-terminal half of ECT2, leading to
autoinhibition (discussed further below). The C-terminal half is the catalytic
core of the protein and contains a tandem array of Dbl-homology (DH) and
pleckstrin-homology (PH) domains (Tatsumoto et al., 1999). The extreme
C-terminus region of ECT2 does not exhibit significant homology to any
known protein domains or motifs (Fields & Justilien, 2010). The N- and
C-terminal domains of ECT2 are separated by a small central S domain,
which harbors two nuclear localization sequences that regulate the intracel-
lular localization of ECT2 (Fields & Justilien, 2010).
ECT2 is best understood for its role in cytokinesis (Glotzer, 2005; Piekny
et al., 2005; Wolfe & Glotzer, 2009; Wolfe, Takaki, Petronczki, & Glotzer,
2009; Yuce, Piekny, & Glotzer, 2005). RhoA plays the role of chief mod-
ulator in cytokinesis by initiating the formation of the contractile ring
(Werner & Glotzer, 2008). This involves the Rho-mediated activation of
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the actin assembly factor, formin, and phosphorylation of the RLC of myo-
sin II. ECT2 acts as a primary GEF for Rho during cytokinesis. It ensures the
correct localization and activation of Rho during cell division and is a crucial
regulator for cytokinesis in all the metazoans analyzed to date (Werner &
Glotzer, 2008; Yuce et al., 2005).
The profound contribution of ECT2 to cytokinesis has tended to obscure
any potential extramitotic function that it may have. This, taken with its pre-
dominant localization in the nucleus of isolated interphase cells (the common
system to study cytokinesis), has led to the notion that ECT2may principally
serve to regulate cytokinesis. Nonetheless, extramitotic functions for ECT2
are beginning to emerge. Pebbles, theDrosophila homolog of ECT2, contrib-
ute to mesoderm migration in the fly embryo (Schumacher, Gryzik,
Tannebaum, & Muller, 2004; Smallhorn, Murray, & Saint, 2004), while
ECT2 has been identified at the apical junctions of cultured mammalian epi-
thelia when they are grown as monolayers (Liu, Ishida, Raziuddin, & Miki,
2004; Ratheesh et al., 2012). In the latter situation, ECT2 can interact with
the Par6 apical polarity complex to influence apical–basal polarity (Liu,
Ohno, & Miki, 2006). Additionally, it contributes to stimulating Rho sig-
naling at the ZA. Depletion of ECT2 reduced GTP-Rho signaling at apical
cadherin junctions. This was accompanied by loss of myosin II and a decrease
in contractile tension at the junctions (Ratheesh et al., 2012). Thus, ECT2
represents one GEF that can support Rho signaling at cell–cell junctions.
4.5. p190 RhoGAP
The p190RhoGAP family comprises twomembers: p190A and p190B,which
are widely expressed in human, rat, fly, and mouse (Chakravarty et al., 2000;
Settleman, Narasimhan, Foster, & Weinberg, 1992). These proteins are
encoded by separate genes and share 50% sequence homology (Ponik,
Trier, Wozniak, Eliceiri, & Keely, 2013). Both contain three major structural
features: an N-terminal GTP-binding domain (GBD), a large-middle domain
responsible for various protein–protein interactions, and a C-terminal GAP
domain (Tcherkezian & Lamarche-Vane, 2007; Fig. 3A). They show GAP
activity toward RhoA, Rac 1, and Cdc42, with highest activity for RhoA
(Settleman et al., 1992).Of note for this discussion, both p190RhoGAPs have
been identified at cadherin-based cell–cell junctions. p190A RhoGAP was
found at N-cadherin-mediated cell–cell junctions, where its recruitment
involved an association p120-ctn (Wildenberg et al., 2006). p190B RhoGAP
can also be found at epithelial cell–cell junctions (Ratheesh et al., 2012).
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Its junctional localization is especially interesting, as p190B has been
implicated in regulating epithelial architecture both during morphogenesis
and in disease. p190B is highly expressed in the terminal end buds of the
mouse mammary gland and its deletion impairs ductal morphogenesis
(Chakravarty, Hadsell, Buitrago, Settleman, & Rosen, 2003). On the other
hand, overexpression of p190B caused complete disruption of mammary
epithelial architecture (Vargo-Gogola, Heckman, Gunther, Chodosh, &
Rosen, 2006). The precise expression of p190B activity thus seems to
be critical for its impact on tissue organization. p190B is also overexpressed
in mammary carcinomas, and its expression can influence mammary tumor
progression in mouse models. Overexpression of p190B accelerated tumor
development in an MMTV-Neu model system, while haploinsufficency
for p190B retarded tumor development in this system (Heckman-
Stoddard et al., 2009). Thus, p190B was necessary for epithelial morpho-
genesis but its overactivity might contribute to tumorigenesis. Given the
close relationship between E-cadherin function and dysfunction during
epithelial morphogenesis and tumorigenesis, respectively, this raises the
interesting possibility that p190 might influence Rho signaling at
junctions.
Indeed, both p190A and p190B have been implicated in regulating
Rho signaling at junctions. Early studies demonstrated that acute engage-
ment of Xenopus C-cadherin induced a transient decrease in Rho signaling
through p190, although the precise paralog responsible was not identified
(Noren, Arthur, & Burridge, 2003; Noren, Liu, Burridge, & Kreft,
2000). Subsequently, Wildenberg et al. (2006) reported that p190A
RhoGAP could be recruited to N-cadherin-based adhesions through an
association with p120-ctn, leading to local inactivation of the Rho-ROCK
pathway. In epithelial cells, recruitment of p190B to apical cadherin
junctions also contributes to inactivating Rho (Ratheesh et al., 2012).
Therefore, both p190A and p190B RhoGAP may serve to inactivate
Rho at cadherin junctions, perhaps with different contributions in different
cellular contexts.
4.6. Coordinating GEF and GAP activity
Formally, it might be predicted that the generation of a Rho signaling
zone would necessitate coordinated regulation of both GEF and GAP
activities. Recruitment and/or activation of a GEF(s) would stimulate
Rho signaling, while GAP activity would need to be simultaneously
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antagonized to prevent the premature inactivation of Rho. This paradigm
has already been developed for the Rho zone of the cytokinetic furrow
(Mikawa, Su, & Parsons, 2008). Interestingly, a common mechanism—
the centralspindlin complex—is also implicated in supporting the Rho zone
at ZA (Fig. 3B).
Centralspindlin is an evolutionarily conserved protein complex, which
was first identified at the central spindle of the mitotic apparatus. It is a
tetrameric complex comprising a dimer of MKLP-1/ZEN-4, a member
of the kinesin family of microtubule-binding proteins, and a dimer of
hCYK-4/MgcRacGAP (Mishima, Kaitna, & Glotzer, 2002). It concen-
trates at the contractile furrow during cytokinesis, a process that reflects
multiple molecular mechanisms (Glotzer, 2005; Somers & Saint, 2003).
These include association with the microtubules of the central spindle, likely
mediated by MKLP-1/ZEN-4, and binding of hCYK-4/MgcRacGAP to
phosphoinositides at the inner leaflet of the plasma membrane (Glotzer,
2009). The junctional localization of centralspindlin at the ZA also requires
dynamic microtubules and binding of centralspindlin to the N-terminus of
α-catenin (Ratheesh et al., 2012). Importantly, depletion of centralspindlin
reduced Rho signaling at the ZA and decreased junctional contractility
(Ratheesh et al., 2012). Similar effects occurred when the mechanisms
responsible for recruiting centralspindlin to junctions were perturbed. Thus,
centralspindlin controls Rho signaling to support contractility at interphase
cadherin junctions as it does to support the contractile furrow during cyto-
kinesis. At the ZA, as well as in cytokinesis, localization of centralspindlin
appears to be regulated through coincidence detection (Carlton &
Cullen, 2005), where multiple mechanisms must coincide to ensure that
centralspindlin is localized to the correct place with the cell with both spatial
and temporal fidelity.
Once it is correctly localized to the cortex, centralspindlin can regulate
Rho through ECT2. CYK-4/MgcRacGAP can bind directly to the
N-terminal BRCT domain of ECT2, an interaction, which is responsible
for recruiting ECT2 to the central spindle during cytokinesis (Yuce et al.,
2005). In the absence of centralspindlin, ECT2 does not localize either to
the central spindle during cell division or to the ZA of interphase epithelial
monolayers (Ratheesh et al., 2012; Yuce et al., 2005). In cell division, this
association is regulated by protein phosphorylation, as Polo-like kinase 1
(PLK1) phosphorylates CYK-4 to generate a phophoepitope that is recog-
nized by the BRCT domain of ECT2 (Wolfe et al., 2009). This interaction
may also serve to activate ECT2, by relieving its autoinhibitory
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conformation. The C-terminus of ECT2 may also contribute to its cortical
localization during cytokinesis (Su, Takaki, & Petronczki, 2011), but this
also appears to be downstream of the influence of centralspindlin and protein
phosphorylation by CDK1. Therefore, centralspindlin may lie at the top of a
signaling pathway that activates Rho through ECT2 to support junctional
contractility. However, what protein kinases may regulate centralspindlin
and ECT2 at junctions remain to be identified.
In addition to promoting Rho activation at the ZA, centralspindlin can
also antagonize the junctional accumulation of p190B RhoGAP, which
increased when either MLKP1 or hCYK-4/MgcRacGAP was depleted.
This accumulation of p190B contributed to the fall in junctional Rho sig-
naling when centralspindlin was perturbed, as the change in Rho could be
ameliorated by simultaneous depletion of p190B. Therefore, centralspindlin
can support junctional Rho signaling by both recruiting a GEF and antag-
onizing an inactivator (Ratheesh et al., 2012).
How, then, does centralspindlin antagonize junctional p190B? One
possibility is that centralspindlin blocks the mechanism responsible for
recruiting p190B to junctions. One such recruitment mechanism is signaling
by another Rho family GTPase, Rac, which can bind directly to p190B and
promote its cortical localization (Bustos, Forget, Settleman, &Hansen, 2008;
Wildenberg et al., 2006). Indeed, depletion of centralspindlin increased Rac
signaling at junctions and inhibition of Rac blocked the junctional accumu-
lation of p190B. Presumably, then, centralspindlin limits the junctional accu-
mulation of p190B by dampeningRac signaling. Exactly how centralspindlin
may inhibit junctional Rac signaling is not understood; however, CYK-4
itself is a candidate, as it possesses Rac GAP activity ( Jantsch-Plunger et al.,
2000). Interestingly, Rac signaling also promoted the recruitment of
p190A RhoGAP to N-cadherin junctions (Wildenberg et al., 2006). How-
ever, this did not appear to involve direct binding of GTP-Rac to p190A.
Instead, Rac-induced generation of reactive oxygen species promoted tyro-
sine phosphorylation of p190A and its associated protein, p120-RhoGAP, by
inhibiting a protein tyrosine phosphatase (Noren et al., 2003). Whether
centralspindlin may also participate in regulating the junctional recruitment
of p190A RhoGAP has yet to be investigated.
4.7. Other mechanisms
While current experience with ECT2 and p190B illustrates the capacity for
coordination of GEFS andGAPs, it is likely that other combinations of GEFs
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and GAPs contribute to regulating junctional Rho signaling in other cir-
cumstances. Nor is control of the Rho GTPase cycle the only way in which
its spatial expression can be influenced. Potentially, other Rho-binding pro-
teins may contribute by limiting the diffusion of GTP-Rho and/or promot-
ing its localization with GEFs and effectors. An interesting example is
provided by anillin, a scaffolding protein that is found at the cytokinetic fur-
row and was also recently identified at cell–cell junctions (Piekny &Glotzer,
2008; Reyes et al., 2014). Anillin can bind directly to several proteins that
regulate contractility, including Rho itself, ECT2, and myosin II (Piekny &
Maddox, 2010). Depletion of anillin in Xenopus embryos perturbed the
integrity of cadherin-based cell–cell junctions, associated with unstable
bursts of GTP-Rho signaling at those junctions (Reyes et al., 2014).
Whether that aberrant Rho signaling was responsible for the loss of junc-
tional integrity remains to be determined.
4.8. Localizing ROCK to junctions
Spatial regulation of signaling is not confined to the upstream elements of the
Rho signaling pathway. Instead, it is increasingly evident that it can extend
to mediators of Rho signaling, including the ROCK itself. Consistent with
the notion that coincidence detection can define the spatial rigor of Rho
expression (Carlton & Cullen, 2005) ROCK localization is also determined
by multiple mechanisms.
ROCK was among the first Rho effectors to have been identified. Two
ROCK isoforms (ROCK-1 and ROCK-2) are found in mammalian cells
(Amano, Nakayama, & Kaibuchi, 2010; Julian & Olson, 2014; Riento &
Ridley, 2003). These share a broadly similar primary structure consisting
of an N-terminal kinase domain, a central coiled-coil domain, and a
C-terminal region which bears both the GTP-Rho-binding domain
(RBD), and a lipid-binding PH domain (Fig. 4B). The kinase domain of both
isoforms is highly conserved at the amino-acid level (92% identity),while over-
all they share 62% identity. GTP-bound Rho activates ROCK by altering its
intramolecular conformation. In the absenceofGTP-Rho,ROCKexists in an
autoinhibited state where an intramolecular association between the
C-terminal region and theN-terminal kinase domain inhibitsROCKactivity.
Binding of GTP-Rho to theRBD then releases this autoinhibitory conforma-
tion, thus activating the kinase (Fig. 4B; Amano et al., 2010;Riento &Ridley,
2003). As noted earlier, ROCK plays a canonical role in mediating the
regulation of myosin II by Rho, including that at cadherin junctions.
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Since the kinase domain is highly conserved between these two isoforms,
it has often been assumed that they phosphorylate a similar range of sub-
strates. However, it is increasingly apparent that they differ in their expres-
sion and protein–protein interactions, suggesting that they may have
different biological functions (Amano et al., 2010; Sandquist & Means,
2008; Sandquist, Swenson, Demali, Burridge, & Means, 2006;
Schofield & Bernard, 2013). Interestingly, these differences extend to their
subcellular localization. ROCK-2 has been reported to localize in the cyto-
plasm, globally at the plasma membrane and also at the cleavage furrow dur-
ing cytokinesis (Schofield & Bernard, 2013). In contrast, recent studies have
reported the selective concentration of ROCK-1 at the apical junctions of
epithelial cells (Smith et al., 2012). This suggests that mechanisms exist to
selectively colocalize GTP-Rho with this key effector at cadherin junctions,
thereby establishing a Rho-ROCK-signaling module at the junctions.
ROCK bears multiple binding domains that can influence its cortical
localization. The PH domain appears to be necessary for its association with
the membrane, but was not sufficient to confer concentration at cadherin
junctions (Schofield & Bernard, 2013). Other coincident factors therefore
appear to collaborate to concentrate ROCK at junctions. One of these is
likely to be GTP-Rho itself, as deletion of the RBD generated a mutant
ROCK that could associate with the membrane but was unable to concen-
trate at cadherin junctions (Simoes Sde, Mainieri, & Zallen, 2014).
There is also emerging evidence that junctional proteins themselves can
contribute to localizing ROCK-1. One interesting role is played by the
adaptor protein Shroom, which was first identified in a screen for mouse
mutants that disrupted neural tube closure (Hildebrand & Soriano, 1999).
Subsequent characterization identified a single Shroom gene in Drosophila
and four Shroom isoforms (Shroom 1–4) in mammalian cells. Despite their
number, many of these mammalian Shroom genes participate in regulating
processes that involve contractility at junctions, including apical constriction
in embryonic epithelia and junctional contractility in endothelia (Bolinger,
Zasadil, Rizaldy, & Hildebrand, 2010; Hildebrand, 2005; Simoes Sde et al.,
2014). Shroom is an actin-binding protein (Hildebrand & Soriano, 1999)
that localizes to cell–cell junctions, including cadherin junctions through
an association with the cadherin-associated protein, p120-catenin (p120-
ctn) (Lang, Herman, Reynolds, Hildebrand, & Plageman, 2014). Its contri-
bution to junctional contractility may reflect in part its ability to recruit both
F-actin and myosin II to junctions (Hildebrand, 2005). However, an inde-
pendent contribution to contractility comes from its additional ability to
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interact directly with ROCK. The junctional accumulation of ROCK
could be promoted or reduced by the expression or depletion of Shroom,
respectively (Nishimura & Takeichi, 2008). Further, dominant-negative
mutants of Shroom that disrupt the interaction between ROCK and endog-
enous Shroom perturb junctional tension and apical constriction
(Nishimura & Takeichi, 2008).
Shroom may then collaborate with Rho in recruiting ROCK to junc-
tions, an influence that appears to be closely tied to cell polarity (Simoes Sde
et al., 2014). Not only does Shroom contribute to localizing ROCK at the
ZA in epithelial cells that have undergone apical–basal polarization, but also
it participates in regulating junctional signaling during planar polarization.
This is demonstrated when Drosophila embryos undergo cellular
rearrangements during axis elongation. At this stage, ROCK is not only
accumulated at apical adherens junctions but also distributed in a planar
polarized pattern to promote the remodeling of cell–cell junctions. Rho
is necessary for this process, because of its ability to recruit ROCK to junc-
tions, but Shroom also contributes by conferring planar polarized distribu-
tion on junctional ROCK (Simoes Sde et al., 2014).
Thus, the coordinated spatial localization of ROCK and Rho is a char-
acteristic feature that contributes to contractility at cadherin junctions. It is
likely that we have only begun to unravel the ways in which this coordi-
nation is established and how it affects contractility. For example, it remains
to be determined whether the ability of p120-ctn to bind ROCK (Smith
et al., 2012) is solely mediated by Shroom, or whether other interactions
also participate. Furthermore, ROCK can also potentially feedback to influ-
ence Rho signaling by regulating p190 RhoGAPs. Both p190A and p190B
are recruited to the plasma membrane by association with members of a
family of atypical GTPases, Rnd1 and Rnd3, respectively (Oinuma,
Kawada, Tsukagoshi, & Negishi, 2012; Wennerberg et al., 2003). These
recruitment mechanisms are disrupted by ROCK, albeit by different
molecular mechanisms (Riento et al., 2005). ROCK can phosphorylate
p190A directly, thereby disrupting its interaction with Rnd1 (Mori et al.,
2009). In contrast, ROCK does not appear to directly target p190B but,
instead, phosphorylates Rnd3 to sequester it in the cytosol, preventing it
from associating with the plasma membrane (Riento et al., 2005; Riou
et al., 2013). By either pathway, ROCK antagonizes the membrane accu-
mulation of p190, thereby potentially sustaining Rho signaling. However,
whether these affect Rho signaling at cadherin junctions remains to be
explored.
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5. CLOSING COMMENTS
In conclusion, cell–cell junctions can be considered as active mechan-
ical agents, where many molecular pathways are coordinated to ultimately
integrate adhesion with the actomyosin contractile apparatus. The product,
contractile tension at junctions, may then be regarded as the emergent prop-
erty of an extremely complex system. An interesting challenge for the future
will be to develop approaches to make sense of this complexity: defining the
key architecture(s) of the system and parsing the rules that regulate it. One
issue will be to understand whether (and if so, how) levels of tension may be
regulated. It might be supposed, for example, that established tissues at
homeostasis would display relatively stable levels of tension, compared with
morphogenetically active tissues that are undergoing neighbor exchange or
apical constriction. We will need to develop approaches to quantitatively
characterize contractile tension in these different contexts as the basis for
understanding their regulation. Finally, although we have focused on the
basic cell biology of junctional contractility, what we learn is likely to have
implications for understanding disease as well as development. It is interest-
ing to note that a regulator of junctional Rho, such as p190B, is implicated in
cancer. Whether this impact occurs through dysregulation of junctional
contractility is an interesting, open question. Our growing understanding
of the complex mechanisms that make junctions active mechanical agents
then holds the promise of informing our understanding of cell biology in
disease.
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